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Designing Synthetic Environments to Control
Valvular Interstitial Cells In Vitro
By: Kent E Coombs

Abstract

Aortic valve disease (AVD) is a large contributor to health costs in the
United States affecting 2.8% of the population greater than 75 years old. With a
growing elderly population due to medical advances, AVD will continue to rise in
prevalence over time. Current treatments for AVD are insufficient due to a lack of
preventative therapies and the bioprosthetic valves used for surgical replacement
have major limitations. Tissue engineered heart valves (TEHVs) present an ideal
solution to current AVD needs because of their biocompatibility, capability to
integrate with the host’s tissue, and ability to utilize the natural repair
mechanisms of the body. To achieve this goal, we designed synthetic
environments with specific cell phenotypes and scaffold properties in order to
direct cellular behavior and tissue growth in vitro. In this work cell
subpopulations, mechanical stiffness of the substrate, and material surface
charge were all studied to understand how the primary cells of the aortic valve,
valvular interstitial cells (VICs), were affected by specific environmental cues.
These studies were then translated from monolayer culture into a threedimensional hydrogel system for the study of VICs in a more physically relevant
cell culture system.
v

Table of Contents
Contents
Chapter 1 .............................................................................................................. 1
Introduction ........................................................................................................... 1
Cardiovascular Disease and the Heart Structure .............................................. 1
Aortic Valve Disease (AVD) .............................................................................. 3
Treatment of AVD ............................................................................................. 5
Cells of the Aortic Valve .................................................................................... 7
Biological Tissue Engineered Heart Valves .................................................... 12
Synthetic Tissue Engineered Heart Valves ..................................................... 14
Microenvironmental Cues ............................................................................... 21
Figures ............................................................................................................ 25
References...................................................................................................... 30
Chapter 2 ............................................................................................................ 38
Specific Aims ...................................................................................................... 38
Overall Objective ............................................................................................. 38
Chapter 3 ............................................................................................................ 40
Isolation and Characterization of Valvular Interstitial Cell Subpopulations ......... 40
Abstract ........................................................................................................... 41
Background ..................................................................................................... 43
vi

Material and Methods ..................................................................................... 46
Cell Culture............................................................................................................................. 46
Differential Detachment Protocol and Kinetic Study............................................................. 47
Growth Curve ......................................................................................................................... 48
Gene Expression..................................................................................................................... 49
Integrin Expression ................................................................................................................ 49
Statistics ................................................................................................................................. 50

Results ............................................................................................................ 50
VIC Subpopulation Isolation and Growth .............................................................................. 50
VIC Phenotype........................................................................................................................ 51
Subpopulation Surface Markers ............................................................................................ 51

Discussion....................................................................................................... 52
Figures and Tables ......................................................................................... 57
References...................................................................................................... 64
Chapter 4 ............................................................................................................ 70
Isolated Effect of Stiffness on Valvular Interstitial Cell Differentiation ................. 70
Abstract ........................................................................................................... 71
Introduction ..................................................................................................... 72
Materials and Methods .................................................................................... 75
Substrate Fabrication ............................................................................................................. 75
Compressive Modulus............................................................................................................ 75
Contact Angle Goniometry .................................................................................................... 76
X-Ray Photoelectron Spectroscopy (XPS) .............................................................................. 76
Valvular Interstitial Cell Isolation and Culture ....................................................................... 77
Apoptosis ............................................................................................................................... 77
Growth Curve ......................................................................................................................... 78

vii

Quantitative Polymerase Chain Reaction .............................................................................. 78
Optical Microscopy and Immunocytochemical Staining (ICC) ............................................... 79
Statistics ................................................................................................................................. 79

Results ............................................................................................................ 80
Substrate Fabrication ............................................................................................................. 80
Compressive Modulus............................................................................................................ 80
Sessile Drop Goniometry ....................................................................................................... 80
X-Ray Photoelectron Spectroscopy (XPS) .............................................................................. 81
VIC Attachment, Growth, Cytocompatibility ......................................................................... 82
Gene Expression and Immunocytochemical Staining (ICC) of VICs ....................................... 82
Late Stage VIC morphology and Nodule Formation .............................................................. 83

Discussion....................................................................................................... 84
Acknowledgements ......................................................................................... 90
References...................................................................................................... 91
Figures and Tables ......................................................................................... 98
Chapter 5 .......................................................................................................... 106
Surface Chemistry Regulates Valvular Interstitial Cell Differentiation In Vitro .. 106
Abstract ......................................................................................................... 107
Introduction ................................................................................................... 109
Materials and Methods .................................................................................. 112
Reagents and Chemicals ...................................................................................................... 112
Fabrication of Self Assembled Monolayers ......................................................................... 112
Contact Angle Measurements ............................................................................................. 113
X-Ray Photoelectron Spectroscopy (XPS) ............................................................................ 113
Atomic Force Microscopy .................................................................................................... 114
Ellipsometry ......................................................................................................................... 114

viii

Primary Cell Extraction & Characterization ......................................................................... 114
Cell Growth & Viability ......................................................................................................... 116
Calcium Content................................................................................................................... 117
Gene Expression................................................................................................................... 117
Immunocytochemical (ICC) Staining .................................................................................... 118
Statistical Analysis ................................................................................................................ 119

Results .......................................................................................................... 119
Surface Characterization of Self-Assembled Monolayers.................................................... 119
Proliferation and Cellular Density of VICs ............................................................................ 120
Morphological Variation Between Surfaces ........................................................................ 121
Development of Calcified Nodules ...................................................................................... 121
Genetic Analysis of Phenotypic Markers ............................................................................. 123

Discussion..................................................................................................... 124
Alkanetiolate Self-Assembled Monolayers .......................................................................... 124
Media-Induced Osteoblastic VICs ........................................................................................ 125
Non-activated VIC Calcium Deposition on CH3-SAMs ......................................................... 125
Osteoblastic VIC Differentiation on NH3+-SAMs .................................................................. 126
Delayed Growth on OH-SAMs.............................................................................................. 128
Non-Osteoblastic Activation of VICs on COO--SAMs............................................................ 128
Cell-Material Phenotypic Signaling ...................................................................................... 129
Experimental Limitations ..................................................................................................... 130

Conclusions .................................................................................................. 131
Acknowledgments ......................................................................................... 132
Figures .......................................................................................................... 133
References.................................................................................................... 141
Chapter 6 .......................................................................................................... 152

ix

Nitrogen Sparge Synthesis and Characterization of Oligo(Poly(Ethylene Glycol)
Fumarate) Macromer ........................................................................................ 152
Abstract ......................................................................................................... 153
Introduction ................................................................................................... 155
Experimental Section/Materials and Methods ............................................... 156
Reagents and Chemicals ...................................................................................................... 156

Synthesis of Oligo(Poly(Ethylene Glycol) Fumarate) (OPF) ......................... 157
Polyethylene Glycol (PEG) Drying ........................................................................................ 157
OPF Oligomer Synthesis – Triethylamine (TEA-OPF) ........................................................... 157
OPF Oligomer Synthesis - Nitrogen Sparging (N2-OPF) ....................................................... 158

Characterization of OPF ............................................................................... 159
Degree of Oligomerization ................................................................................................... 159
Molecular Weight ................................................................................................................ 159
Fluorescent Byproduct ......................................................................................................... 160
Melting Temperature and Crystallinity ................................................................................ 160
Yield...................................................................................................................................... 161

Characterization of Crosslinked OPF Hydrogels ........................................... 161
Crosslinking of OPF .............................................................................................................. 161
Water Ingress and Removal of Uncrosslinked Material ...................................................... 162
Hydrogel Elasticity................................................................................................................ 163

Results and Discussion ................................................................................. 163
Synthesis and Characterization of OPF ................................................................................ 163
Characterization of Crosslinked Hydrogel Properties .......................................................... 166

Conclusions .................................................................................................. 168
Supporting Information .................................................................................. 169
x

Appendix/Nomenclature/Abbreviations ......................................................... 169
Acknowledgements: ......................................................................................... 169
Figures and Tables ....................................................................................... 171
References.................................................................................................... 179
Chapter 7 .......................................................................................................... 186
Modification of OPF for 3D Hydrogel Environments ......................................... 186
Abstract ......................................................................................................... 187
Introduction ................................................................................................... 188
Material and Methods ................................................................................... 192
Synthesis of Oligo(Poly(Ethylene Glycol) Fumarate) (OPF).................................................. 192
GPC of OPF ........................................................................................................................... 193
Dialysis and Functionalization of OPF .................................................................................. 193
Nuclear Magnetic Resonance (NMR) of OPF ....................................................................... 194
Crosslinking of Functionalized OPF Hydrogels ..................................................................... 194
Primary Cell Extraction and Culture ..................................................................................... 195
Encapsulation of Cells .......................................................................................................... 195
Live/Dead assay ................................................................................................................... 196

Results .......................................................................................................... 196
Characterization and Functionalization of OPF ................................................................... 196
Viability of Encapsulated VICs .............................................................................................. 197

Discussion..................................................................................................... 198
Conclusion .................................................................................................... 201
Figures and Tables ....................................................................................... 204
References.................................................................................................... 208
xi

Chapter 8 .......................................................................................................... 212
Conclusion ........................................................................................................ 212
Summary....................................................................................................... 212
Specific Aim 1 ....................................................................................................................... 212
Specific Aim 2 ....................................................................................................................... 215
Specific Aim 3 ....................................................................................................................... 220

Broader Impacts............................................................................................ 224
References ........................................................................................................................... 227

xii

Chapter 1
Introduction

Cardiovascular Disease and the Heart Structure
Cardiovascular disease (CVD) is the number one killer in industrialized
countries, responsible for 1 of every 3 deaths in the United States [1].
Disproportionately affecting individuals greater than 65 years of age, CVD
presents a significant burden on the healthcare system. A common type of CVD
is heart valve disease, which can cause heart failure due to increased overall
burden on the heart. Of the patients with severe aortic valve stenosis, fifty
percent are referred for cardiothoracic surgery which typically costs between
$80,000 - $200,000 dollars [1].
During normal function, the heart is responsible for unidirectional flow of blood
throughout the cardiovascular system. It is composed of four main chambers and
four valves. Deoxygenated blood enters the right atrium from the veins before
being forced, by contraction of the right atrium, through the tricuspid valve into
the right ventricle. The expansion of the right ventricle causes blood to fill the
cavity and force the tricuspid valve closed. Next, the right ventricle contracts to
push deoxygenated blood through the pulmonary valve and pulmonary artery to
the lungs. Oxygenated blood returns from the lungs through the pulmonary veins
into the left atrium before passing through the mitral/bicuspid valve into the left
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ventricle. Contraction of the left ventricle ejects blood through the aortic valve
and out into the body.
All four valves have one of two general structures, semilunar and
atrioventricular. The atrioventricular valves (pulmonary and mitral) have chordae
tendineae extending from the valve leaflets to the corresponding atria wall, which
force these valves to open and close with the expansion and contraction of the
corresponding ventricles. The semilunar valves on the other hand have a
tricuspid structure and are opened and closed purely by the changing pressure
gradients created by pumping heart chambers. As the ventricle contracts, the
atrioventricular valve closes, and the pressure increases to force open the
semilunar valve. As the ventricle relaxes the pressure decreases and is
overcome by the pressure on the arterial side of the valve causing the
atrioventricular valves to open.
The aortic valve (AV) is the most commonly diseased valve of the heart [2].
This due to the higher-pressure gradients the AV must endure in normal day to
day functions [3]. The AV is a tricuspid valve with three leaflets that are less than
1 mm thick [4, 5]. Despite the thinness of the valve, there are three identifiable
layers with specific functions and microstructures; the ventricularis, spongiosa,
and fibrosa [4, 6-9]. The fibrosa lies on the atrial side of the aortic valve and is
composed of organized collagen 1 bundles (Figure 1). Lining the leaflets
circumferentially, these collagen bundles provide physical durability against the
compressive forces exerted on the valve in the closed position [10]. However, the
2

collagen fibers crimp as the AV opens to allow the leaflet to bend easily. The
spongiosa layer is comprised of mainly sulfated glycoaminoglycans (GAGs) like
chondroitin sulfate, dermatan sulfate, hyaluronan, as well as other proteoglycans
[2]. This layer acts as a lubricating layer between the fibrosa and the
ventricularis. The ventricularis lies on the ventricle side of the AV and is
composed of elastin bundles. Aligned radially, these elastin fibers help the AV
stretch and retract properly with the cycling heart [2, 4, 11]. The specific
extracellular matrix (ECM) proteins and specialized structure of the aortic valve
are designed to deal with the dynamic environment in the heart. However, due to
the high-pressure gradients, flow profiles, and varying mechanical stresses, the
AV is the most common valve to become diseased. As a result, it is the most the
frequently studied valve and is targeted for developing tissue engineered AV
replacements.

Aortic Valve Disease (AVD)
Age and factors such as family history, diet, and weight increase the risk
of developing AVD. AVD impairs the proper opening and closing of the valve due
to increased thickness and decreased flexibility (Figure 2) [12]. Thickening and
stiffening of the AV disrupts the ability of the leaflet edges to coapt, allowing
blood to leak back through the valve from the arterial side into the ventricle, a
process known as regurgitation. Simultaneously the decreases in the ability for
the valve to open and close, known as stenosis, disrupts the efficient movement
3

of blood out of the heart creating eddies and reducing pressures [11]. This is
particularly important because the coronary arteries which feed the heart
oxygenated blood are on the arterial side of the AV. Improper blood flow and
pressure gradients caused by AVD disrupt the distribution of blood to the heart
muscles through the coronary arteries to induce further stress. These conditions
force the heart to work harder to pump blood out to the rest of the body with an
inferior blood supply. This increases the burden on the heart, and without
treatment will eventually result in heart failure.
Despite its prevalence, the exact mechanism of development for AVD
remains unclear. This is in part due to the difficulty in diagnosing AVD at early
stages, as well as a lack of laboratory models to study pathological AVD
progression in relevant controlled systems. The most commonly accepted theory
of AVD development is long term wear and tear with altered mechanical loading
both acute and chronic due to hypertension, high blood pressure, or inflammation
increases stress on the valve [13, 14]. These stresses lead to inflammation and
breakdown of ECM. Valvular interstitial cells (VICs) activate to repair the damage
but persistent inflammation, repeated repairs, and in increases in collagen 4 over
time form scar tissue. Failure to properly replace tissue is accompanied by
increases in disorganized ECM resulting in thickening of the valve [14]. This
process of thickening known as fibrosis alters the valve microenvironment which
affects neighboring VIC and causes ECM changes to cascade out in the
surrounding valve leading to AVD [13].
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Without a better understanding of the mechanisms that cause AVD, better
markers to diagnose AVD in early stages of development, and better
preventative treatments, AVD prevalence will continue to rise and generate a
large burden on the healthcare system. If better in vitro models that closely mimic
the AV could be developed then these models could be studied to develop new
drug treatments and a better understanding of AVD at the cellular signaling level.
Furthermore, creating better valve replacements for diseased valves will
decrease the cost of AVD care and increase patients’ quality of life.

Treatment of AVD
Currently the gold standard of treatment for AVD is to completely replace the
diseased AV using either a biological or synthetic valve (Figure 3). Biological
valves are derived from xenograft tissue, normally porcine or bovine, and are
treated to mimic the structural and mechanical properties of the aortic valve. This
treatment includes cutting and molding the tissue into the correct shape before
undergoing decellularization and crosslinking. This process removes all the
donor animal’s cells and DNA from the tissue graft preventing host immune
response [15].
One of the major drawbacks of biological xenograft valves are that they
degrade over the timespan of 5-20 years dependent on the level of patient’s
physical activity [2, 16]. This happens because the crosslinking process destroys
the functional properties of the proteins that make up the implanted valve, so the
5

valve no longer supports proper cellular attachment, growth, or repair. These
biological valves are also prone to calcification and degradation over time.
Although 10-15 years is fine in older less active patients, this presents a problem
in active younger adults and in pediatric patients with longer lifespans. Many of
these younger patients will require additional surgeries as the biological valve
wears out and pediatric patients will need the valve replaced periodically as they
grow to match the valve size to the growing aorta.
Synthetic valves, which have different mechanical properties compared to
biological valves do not wear out and are generally made of metals or plastics
[16]. Their long lifetime makes them more suitable for younger patients who will
need a functional valve for a longer period of time. However, because they are
made of synthetic materials they have thrombogenic surfaces, which can cause
blood clotting and increase the risk of stroke [16]. To counteract clot formation,
patients must use anticoagulation therapies, decreasing quality of life due to
increased risk of bleeding, drug side effects, and the time and money required to
maintain lifelong therapy. Also, like biological replacement valves, synthetic heart
valves do not grow with the body so again pediatric patients would require
multiple replacement surgeries as they grow.
The final type of valve less commonly available are human allograft valves
harvested from cadavers, organ donors, or heart transplant recipients [17, 18].
This type of replacement has the best functional properties with excellent
hemodynamic function, low thrombogenicity, and resistance to infections, but still
6

commonly fail between 10-20 years after implantation [17-19]. In addition, since
their natural source is humans, the supply is severely limited.
Despite the effectiveness of current valve replacements to treat AVD they all
exhibit major limitations. When combined with the fact that current valve
replacements can’t grow or integrate into the host there is significant room for
improvement.
Tissue engineered heart valve (TEHV) replacements that could integrate into
the native tissue, utilize the body’s self-repair mechanisms to maintain
themselves, and grow would overcome all the issues mentioned above.
However, to develop these TEHVs a better understanding the aortic valve cell
biology during health and disease needs to be established.

Cells of the Aortic Valve
Within each leaflet of the AV there are two main cell types. The first cell type,
valvular endothelial cells (VECs), are found lining the outside surface and are
important in presenting a non-thrombogenic exterior to prevent blood clotting.
VECs help to maintain valve homeostasis through their ability to detect
mechanical stresses as well as through the secretion of signaling factors to
control VIC behavior [20-22]. An example of the importance of VEC maintenance
of homeostasis can be seen in bicuspid aortic valves (BAV). These valves are
inherited congenitally and have a two-leaflet structure instead of the tri-leaflets
normally seen in this area. The BAV structures creates an environment of
7

increased mechanical stress which makes them prone to endothelial dysfunction
and denudation. Loss of the endothelial layers result in the BAV leaflets quickly
becoming diseased and is therefore commonly replaced early in life. A study of
bicuspid aortic valves (BAV) correlates the increase in endothelial dysfunction
and inflammation to decreases in endothelial nitric oxide synthase (eNOS)
expression within the valve. Without eNOS expression in VECs the VICs of the
aortic valve became diseased [23]. This interaction is dictated through the
molecule nitric oxide (NO) which is produced by eNOS in VECs. Loss of this
critical homeostasis molecule allow VICs to enter a diseased state and modify
the valves causing AVD.
Confirmation of the role of NO was confirmed in vitro using VIC cultures
where NO donors or NOS inhibitors were added to inhibit or promote
differentiation of VICs to a diseased osteoblastic VIC (OB VIC) phenotype,
respectively. Using both single cultures of VICs and co-cultures of VIC/VECs,
addition of NO helped to prevent VIC activation and switching to an OB VIC
phenotype. Inhibition of NO did the opposite allowing VICs to remain
inappropriately activated, which is hypothesized to eventually lead to AVD in vivo
[21, 22, 24]. The notch 1 signaling pathway was identified as one mechanism by
which NO prevented aVIC calcification, but many other pathways still need to be
explored [25-27]. In summary the presence of VECs in vitro and in vivo can alter
the behavior of VICs and should be considered for tissue engineering
applications.
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The second more commonly studied cell type VICs are found dispersed
throughout the three layers of the AV. They are responsible for synthesizing new
tissue to repair the valve and play important roles in the fibrosis and calcification
of the valve during AVD. The wide-ranging roles of VICs are possibly due to
subpopulations in each layer of the AV, as well as the natural plasticity of VICs
which allows them to switch phenotypes in response to the environmental factors
around them.
The VIC phenotypes identified to date include quiescent VICs (qVICs),
activated or myofibroblastic VICs (aVICs), osteoblastic VICs (OB VICs), and
progenitor VICs (pVICs) (Figure 4). The main cell phenotype that dominates the
adult valve is quiescent VICs (qVICs). During normal valve activity qVICs
maintain valvular structure and stability with low ECM turnover and little to no
proliferation. qVICs respond to inflammatory factors and cytokines released by
damaged valve tissue and switch to an activated VIC (aVIC) phenotype. aVICs
repair the heart valve when it becomes damaged or diseased and then undergo
apoptosis or switch back to a qVIC phenotype when the tissue is repaired and
inflammation decreases. aVICs are also the most commonly seen phenotype in
the laboratory proliferating rapidly, laying down extracellular matrix, migrating,
and expressing alpha smooth muscle actin. If aVICs remain inappropriately in
vivo, remodeling and disorganization of the heart valve ECM leads to valve
thickening and stiffening referred to as fibrosis [14]. Disorganization of the heart
valve ECM due to fibrosis is hypothesized to lead aVICs to differentiate to
osteoblastic VICs (OB VICs) expressing osteoblastic markers like osteocalcin,
9

runX2, CBFa, and osteopontin. OB VICs exacerbate valvular disease by
calcifying surrounding matrix and forming calcific nodules. The local stiffening of
tissue due to calcification and fibrosis is thought to promote nearby VICs to
switch to an OB phenotype to propagate disease throughout the valve.
In vitro, OB VICs form calcified nodules via two separate mechanisms. The
first mechanism, osteogenic calcification, is caused by the differentiation of VICs
in osteoblastic induction media. When exposed to certain factors like TGF-β1,
dexamethasone, and ascorbic acid, aVIC in culture switch to an OB VIC
phenotype, clump up, and surround themselves in a calcific matrix. This process
is similar to that of ectopic bone formation with a calcified matrix surrounding
living cells and is seen in later stages of AVD. The second mechanism,
dystrophic calcification is also seen during valve disease and occurs when VICs
contract into a large clump of cells to form an amorphous calcium crystal with an
apoptotic core [28]. This type of nodule is commonly seen in vitro when VICs
grow to super confluence with edges of cells pulling back from the substrate to
form large aggregates. Once detached, the VICs in the center begin to apoptosis
and form a calcified nodule. Both osteogenic and dystrophic nodules are seen
during disease development in vivo but these mechanisms are not usually
differentiated in in vitro cultures. Therefore, designing better model systems to
help identify signaling molecules unique to each process is very important for
future research for growth of healthy TEHVs.
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pVICs are one of the less studied phenotypes. They are assumed to be stem
cell derived VICs that either circulate in the blood before entering the valve or
reside in small amounts within the AV. Their role is thought to be in valve repair
where they support repair through unknown processes [29]. Until these cells can
be definitively isolated using defined progenitor markers their exact role in AVD
and valve repair will remain unclear.
An interesting aspect of VICs that remains less explored is that they are a
heterogeneous population of cells. These cells reside throughout the three
distinct layers of the aortic valves with very different ECM environments,
therefore it is likely these cells have different functions within each valve layer.
Yet most studies isolate the entire populations of VICs from the valve to use for
experimentation without further separation. Recent work has shown that from
the entire population of VICs a very small subpopulation of progenitor cells can
be isolated by flow cytometry using the progenitor marker ABCG2+ or a colony
formation assay [30, 31]. In both cases VICs characterized as progenitor cells
were more sensitive to osteoblastic (OB) differentiation when exposed to
osteogenic induction media than unseparated VICs. Separation of VICs in these
studies either yielded a very small amount of cells or required isolation of single
cells to grow into colonies for characterization, so developing a robust and
efficient method to separate distinct subpopulations from the valve needs to be
developed. In addition, it has been shown that fibrotic and calcific lesions first
appear on the fibrosa layer while disease of the spongiosa side of the leaflet is
seen later. This suggests that within the valve there may be specific VIC
11

subpopulations in each leaflet that might be disease resistant or disease prone.
Separating these subpopulations is a huge challenge as there are no surface
markers currently identified in VIC literature for the different VIC phenotypes and
our current isolation method collects all VICs from the valve and combines them
for culture. If 1) VICs could be separated into subpopulations with distinct
differences in phenotype and 2) unique surface markers could be identified for
each subpopulation, then VICs could be more easily sorted into subpopulations
immediately after extraction and used more appropriately in TEHV endeavors.
With most research currently using the entire VIC population extracted from
valves, small differences between different VICs subpopulations is largely
ignored. If healthy TEHVs are going to be made, cell subpopulations need to be
fully understood to avoid unintended side effects. The problem of unique surface
markers is addressed in chapter two, which looks at separating different VIC
subpopulations based on adhesion characteristics and then characterizing the
subpopulations for phenotypic differences and unique surface markers.

Biological Tissue Engineered Heart Valves
Due to the complications of allogenic, biological, and synthetic valves, tissue
engineers are developing TEHV as better replacements. Ideally, TEHVs should
be composed of biologically compatible tissue and material which would have the
ability to integrate into the host and become tissue in the body. Properly
designed TEHVs could provide an ideal solution to current valve limitations of
12

thrombogenicity, poor hemodynamic profiles, and lack of longevity. Additionally,
TEHVs that truly integrate into the host would revolutionize pediatric care by
eliminating the need for additional surgeries. While no TEHV currently exists in
the medical market there are several strategies currently being used for their
development.
One common approach is to design biological TEHVs with or without cells
that have the mechanical stability to act as a replacement valve immediately after
surgery. However, these TEHV also exploit the body’s natural regenerative
capacity to induce cellular repair and tissue formation [32]. In this system, the
TEHV could be made of natural and/or synthetic biomaterials with or without
seeded cells. After implantation, these TEHVs would immediately act as a
functioning valve, but over time would promote cellular infiltration, migration, and
growth onto the scaffold to induce tissue formation. The scaffold would then
either reside permanently in the tissue creating a hybrid cell/biomaterial valve or
slowly degrade away as it is replaced by naturally created tissue. To be
successful, the slow maturation of this type of valve inside the body would need
to be fine-tuned and have carefully controlled cellular growth. Furthermore, the
mechanical properties of this material or material/cell hybrid would need to
remain stable at all stages of tissue formation so that the valve always works
properly.
One of the most successful examples using the strategy above is using a
natural biomaterial to create a tube within a tube heart valve (Figure 5). By
13

collapsing one of two decellularized ECM tubes inside the other, a tricuspid valve
structure is created [33, 34]. The ECM tubes are 16mm long and grown in vitro
on a circular scaffold in a bioreactor using a fibrin ECM coated with ovine
endothelial cells over two weeks. The resulting cell ECM tube is decellularized
and one tube is placed inside the other. The inner tube is attached to the outer
tube in a specific pattern using degradable sutures before being collapsed to
make a structure very similar to that of the pulmonary valve (Figure 5). These
tube-within-tube valves have been implanted into sheep and shown to function
up to 8 weeks, at which point the study was ended. Analysis of the valves shows
there is still room for improvement due to declining valve function caused by a
loss of tensile strength, as well as large differences in valve thickness at 4-6
weeks in vivo.

Synthetic Tissue Engineered Heart Valves
A second TEHVs development strategy is to grow mature, functional valve
tissue in the laboratory using synthetic materials. These synthetic materials could
be engineered to promote specific cellular behaviors to guide cell growth to
produce mature tissue in a bioreactor. As a fully functional tissue grown in the
lab, it would directly replace diseased tissue much like current replacement
valves. However after healing, the body’s natural repair mechanisms would
maintain the valve. The advantage of this type of TEHV would be that all the
biomaterials and non-biological factors could be removed or degraded before
14

implantation leaving only biological material. Also, because the tissue should
already be fully mature, this strategy does not rely on in vivo maturation and
tailoring of material degradation with tissue deposition.
Examples in the literature implementing this strategy in TEHV development
can been found in the biomaterials field of hydrogels. Hydrogels are made from
natural or synthetic polymers that produce very soft scaffolds and are currently
being investigated as platforms to create model AV systems and grow viable soft
tissue. The soft nature (2-12 kPa) of hydrogels and tunability of their physical and
chemical properties make them a useful platform to try to control cellular growth
and differentiation using bioactive molecules [35-38].
In the realm of synthetic hydrogels, modified polyethylene glycol (PEG) is the
most commonly used synthetic material. As a hydrophilic molecule that absorbs
water, PEG forms hydrogels that allow for efficient nutrient diffusion and waste
removal while providing a self-supporting three-dimensional structure. However,
the very hydrophilic backbone of unmodified PEG does not allow proteins to stick
to its surface preventing cellular attachment. This creates an environment where
PEG based hydrogels provide a unique non-fouling surface that can be modified
with bioactive molecules that cells interact with. Ideally, the proper bioactive
molecules incorporated into PEG-based hydrogel will not only induce cellular
attachment, but also promote advantageous cellular behaviors through the
activation of certain cellular signaling pathways.
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Bioactive molecules are commonly attached to PEG by attaching reactive
molecules like acylate or N-hydroxysuccinimide to PEG’s hydroxyl end groups.
These reactive end groups can in turn be used for a number of different
chemistries attaching various bioactive molecules. For example, a modified PEG
gel in VIC literature is PEG-PQ/PEG-RGDS hydrogel [35, 38, 39]. In this
hydrogel, the PQ peptide (GGGPQGYIWGQGK) is an MMP-2 degradable amino
acid sequence while peptide RGDS promotes VIC attachment to the hydrogel
[38, 39]. To encapsulate VICs, the modified PEGs are mixed together and then
crosslinked using light-initiated free radical polymerization. In these hydrogels,
VICs survived long term culture up to 42 days and mimicked the normal cellular
morphology of valve tissue with deposition of relevant ECM molecules; collagen,
elastin, and glycosaminoglycans.
While the results are very promising, the main disadvantage of system is that
once the cells are encapsulated in the hydrogel, the formation ECM was random
and unlike the controlled structures seen in vivo [22, 39]. A lack of knowledge
about what signaling pathways are activated, which biological peptide
combinations are ideal for controlling VIC behavior, and how the deposition of
ECM is guided during development means the structures currently being made
do not have the physical characteristics of native valve tissue. Also, in the PEGPQ/PEG-RGDS hydrogels, a peptide sequence originally found on fibronectin
known as the RGD motif was used to promote cellular attachment. Fibronectin
coated surfaces have been shown to help protect VIC from osteoblastic
differentiation, but it is not one of the main ECM proteins found in the AV [40-43].
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The main components of AV ECM are collagen 1, elastin, and sulfated (GAGs)
glycosaminoglycans, all of which do not have available RGD sequences for
binding in their native conformations [43]. Interestingly, RGDs are present on the
bone forming protein osteopontin, and upregulation of osteopontin gene
expression in diseased valves is considered a marker of VIC osteoblastic
differentiation [37]. While RGD allows VICs to adhere to the gel, the signaling
pathways activated in VICs by these adhesion molecules are unknown.
Research in the downstream signaling of VICs in RGD based gels need to be
further studied. To make matters more complex, the AV has multiple ECM
proteins with different binding motifs for VICs. Recapitulating this complex
environment in vitro using multiple peptides distributed in a hydrogel in a specific
orientation and concentration could be a useful tool to control VIC behavior and
growth.
Degradation rate of the hydrogels scaffold are also crucial to future studies.
PEG by itself is not degradable, however by attaching specific peptides or
molecules the degradation rate of the hydrogel can be tailored to support certain
cellular functions. For example, to proliferate in hydrogels cells need to have
space created by removing/degrading the surrounding material. The rate of
degradation of the hydrogel must be fast enough to allow cells to proliferate
without compromising the three-dimensional (3D) structure and mechanical
properties of the scaffold. In recent studies, degradation rates have been shown
to effect VIC behavior in PEG-RGD/PEG-PQ hydrogels [35, 39]. VICs grown in
softer gels with fewer crosslinks were compared to cells in stiffer hydrogels with
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more crosslinks [38]. The cells showed a maximal spreading at 7 days in the
softer gels compared to the cells in stiffer gels which took 14 days to fully spread.
These gels took advantage of VIC’s ability to degrade the hydrogel by producing
proteases. The space created by protease degradation of the molecule PQ
allowed for VIC spreading and proliferation.
Another interesting approach to increase the biological relevance of hydrogels
is to culture two cell types in a co-culture system. VICs were encapsulated in
hydrogels by partially crosslinking them inside a PEG-PQ/PEG-RGDS hydrogel.
Next an RKR peptide, which promotes VEC attachment, in buffer was used to
cover the surface of the gel and this gel was exposed to light a second time. The
second light exposure finished crosslinking the hydrogel internally while also
attaching RKR peptides to the surface. After washing away excess RKR peptide,
VECs were seeded on the surface of the hydrogel. This unique cell culture
platform with VICs on the inside and VECs lining the surface mimics the native
valve structure [22, 35, 39]. Long term analysis of these studies show increased
VIC viability and secretion of ECM normally found in the AV, but the system still
lacks the complexity and protein structures seen in vivo.
One of the limitations of PEG hydrogel chemistry is the reliance on end group
functionalization, meaning that each PEG molecule is limited to the ends being
modified. This limits each PEG molecule to having a bioactive molecule added
to one side since while the other is needed for crosslinking. Therefore,
developing a material that can be modified at multiple sites that can be used
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interchangeably as crosslinking sites or attachment site for biomolecules would
be superior in making complex hydrogels. With such a molecule, more than one
bioactive molecule could be attached to a hydrogel to investigate how
combinations affect cellular behavior. A current example of a multifunctionalizable PEG molecule from the lab of Kristi Anseth is an eight-armed
poly(ethylene glycol)-norborene (PEG-N). This PEG molecule exists in a star
formation with eight end groups available for functionalization. Utilizing a thiolene reaction, cysteine specific peptides and a protease degradable linker peptide
were added to PEG-N [38]. This PEG-N hybrid molecule was used to form
hydrogels with one of three cysteine functionalized adhesive peptides, fibronectin
(RGD), elastin (VGVAPG), or collagen-1 (P15), with either the degradable linker
peptide KCGGPQG↓IWGQGCK or KCGGPQG↓IAGQGCK from collagen [38].
Results showed that VICs had an elongated morphology in RGD hydrogels as
well as significantly more global MMP production at 14 days in RGD and P15
hydrogels. Despite the elegance of this system, it stills lacks a degree of
tunability because of the massive size of an eight-star PEG molecule. These
molecules are made of 8 PEG molecules with MW of 40,000. Because of this the
hydrogel formed from this molecule creates extremely soft hydrogels and cannot
be tailored easily to alter stiffness.
A different strategy to making hydrogels uses natural methacrylated polymers
like hyaluronic acid, collagen, and gelatin [37, 44]. Using mixtures of
methacrylated gelatin and methacrylated hyaluronic acid (HA), one study
encapsulated VICs in natural polymer hydrogels of various stiffness [37]. With the
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gel’s compressive moduli ranging from 4-12 kPa, the changes seen in VIC
behavior were attributed to differences in gel stiffness. However, as the ratios of
gelatin to hyaluronic acid are changed to achieve different stiffness’s, the number
of cell-adhesive sites and the local chemistries in the gel also changed. VICs
have been shown to be sensitive to these types of changes and are likely
affected [39, 45-47]. While natural polymers are advantageous in that they have
multiple adhesion sites for VIC attachment, support VIC survival, and cellular
remodeling they also have inherent biological variations that are difficult to
control. Therefore, replication of environments to test cellular responses in
natural polymers is difficult [48]. Additionally, natural polymers are less tunable
than synthetic polymers so functionalizing or changing specific aspects of a
natural polymer is problematic.
The main issue with current TEHV strategies comes from the lack of
knowledge of cellular signaling and growth of healthy heart valve tissue in the
laboratory. For example, understanding how mechanical cues from the scaffold
control cell function and growth remains largely unstudied. For TEHVs to become
a reality, detailed knowledge of how cells react to scaffold macro and
microenvironments in vitro is required. Without well designed and highly
controllable cell culture environments to mimic the heart valve as well as
methods to control cellular growth and differentiation, creating functional TEHVs
will continue to fall short.
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Microenvironmental Cues
Understanding how changes in the scaffold microenvironment effect VIC
behavior is crucial in the design and synthesis of future biomaterials. In current
studies, VICs are expanded to relevant numbers in plastic culture flasks made
from treated tissue culture polystyrene (TCPS). TCPS is used as a cell culture
platform because cells attach well and proliferate rapidly, and VICs are no
exception. However, after reaching confluence on TCPS, VICs contract and form
dystrophic OB nodules. This diseased behavior cannot be tolerated in lab grown
healthy heart valve tissue.
We hypothesize that there are a two microenvironmental cues that are
commonly overlooked on TCPS that may affect VIC behavior. First, TCPS is a
stiff plastic with a compressive modules around 30.6 ± 10.9 GPa, which is high
compared to tissues of the body [49]. For comparison, the aortic valve measured
using different procedures has been shown to have a modulus ranging from 0.3
to 25 kPA [50-52]. Literature also reports that stiffness of the underlying substrate
affects the behavior of many different cell types i.e., fibroblasts, neuronal cells,
cardiovascular endothelial cells, and pre-osteoblastic cell lines [36]. This
evidence, combined with the observation that the valve environment stiffens with
age and AVD progression, suggests that mechanical cues like stiffening of the
substrate may induce VICs toward a disease state [52, 53]. To investigate this
possibility we designed unique co-polymers with compressive moduli ranging
from 25 to 4700 kPa, that did not have changing surface chemistries. This copolymer system was one of the first to examine cell behavior over a large range
21

of moduli independent of surface chemistry, to isolate reactions to changes in
substrate stiffness alone. The results of this project are presented in chapter 2 of
this dissertation.
The second micro-environmental cue that has been overlooked on TCPS is
surface chemistry. TCPS is treated with an oxygen plasma to insert oxygen
functionalities at the ring site of polystyrene [54]. This process imparts a net
negative charge to the surface of TCPS which increases cell attachment and
viability [54]. A negative charge is important to consider because it is also seen
during aortic valve development on hyaluronic acid, a molecule seen at high
concentrations in the endocardial cushion [55]. This developmental environment
is supportive of cellular proliferation and migration. We hypothesized that if the
material culturing VICs had a negative charge, VICs would attach easily and
proliferate rapidly.
In chapter three we use a model system in which the surface chemistry of the
underlying substrate can be easily modified by creating an ordered monolayer of
self-assembled alkanethiols with specific chemistries. Using this technology, we
tested how negatively charge, positively charge, hydrophobic, and hydrophilic
surfaces affect VIC behavior.
To further improve biomaterials for TEHV development, our studies of
stiffness and surface chemistry need to be transitioned into a 3D cell culture
system. Therefore, we synthesized a PEG based hydrogel oligo ((polyethylene)
glycol fumarate) (OPF). This molecule has a number of advantages over other
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PEG hydrogels because it is degradable though ester hydrolysis, easily tailored
to alter stiffness, and has multiple sites per molecule which can be functionalized
to alter the molecular structure. This molecule has not been used extensively due
to a lack of availability in the market and it's difficultly to synthesize. In chapter
four we address these issue with a new synthesis method that takes less time,
generates less waste, requires less post-processing, and decreases the overall
difficultly of synthesizing OPF.
Using this newly generated OPF polymer we engineered a model system to
test how VICs react to charge in 3D hydrogels. In chapter 5 we show that OPF
can be functionalized with different alkanethiols to create OPF molecules with
specific charged alkanethiols from previous work. We then used the modified
OPF-alkanethiol molecules to create hydrogels to encapsulated VICs and study
their behavior in charge environments. Additionally, these gels were engineered
so that they would have low stiffness levels to better mimic native aortic valve
tissue. The results from this study are described in chapter five.
In summary, understanding the microenvironmental cues at the cell-material
interface of a scaffold how they are interpreted by VICs is important to advance
the synthesis of TEHVs. Selecting a relevant VIC subpopulation and defining an
efficient way of isolating them is an important first step in this process. Using
engineered materials to isolate the specific mechanical cues that affect cellular
growth and behavior will expand understanding of how to include mechanical
cues in 3D hydrogel systems. These tailored hydrogels with advantageous
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properties will grow the best TEHV for further study. Eventually, reiterations of
this process will advance biomaterials enough that cell signaling and behavior
can be completely controlled, and the TEHV created in a lab can be used a
functional replacements for AVD.
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Figures

Figure 1. An image of a 1x1 mm
cross-section of the aortic valve.
Buchanan 2014.
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Figure 2. A) Healthy and B) a disease aortic valves showing changes in
leaflet structure due to fibrosis and calcification.
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A

B

Figure 3. A) A biological valve before implantation and the degradation seen
after removal due to degradation. B) A synthetic valve replacement before
implantation.
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Figure 4. Valvular Interstitial Cell (VIC) phenotypes seen in vitro with
representative morphology, and common gene markers.
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Figure 5. A) Collapsed tube within a tube structure with sutures to make a
tricuspid valve. (Reimer J, Ann Biomed Eng, p.439-451, 2017)
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Chapter 2

Specific Aims

Overall Objective
As the world population becomes more aged, the burden on medical care
systems continues to increase. With a disproportionate effect on the elderly,
valvular heart disease in the US is estimated to affect 2.8% of the population.
The current replacement valves for diseased heart valves have major limitations
in their limited lifespan or requirement of lifelong anticoagulation therapies.
Therefore, the objective of this body of work was to identify and develop synthetic
environments to grow healthy tissue engineered aortic valve tissue in vitro.
In the course of this work the following specific aims were investigated:
Specific Aim 1: Identify relevant VIC subpopulations for tissue engineering.
To identify possible subpopulations within valvular interstitial cells for use in
synthetic culture systems, subpopulations of VICs were isolated and
characterized based on differences in adhesion during culture.
Specific Aim 2: Define environmental factors that create the ideal substrate to
grow valvular interstitial cells models of health or disease.
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To define how specific environmental factors such as surface charge and
substrate stiffness affect valvular interstitial cell behavior in vitro and identify
scaffolds for the control of valvular interstitial cell behavior.
Specific Aim 3: Develop a modifiable 3D hydrogel system to elucidate the effects
of microenvironmental cues on VIC behavior in 3D.
To develop a tunable, three-dimensional scaffold to study the effects of
charged environments and material stiffness on the growth and behavior of
valvular interstitial cells in a relevant tissue engineering model.

By characterizing valvular interstitial cell subpopulations and
environmental cues of synthetic scaffolds that support valvular interstitial cell
growth while dictating tissue formation, we have advanced the knowledge of
aortic valve tissue engineering. In addition, this work has also provided new cell
culture systems that are more accurate models of the aortic valve for the
development of better AVD therapeutics.
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Abstract
Valvular interstitial cells are a heterogeneous population that are normally
isolated as a single population from the aortic heart valve. Separating VICs into
different subpopulations has been difficult in vitro due to a lack of unique
markers. This study uses a simple adhesion based detachment technique to
isolate subpopulations of VICs which we call more adherent and less adherent.
Characterization of these subpopulations shows that the more adherent VIC
subpopulation is an osteoblastic-like (OB) phenotype expressing increased alpha
smooth muscle actin (αSMA), osteocalcin (OCN), and transforming growth factor
beta 1 (TGF-β1). Three different integrins were investigated as possible surface
markers of VIC differentiation; alpha-V beta-3 (αVβ3), alpha-V beta-5 (αVβ5),
and alpha-2 beta-1 (α2β1) in more adherent, less adherent, and unsorted VICs,
respectively. αVβ3 was significantly upregulated in more adherent VICs and,
when correlated with the increase in osteoblastic markers, αVβ3 should be an
interesting marker for sorting VIC subpopulations directly from the aortic valve in
future work. Additionally, the more adherent subpopulation proliferates more
slowly and has a rhomboidal morphology similar to that of osteoblastic media
induced VICs. Less adherent VICs on the other hand, proliferate significantly
faster, don’t express OB markers, and don’t express αVβ3. These data suggest
less adherent VICs are a healthier active subpopulation that would be useful for
heart valve tissue engineering research. Overall, differential detachment methods
were used to isolate a more adherent subpopulation with an osteoblastic
phenotype and an active “healthy”, less adherent VIC subpopulation from the
41

heterogeneous VIC population exists in the valve. These results highlight the
heterogeneity of recently excised VICs and show that relevant subpopulations
exist in the valve to study both valve health and disease.
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Background
Aortic valve disease (AVD) elevates mortality and cardiovascular
complications due to increased burden on the heart caused by obstructed blood
flow due to calcification and stenosis of the valve (1, 2). Disease progression is
attributed to a native valve cell population, valvular interstitial cells (VICs). In vivo
these cells are dispersed throughout the three layers of the aortic valve the
fibrosa, spongiosa, and ventricularis. VICs are responsible for the build-up of
matrix and the formation of calcific nodules that result in thickening and loss of
flexibility of the valve leaflets leading to AVD (3). Interestingly, calcified nodules
first appear in the fibrosa layer of the valve (4). This suggests that the unique
environment of the fibrosa make VICs in that area more likely to undergo
osteoblastic differentiation and create nodules. Despite this observation, when
VICs are taken from the valve, little work has been done to try and separate this
more osteoblastic-prone subpopulation of cells.
Instead, VICs have been removed from the entire valve and treated as a
homogenous group characterized as having a highly plastic phenotype with the
ability to differentiate in vitro into activated/myofribroblastic, osteoblastic-like,
progenitor, and quiescent phenotypes (5-9). In the laboratory the two most
commonly observed phenotypes are activated/myofibroblastic (aVICs) and
osteoblastic (OB VICs), identified by markers outlined in Table 1. aVIC are
characterized as VICs that proliferate rapidly and secrete ECM, whereas OB VIC
represent the disease phenotype that form calcific nodules in vitro with the
expression of bone specific genes like osteocalcin, osteopontin, and alkaline
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phosphatase (Table 1). It is unclear from this work if the multiple phenotypes in
vitro are a result of the in vivo VIC population changing phenotype or if culture
conditions allow a specific subpopulation of VICs to become dominate and take
over the culture. To answer this question, the first step is to identify specific
subpopulations of VICs.
In prior studies, a small but distinct VIC morphologic and phenotypic
subpopulations have been isolated and shown to be more reactive to
osteoblastic (OB) differentiation in OB induction media (10-12). For example, a
mesenchymal progenitor cell population isolated from VICs using a colony
forming unit assay, can differentiate into osteogenic, adipogenic, chondrogenic,
or myofibrogenic lineages using different induction medias (10).
Another progenitor cell subpopulation was isolated using the cell surface
marker ABCG2+ and fluorescent activated cell sorting. This small (~5%) ABCG2+
VIC subpopulation showed increased secretion of calcified extracellular matrix in
osteoblastic induction media over ABCG2- populations (11). These studies
demonstrate the existence of VIC subpopulations which are responsive to
specific environmental cues.
Currently, osteogenic media induction is commonly used in vitro to make
VIC’s exhibit osteoblastic-like (OB) properties (10, 11, 13-15). However, the use
of osteogenic induction media does not recapitulate disease development
conditions in vivo (16, 17). Presumably, chronic buildup of extracellular matrix
(ECM) causing valve thickening and stiffening is due to a small population of OB
VICs (16, 18). It seems more likely, therefore, that a small OB-like or OB-prone
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subpopulation of VICs exists natively within the valve that can cause disease
later in life. Despite these observations, little work has been done to isolate,
separate, or identify an OB prone VIC subpopulation within the valve. Therefore,
we designed studies to identify a method to directly isolate various VIC
subpopulations that can be used to better study VIC disease progression and to
identify a healthy subpopulation for heart valve tissue engineering.
Some VICs take longer to detach from TCPS during passaging than
others and in 2006 Belvins et al used a differential adhesion method to separate
VICs grown on tissue culture polystyrene (12). They concluded that increased
adhesion strength corresponded with a myofibroblastic phenotype using αSMA
as the primary marker. However, recent work has shown that both the aVIC and
OB VIC phenotypes show increased levels of αSMA in vitro (9, 19-21). We
hypothesized that the more adherent VIC subpopulation is actually an
osteoblastic phenotype that would have a faster doubling time and increased
expression of OB genetic markers. The rationale behind this hypothesis was that
the more adherent VIC subpopulation display an irregular cuboidal morphology
similar to OB VICs. As such, additional markers to test for OB VICs were
evaluated. The best marker of VIC OB differentiation is the bone specific protein
osteocalcin (OCN) which is only seen in OB VICs. Additionally, transforming
growth factor beta 1 (TGF-β1) which is upregulated in AVD and used to force VIC
to an OB phenotype was also measured as a marker of VIC OB differentiation
(16, 19, 22, 23).
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To reliably separate these subpopulations directly from the valve, surface
markers that can be used for fluorescent activated cell sorting need to be
identified. Given recent studies correlating integrin expression levels to changes
in the phenotype of other cell types, differences in integrin expression of VIC cell
subpopulations were examined (3, 24-26). α2β1, a collagen 1 binding integrin,
was investigated because during AVD collagen 1 expression and fragmentation
greatly increases (16, 27). Therefore, increased presence of α2β1 in VICs is
reflective of VICs during AVD. Additionally, the integrins αVβ3 and αVβ5 were
measured. In the valve αVβ3 is minimally expressed, but becomes significantly
upregulated in aVICs in vitro. αVβ5 increases when pre-osteoblastic cell lines are
induced to and osteoblastic phenotype (16, 25, 26, 28-30). These markers were
investigated as potential markers id aVIC and OB VIC subpopulations. The
overall aim of this work was to characterize the VIC subpopulations isolated from
the heterogeneous population of VICs and to identify cell surface markers.

Material and Methods
Cell Culture
VICs were extracted from porcine aortic heart valves using a previously
published method (31). Briefly, hearts were shipped overnight on ice (Hormel).
Aortic valve leaflets were excised from hearts and treated with collagenase II
(Worthington) (15 min, 37°C) and scraped to remove the unwanted valvar
endothelial cells (VECs) located on the surface of the leaflet. Tissue was then
incubated in fresh collagenase to release the valvular interstitial cells. After a 60
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to 70 min incubation, the remaining tissue was removed and the collagenase/cell
solution collected and spun down. The cell pellet was resuspended in growth
media [199 EBSS Hyclone media supplemented with 10% fetal bovine serum
(FBS) (Hyclone), 1% penicillin/streptavidin (Hyclone), and 1% fungizone
(Hyclone)]. The cell suspension was treated with Dynabeads CD31+ Endothelial
Cell (ThermoFisher Scientific) to remove any residual valvular endothelial cells.
The resulting VICs were plated onto TCPS and cultured under normal conditions
at 37⁰C with 5% CO2 in growth media. These cells were considered to be
passage 0. At ~80% confluence, these cells, underwent the differential
attachment protocol.
Osteoblastic media [199 EBSS Hyclone media supplemented with 10%
FBS, 10-8 M dexamethasone, 10 mM ß-glycerolphosphate, 2mM ascorbic acid]
was added 12 hours after seeding to induced VICs to OB phenotype. A small
portion of VICs from P0 did not undergo differential attachment and were frozen
to be used as unsorted heterogeneous VICs.

Differential Detachment Protocol and Kinetic Study
P0 VICs were grown to 80% confluence, media removed and cells were washed
in Dulbecco’s Phosphate Buffer Saline (DPBS) without calcium or magnesium
and treated with 2 mL of dilute trypsin EDTA (0.025% DPBS). After two minutes
of incubation at 37˚C, the solution and lifted cells were collected. New dilute
trypsin solution was added to the flask and incubated for 2 additional minutes at
37 °C and again the solution and released cells were collected. Additional dilute
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trypsin treatment steps with incubation and collection were repeated until all cells
were detached from the flask as determined by optical microscopy. The cell
number of each collection was counted using a Z2 Beckman Coulter Counter to
determine the total number of cells. The first 25% of cells to detach (less
adherent), and the last 25% of cells to detach (more adherent) were kept. Less
adherent and more adherent VICs were reseeded separately under normal
conditions, becoming passage 1 cells (P1), and grown to 80% confluence. The
dilute trypsin method described above was repeated except that from less
adherent cell population only the 1st 25% of VICs to detach and from more
adherent only the last 25% of VICs to detach were reseeded and used in
subsequent passages. After the third dilute trypsin treatment, the cell number of
each fraction of the less and more adherent cell populations was plotted before
reseeding. The next passage was done using a normal trypsinization and freeze
down of P3 cells. A small proportion of the P0 VICs did not undergo the
differential attachment protocol and were passaged 3 times normally before
being frozen to generate the heterogeneous and OB VIC cell populations.

Growth Curve
The doubling times of the less adherent, more adherent, heterogeneous
VICs and OB VICs populations were determined. Briefly, all cell types were
seeded at 25,000 cells/cm2 in a 6-well TCPS plates with growth media. OB VIC
induction media was added to OB VICs 12 hours after seeding. Media was
changed every 2 days. At each time point 3-5 wells of growing VICs were
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trypsinized, and counted on a Z2 Beckman Coulter Counter. Doubling times were
calculated as the slope of the best fit line to the area of exponential growth of
each curve.

Gene Expression
Less adherent, more adherent, and heterogeneous VIC gene expression was
examined at day 3. VIC mRNA was extracted using RNeasy plus Micro kits
(Qiagen) and concentration determined using a NanoDrop 2000C. Next, 100 ng
of mRNA were converted to cDNA as per manufacture’s instructions using twostep RT PCR GoScript Reverse Transcription Kit (Promega). The cDNA was
then interrogated by the ΔΔCT method using qPCR on a Step-One RT PCR
System (Applied Biosystems). Taq-Man probes for alpha smooth muscle actin
(αSMA) (Ss04245588_m1), osteocalcin (OCN) (Ss03373655_s1), transforming

growth factor beta 1 (TGF-β1) (Ss03382325_u1), Collagen 1 (Ss03375690_u1),
elastin (AJLJIR9), and the endogenous control glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) (Ss03374854_g1) were used.

Integrin Expression
Heterogeneous, more adherent, and less adherent VICs were grown for 3 days
and treated with 5mM EDTA in DPBS to facilitate detachment followed by gentle
scraping. Collected cells were pelleted and resuspended at ~500,000 cell/ml in
ice cold phosphate-buffered saline (PBS), 1% BSA, and 0.02% sodium azide.
Cells were then labeled with 3uL/ml of the following antibodies (ab), αvβ5-Alexa
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647 MS (Novus, FAB2528R), αvβ3-FITC mouse (Sigma-Aldrich, MAB1976F),
α2β1 mouse (Sigma-Aldrich, MAB1998Z), mouse IgG1 κ -FITC (Biolegend,
400110), mouse IgG1, κ- Alexa 647 (Biolegend, 400130), and mouse IgG1 κ
(Biolegend, 401402) for 30 min at 4°C. The secondary ab Alexa 488 goat antimouse (Life Technologies A11017) 1.5 uL/mL was added to samples stained
with primary α2β1 Ms, mouse (BALB/c) IgG1, or IgG1 κ primary ab’s and
incubated for another 20 min on ice. All samples were kept on ice until read on
the Attune NXT Flow cytometer.

Statistics
All results were analyzed using one-way ANOVA and two-tailed t-tests to
determine significance at a 95% confidence interval (p < 0.05). All analyses were
done using GraphPad Prism 7 software.

Results
VIC Subpopulation Isolation and Growth
Two subpopulations of VICs (more adherent and less adherent) were
isolated (Fig 1). Less adherent VICs detached more rapidly than more adherent
VICs with 90% of each subpopulation detaching in 8 and 14 minutes,
respectively (Fig 2). Distinct morphologies were also observed at day 3 with less
adherent having an elongated morphology compared to more adherent which
have a more irregular cuboidal morphology (Fig 3). Heterogeneous VICs
displayed a combination of both morphologies. Growth curves determined that
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the doubling times of less adherent VICs and OB VICs were significantly faster
than those of more adherent and heterogeneous VICs (Fig 4) (p ≤ 0.05 n=3).

VIC Phenotype
To test for differences in VIC phenotype between the VIC subpopulations
at day 3, mRNA expression of αSMA, OCN, TGF-β1, collagen 1, and elastin
were measured. αSMA and OCN expression were significantly higher in more
adherent VICs compared to all other groups (Fig 5). TGF-β1 expression was
higher in more adherent VICs compared to less adherent VICs. Collagen
expression was similar between all cell subpopulations, while elastin expression
was significantly higher in more adherent cells when compared to heterogeneous
but not less adherent VICs (Fig 5). The upregulation of αSMA, OCN, and TGF-β1
in more adherent VICs suggests this subpopulation is an osteoblastic phenotype.

Subpopulation Surface Markers
To identify surface markers for the different subpopulations of VICs,
integrin expression was determined. Levels of integrins αVβ5, αVβ3, and α2β1
were investigated using flow cytometry (Fig 6). αVβ5 was not statistically different
in more adherent and less adherent VICs but was significantly higher in the
heterogeneous subpopulation. αVβ3 was significantly higher between more
adherent VICs compared to heterogeneous VICs and was not detected in the
less adherent subpopulation. α2β1 was significantly lower in less adherent VICs
compared to other VIC subpopulations. Therefore, αVβ3 and α2β1 are good
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markers to distinguish the less adherent from the more adherent VIC
subpopulations.

Discussion
VICs are a heterogeneous population of cells within the spongiosa,
ventricularis, and fibrosa layers of the aortic valve. Each layer has a distinct ECM
environment as well as different mechanical properties (32). Therefore, VICs
residing in different layers are expected to have a slightly different phenotype.
This idea is also supported by the observation that VICs cultured in vitro display
multiple morphologies (12). However, separating VICs to study the behaviors of
subpopulations has been difficult due to a lack of methods and unique markers to
distinguish and separate subpopulations. Using a differential detachment
method, two distinct subpopulations of VICs with differing levels of adhesion to
TCPS were isolated. Less adherent and more adherent VIC subpopulations were
tested for differences in morphology, proliferation rate, gene expression, ALP
activity, and integrin expression. In previous studies, VICs induced to an OB
phenotype using OB media had an increased rate of proliferation compared to
untreated VICs (20, 21, 23). We therefore hypothesized that the more adherent
VIC population would be an osteoblastic phenotype with a faster doubling time
and increased expression of OB genetic markers (19, 23). A difference in
proliferation rates was found, but the more adherent VICs grew significantly
slower than OB and less adherent VICs (Fig 4).
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The cytoskeletal protein αSMA was originally used to identify
activated/myofibroblastic VICs. More recently it has been shown to be
upregulated in osteoblastic VICs both in vitro and in vivo with a correlation to
increased αSMA stress-fiber formation (16, 19, 21, 23). In this study αSMA
expression was significantly higher in more adherent VICs and, as seen
previously, associated with a more cuboidal VIC morphology (12). The late stage
marker for osteoblastic differentiation in VICs, osteocalcin, was also upregulated
in more adherent VICs, corresponding to recent findings suggesting an
osteoblastic phenotype (19, 21). Furthermore, TGF-β1 expression was
upregulated in the more adherent subpopulation (33). While TGF-β1 expression
is not an established marker of OB differentiation in vitro, it has been shown to be
upregulated in stenotic and calcified valves and is commonly added to VIC media
to induce an OB phenotype (16, 33, 34). In conclusion, osteoblastic media
induced unsorted VICs to proliferate but, it is the slower growing, more adherent
VIC subpopulation which exhibits OB markers and morphology. If this
subpopulation’s behaviors exists in vivo, it would suggest that the faster
proliferation rate of less adherent VICs may dominate heart valve repair over the
slow growing OB-like more adherent VICs. However, the long term behaviors of
osteoblastic more adherent but slow growing VICs could eventually lead to valve
fibrosis and calcification.
Another difference observed between less and more adherent VICs is the
differential expression of ECM proteins. In the heart valve, collagen and elastin
are the most common ECM proteins (8, 27, 35-37). During AVD and with aging
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collagen content increases. Ex vivo studies of the AV cells show VICs undergo
OB differentiation when the collagen in the valve is degraded (16, 27, 38).
Although in this study no significant differences in collagen I expression were
detected between populations, the differences in the ECM proteins should be
further investigated as potential causes of differential growth and phenotype.

Elastin has an intricate role in the control of heart valve health. Proper
formation of elastin with fibrillin microfibrils regulates TGFβ activity (39, 40).
TGFβ is normally sequestered in the ECM on the elastin/fibrillin microfibrils to
inhibit biological activity. As elastin becomes dysregulated during AVD,
sequestration of TGFβ is disrupted resulting in increased availability of TGFβ and
therefore increased signaling (39, 40). Increased elastin expression has been
correlated with VIC OB differentiation caused by surface stiffness and surface
chemistry, independent of OB differentiation media (19, 21). In this study, the
highest levels of elastin were seen in the more adherent VIC subpopulation, with
an OB-like phenotype. We hypothesize that early elastin expression and possibly
loss of proper structural control in vitro leads to loss of fibrillin microfibrils to
sequester TGF-β1. As a result, increased TGF-β1 expression could then help to
force VIC toward the OB VIC phenotype. To test this hypothesis, expression of
other ECM proteins such as fibronectin should be measured and secreted
proteins levels examined along with elastin fiber formation.
During AVD collagen 1 expression increases and existing fibers fragment
(16, 27). Because the primary integrin binding partner for collagen 1 is α2β1,
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increased binding and activation of α2β1 may be related to AV disease
progression. Interestingly in this study, the less adherent subpopulation
expresses less α2β1 than either more adherent or heterogeneous VICs. As this
population seems to be the most resistant to OB differentiation in vitro, α2β1
expression may be a marker of an osteoblastic VIC subpopulation.
VICs with αvβ3 in previous VIC literature have been considered an
activated phenotype that express αSMA and have increased spreading in
hydrogels (26). One of αvβ3’s binding partners in the ECM is fibronectin which
increases in expression during AVD (16, 28). We observed that αvβ3 is highest
in more adherent VICs so that high levels of αvβ3 correlated with an osteoblastic
VIC phenotype rather than an activated phenotype as previously suggested (3,
26). However, unlike previous studies, increases in osteoblastic markers OCN
and TGF-β1 were also seen in more adherent VICs. These data suggest that the
more adherent VICs have transitioned from the activated VIC phenotype to an
osteoblastic phenotype. αvβ3 has also been shown to bind to the bone protein
OPN which is also upregulated during AVD. It would be interesting to measure
OPN in the current subpopulations. Upregulation of OPN in less adherent VICs
would further support that they are an osteoblastic subpopulation (41, 42). In
conclusion, αvβ3 may be an integrin surface marker that identifies the
osteoblastic prone VIC subpopulation within the AV. Future work could use this
integrin as a surface marker to sort healthy and OB prone VICs directly from the
valve.
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Another interesting aspect of this work is that the heterogeneous VIC
population did not always fall directly between more adherent and less adherent
VICs. This is likely due to the influence of the different VIC subpopulations have
on each other within heterogeneous VIC cultures. Additionally, there is a strong
likelihood that there are subpopulations of VICs that we didn’t isolate with the
adhesion based separation technique and these unidentified populations
influence the overall behavior of the larger group.
In summary, this study examined osteoblastic disease markers of different
VIC subpopulations through simple differential detachment methods, without
using OB induction media. The more adherent VIC subpopulation isolated had
increased mRNA expression of αSMA, OCN, TGF-β1, as well as increased ALP
protein activity, suggesting that strongly adhered VICs are an osteoblastic VIC
phenotype. Furthermore, doubling times show that the more adherent
subpopulation of VICs proliferate at a slower rate than less adherent cells,
contradicting the current hypothesis that OB VICs proliferate more quickly than
activated VICs (23). Integrins αvβ3 and α2β1 were also found to be upregulated
in the more adherent subpopulation and therefore may be surface markers to
separate VIC subpopulations using fluorescence activated cell sorting. Overall,
these results demonstrate the heterogeneity of VICs and identify a simple
method to isolate a proliferative healthy subpopulation from an osteoblastic prone
subpopulation within porcine aortic valves.
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Figures and Tables
Table 1. VIC Phenotype Marker Summary
Marker
VIC Phenotype First Found
Alpha smooth
Activated1,2,3
Extracted from
muscle actin*
Valves1,2,3

Citations
1. Mulholland GL
1996
2. Rabkin E.
2001
Osteoblastic?4,6 In vitro
4,5
3. Lui 2007
systems
4. Rush 2016
5. Coombs 2017
Osteocalcin
Osteoblastic
Human calcified
6. Srivatsa SS.
7
valves and
1997
vascular smooth
7. Giachelli C.M.
muscle cells8
2003
Osteopontin
Osteoblastic
Human and
8. Srivatsa SS.
canine calcified
1997
valves9,10 and
9. Mohler, 1999
vascular smooth
10. Giachelli C.M.
3
muscle cells
2003
Alkaline
Osteoblastic
Human calcified
11. Rajamannan,
Phosphatase
aortic valves12
N.M. 2003
and in vitro
12. Monzack M.S.
culture13
2011
TGF-β1
Osteoblastic
Human calcified
13. Jian B. 2003
aortic valve
14. Walker, G.A.
cusps14,15
2004
15. Coombs 2016
*Originally a marker for activated/myofibroblastic VICs it has now be detected
in high levels in osteoblastic VICs. List is not exhaustive.
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Figure 1. Schematics of pop-off procedure.
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Figure 2. Detachment profile of more adherent and less adherent
VIC subpopulations isolated through sequential addition of dilute
(0.025%) trypsin. 90% of less adherent VICs are removed from
the flask after 8 min (4 dilute trypsin treatments) while for more
adherent VICs it take 14 minutes (7 trypsin treatments).
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Figure 3. Optical microscopy after 3 days of growth shows the
representative morphologies of different VIC subpopulations, with
a rhomboidal morphology of more adherent VICs in comparison
to less adherent VICs which have an elongated spindle like
morphology.

60

D o u b lin g T im e (H r s )

40

30

*

*

20

10

B
O

s
u
o
n
e
g
ro
te
e

H

s
e
L

M

o

re

s

A

A

d

d

h

h

e

e

re

re

n

n

t

t

0

C e ll T y p e

Figure 4. Doubling times in hours of heterogeneous, osteoblastic media induced,
less adherent and more adherent VICs. OB and less adherent VICs grew
significantly faster than more adherent VICs (p≤ 0.05*).
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Figure 5. Genetic expression of αSMA, OCN, TGF-β1, collagen 1, and
elastin normalized to the heterogeneous control population. A) More
adherent VICs have significantly higher αSMA than all other
subpopulations. B) OCN is upregulated in more adherent VICs. C)
TGF-B1 is significantly higher in more adherent compared to less
adherent VICs. D) No difference is seen in collagen expression. E)
Heterogeneous VICs have significantly less elastin than other
subpopulations (p≤ 0.05*).
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C

Figure 6. Flow cytometry results of A) αVβ3 integrin b) αVβ5 and c) α2β1
expression in the three VICs subpopulations at day 3. A) Heterogeneous VICs
have significantly less αVβ5 than more and less adherent VICs (*p = 0.05). B)
More adherent VICs have significantly higher levels of αVβ3 than other VIC
subpopulations. C) α2β1 is significantly lower in less adherent VICs.
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Abstract
Previous methods for investigating material stiffness on cell behavior have
focused on the use of substrates with limited ranges of stiffness and/or
fluctuating surface chemistries. Using the co-polymer system of n-octyl
methacrylate crosslinked with diethylene glycol dimethacrylate (DEGDMA/nOM),
we developed a new cell culture platform to analyze the isolated effects of
stiffness independent from changes in surface chemistry. Materials ranging from
25 kPa to 4,700 kPa were fabricated. Surface analysis including goiniometry and
X-ray photoelectron spectroscopy (XPS) confirmed consistent surface chemistry
across all formulations examined. The mechanosensitive cell type valvular
interstitial cell (VIC) was cultured DEGDMA/nOM substrates of differing stiffness.
Results indicate that order of magnitude changes in stiffness do not increase
gene expression of VIC alpha-smooth muscle actin (αSMA). However, structural
organization of αSMA is altered on stiffer substrates, corresponding with the
appearance of the osteoblastic marker osteocalcin and nodule formation. This
research presents the co-polymer DEGDMA/nOM as ideal substrate to
investigate the influence of stiffness on VIC differentiation without the
confounding effects of changing material surface chemistry.

Keywords: Valvular interstitial cell, stiffness, mechanosensing, extracellular
matrix, microenvironment
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Introduction
Cellular functions such as adhesion, spreading, proliferation and gene
expression are affected by the chemical and physical factors of the extracellular
environment [1-9]. Cells respond to these extracellular cues through
mechanosensing proteins, which activate cell signaling cascades [2, 10, 11].
Given the importance of substrate stiffness in controlling mechanosensing
behavior, investigations into the effects of matrix mechanics on cell signaling
have become more prevalent. However, in vitro studies examining substrate’s
mechanical properties effects on cells have been limited due to a lack of material
platforms capable of isolating stiffness over a significant range without changing
the material’s surface chemistry [1-6].
During aortic valve disease, changes in protein deposition and overall
stiffness of the valve are known to increase over time [12, 13]. The primary cells
of the aortic valve, valvular interstitial cells (VICs), are a heterogeneous and
dynamic population that are particularly sensitive to the substrate on which they
are grown [5, 14-16]. In vitro, VICs expanded on tissue culture polystyrene
(TCPS) exhibit myofibroblastic characteristics with an elongated spindle shaped
morphology, rapid proliferation, and expression of alpha smooth muscle actin
(αSMA) [16-20]. Over time, VICs on TCPS adopt an osteoblastic-like (OB)
phenotype attributed to cell confluence [5, 14, 15, 21, 22]. It has also been
suggested that stiffening of the aortic valve’s extra cellular matrix (ECM) may be
able to signal VICs to differentiate to a disease inducing OB phenotype [12, 13,
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16, 23-25]. These observations have led to investigation of the influence of
substrate stiffness on VIC differentiation in vitro.
Classically, αSMA has been used as a marker for myofibroblastic
activation of VICs. More recently, however, αSMA expression has also been
shown to increase in OB VICs [5, 26]. While studies have begun to look at the
role of αSMA as a marker of osteoblastic potential, at this point seminal studies
of stiffness have not included OB markers such as osteocalcin [3, 24, 27-29].
Given the low compressive moduli present in healthy valve tissue, past
studies have focused on relatively small changes in stiffness in the range of soft
tissues. Poly(ethylene glycol) (PEG), photodegradable-PEG/PEG monoacrylate
hybrids, and collagen materials have been used to create substrates of varying
stiffness for investigating VIC behavior. On lower range moduli materials (2-10
kPa) VICs have exhibited a dormant fibroblastic phenotype with minimal αSMA
expression and a low rate of proliferation. Slightly stiffer materials (10-15 kPa)
induced upregulation of αSMA and the VICs were classified as
activated/myofibroblastic phenotype [3, 18, 24, 29]. Quinlan and Biller used
collagen coated polyacrylamide gels to investigate a larger range of stiffness
(150 Pa – 153kPa) [3]. From this range it was shown increasing stiffness results
in greater αSMA expression and stress fiber formation. However, the stiffness
ranges examined in all these previous studies are still too narrow as they failed to
include high compressive moduli materials akin to calcified valve tissue [2, 12].
Although PDMS scaffolds have been studied to cover larger ranges, PDMS
requires surface modification to allow cell adhesion [1, 2]. Further complicating
73

the systematic investigation of stiffness effects on VIC behavior, is the use of
materials with varying surface chemistry. Surface chemistry of the underlying
substrate has been shown to have a dramatic effect on VIC behavior [5].
Therefore, a consistent surface chemistry needs to be maintained in order to
reduce the convolution of surface chemistry effects on VICs, leading us to
develop a new material platform.
In this report we describe the development of a unique cross-linked
polymer system. Using this co-polymer system composed of diethylene glycol
dimethacrylate (DEGDMA) and n-octyl methacrylate (n-OM) monomers, a
material with a wide range of stiffness and a consistent surface chemistry can be
achieved. To our knowledge no systematic study isolating the effect of stiffness
greater than 153 kPa has been reported while looking at VIC osteoblastic
differentiation. This system allows us to investigate the isolated effects of
stiffness on VIC behavior over a wider range of moduli than previously reported
[3, 14, 15, 21, 23, 24, 29]. Comparing soft (25 kPa) and hard (4,700 kPa)
substrates it was hypothesized that increasing stiffness with consistent surface
chemistry would cause VICs to undergo osteoblastic differentiation. As such, this
research marks the best attempt thus far at decoupling underlying stiffness from
changing surface chemistry and isolating stiffness effects on VIC behavior over a
wider range of stiffness.
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Materials and Methods
Substrate Fabrication
Substrates were fabricated using free radical polymerization through
solutions of the monomers n-octyl methacrylate (nOM) and diethyleneglycol
dimethacrylate (DEGDMA) (Scientific Polymer Products) with 1-[4-(2hydroxyethoxy)phenyl]-2-hydroxy-2-methylpropan-1-one (IRGACURE 2959) as a
free radical initiator. Three substrate formulations were fabricated with 3, 19, or
33 wt% DEGDMA, 0.025 wt% IRGACURE 2959, and the remaining wt% of nOM.
Liquid monomers and initiator were mixed for 1 hr at room temperature,
poured into quartz glass molds (3 x 5 x 0.1 cm) and polymerized under UV 365
nm light in a CL-1000 UV light box (UVP LLC) for 300 minutes. DEGDMA/nOM
sheets were cut into 6, 15, and 22 mm diameter circular samples used for
contact angle, surface chemistry, and VIC culture experiments. Before testing, all
samples were submerged in 200 proof ethanol for 48 hours, degassed overnight
under vacuum, and submerged in 18 MΩ water (Millipore) for at least 24 hrs.

Compressive Modulus
Cylindrical samples for testing of compressive modulus were fabricated in
glass vials with an inner diameter of 6 mm and cut to a 2:1 height to diameter
with a wet saw TechCut 5™ (Allied High Tech Products Inc.). Compressive
modulus of the bulk material was determined for all three formulations (n=5)
using an Instron 5500R following ASTM 695 – 02a. The experiment was
performed using MTS ReNew software. Stress – strain curves were analyzed in
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the linear elastic regime (5 – 20% strain) to determine sample compressive
modulus.

Contact Angle Goniometry
Samples were dried under vacuum overnight. Contact angles were
determined using the sessile drop technique on a goniometer (Model 100-00115, ramé-hart). The contact angle between the water droplet and the sample
surface was determined using the DROPimage Standard (ramé-hart).

X-Ray Photoelectron Spectroscopy (XPS)
X-Ray Photoelectron Spectroscopy survey and high resolution spectra
were obtained using Kratos Axis Ultra spectrometer with a monochromatic Al
K(α) (1486.6 eV) source at 225W. Survey spectra were obtained at pass energy
80 eV and high-resolution spectra at pass energy 20 eV. Base pressure was less
than 5 x 10-9 Torr. Charge compensation was accomplished using low energy
electrons. Linear background was used for elemental quantification of C1s and
O1s spectra. Quantification utilized sensitivity factors provided by the
manufacturer. All the spectra were charge referenced to the aliphatic carbon at
285 eV. Curve fitting was carried out using individual peaks of constrained width,
position and 70% Gaussian/30% Lorentzian line shape.
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Valvular Interstitial Cell Isolation and Culture
Valvular interstitial cells were isolated using collagenase digestion from
porcine hearts received within 24 hrs of slaughter (Hormel) as previously
described [5, 30]. After harvesting, residual valvular endothelial cells were
removed from the extracted cell population using CD31+ magnetic dynabeads
[5]. VICs were cultured under normal conditions (37⁰C, 85% RH, 5% CO2) in
classical medium 199 (Hyclone) supplemented with 10% fetal bovine serum
(Hyclone), 1% penicillin/streptavidin (Hyclone), and 1% fungizone (Thermo
Fisher Scientific). VICs were frozen after passage one. Low passage (2-4) VICs
were used in all experiments for consistency. For all cell experiments, VICs were
cultured under normal conditions on treatment surfaces 3, 19, 33%
DEGDMA/nOM or on TCPS surfaces with or without osteogenic induction media
[199 media, 10% FBS, 10 mM β-glycerophosphate, 2mM ascorbic acid, and 10-8
M dexamethasone] added 12 hours after seeding. TCPS was used as the control
surface.

Apoptosis
Apoptosis was measured using Dead Cell Apoptosis Kit with Annexin V
Alexa Fluor 488 & propidium iodide (PI) (Thermo Fisher Scientitific). Annexin V is
an apoptosis marker that becomes available for antibody binding as the cell loses
the ability to regulate the position of inner and outer leaflet membrane proteins,
while PI binds to the DNA of cells that have lost membrane integrity. When both
markers are present, the cell is apoptotic. Briefly, VICs were seeded onto
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DEGDMA/nOM substrates or TCPS and analyzed at seven days. Apoptosis
controls were exposed to 1uM staurosporin for 4 hrs before analysis. All cells
were trypsinized and stained as per manufactures instructions before measuring
fluorescence on the Accuri C6 Flow Cytometer.

Growth Curve
Valvular interstitial cells were seeded at 35,000 cells/cm2. At each time
point, cells were trypsinized and counted on a Beckman Coulter Counter Z2.
Media was changed every two days. Doubling times were calculated based on
the slope of the best-fit line during the exponential phase of growth.

Quantitative Polymerase Chain Reaction
Valvular interstitial cells grown on DEGDMA/nOM substrates were
harvested for mRNA using RNeasy Micro Kits with gDNA removal (Qiagen).
mRNA quality and content was assessed on a NanoDrop 2000C UV/Vis
(ThermoFisher Scientific) and 100 ng converted to cDNA using GoScript Reverse
Transcription Kit (Promega). Gene expression of αSMA/ACTA
(Ss04245588_m1), collagen-1/COL1A1 (Ss03375690_u1), osteocalcin/bone
gamma-carboxyglutamate protein/ BGLAP (Ss03373655_s1) and elastin/EMILIN
(AJLJIR9) were analyzed with TaqMan primers using the ΔΔCT method, on a
StepOne Real Time-PCR System (Applied Bio.). All samples were compared to
GAPDH (Ss03374854_g1) TaqMan primer as the endogenous control and
normalized to TCPS.
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Optical Microscopy and Immunocytochemical Staining (ICC)
Cells were imaged using a phase contrast Nikon Microscope over 7 days
of growth to identify nodule formation. After three days of culture, VICs were fixed
with 10% formalin for one hour and rinsed in DPBS. Cells were permeabilized
with 0.01% (v/v) Tween20 in DPBS (PSBT). Reactive ion removal was conducted
using 10% (m/v) sodium azide and 10µM H2O2 in PBST then rinsed in PBST.
Primary antibody αSMA (ab7817, Abcam) at a 1:1000 dilution was incubated with
sample after blocking with 3% Bovine Serum Albumin (BSA). After washing with
PBST secondary antibody goat anti-mouse AlexaFluor 488 (A11001, Invitrogen)
was diluted to 1:400 and incubated with samples for 60 minutes. Samples were
rinsed with PBST and excess moisture removed before being mounted with
Prolong Diamond Antifade with DAPI P36966 (Thermo Fisher Scientific).
Samples were imaged on a Zeiss LSM 510 META microscope.

Statistics
All results were analyzed using a one-way ANOVA followed by a student’s
T-tests to determine significance at a 95% confidence interval (p ≤ 0.05). All
analyses were done using GraphPad Prism 6 software.
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Results
Substrate Fabrication
Monomers of dietheyleneglycol dimethacrylate (DEGDMA) and n-octyl
methacrylate (nOM) were mixed together with the photo initiator IRGACURE
2959. Exposure to UV light (365nm) results in the generation of two free radicals
per molecule. IRGRACURE radicals then attack the acrylic groups of either
monomer allowing for random co-polymerization (Figure 1). By varying ratios of
DEGDMA:nOM cross-linked substrates with a range of material stiffness from 25
kPa to 4700 kPa were made.

Compressive Modulus
The compressive modulus (n=5) was determined for all three formulations
with 3%, 19%, and 33% DEGDMA having a compressive moduli of 25 ± 2 kPa,
920 ± 60 kPa, and 4,700 ± 300 kPa, respectively (Figure 2). Differences in
compressive modulus were correlate with DEGDMA content and published Tg
values [31].

Sessile Drop Goniometry
Contact angles were used to determine the wettability of surfaces using 18
MΩ water. For 3, 19, and 33 wt% DEGDMA/nOM the contact angles were found
to be 90.1 ± 2.2, 88.0 ± 3.2, and 87.3 ± 3.3, respectively with no statistical
difference between groups indicating similar hydrophobicity.
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X-Ray Photoelectron Spectroscopy (XPS)
The elemental composition and functional groups of the lowest and
highest modulus DEGDMA/nOM material surfaces were analyzed using XPS. A
broad spectrum scan determined the elemental and peak intensity in order to
determine surface elemental composition (Figure 3A). High resolution spectra
scans for carbon and oxygen were obtained to measure chemical species
bonded to these elements. As shown in table 1, the formulations of 3 and 33%
DEGDMA/nOM show nearly identical elemental composition. High resolution
spectra of O1s show similar curves between 3 and 33% DEGDMA/nOM with
peak assignments as follows; O=C, 532.3 eV; C-O-C, 533.9 eV; O-(C=O), 534.4
eV; O-H, 536 eV (Figure 3B, C) [32, 33]. High resolution of C1s peak show
similar curves between 3 and 33% DEGDMA/nOM with the following peak
assignments; aliphatic carbon, 285 eV; C-(C=O)-O, 285.7 eV; C-O, 286.8 eV,
C=O, 288.8 eV (Figure 3D, E) [32, 33]. The observed peak for hydroxyl (O-H,
536 eV) is most likely due to oxidization at the surface from incomplete
conversion of free radicals from polymerization. In both the Cs1 and Os1 spectra,
peak fits for the, α-carbon (C-(C=O)-O, 285.7 eV) and the aliphatic carbons (C-C,
285 eV), α-oxygen (O-(C=O)) and ether (C-O-C), respectively, vary by less than
1 eV at the peak maxima. This variation in eV falls below the detection limit of our
instrument and necessitates the combination of, α-carbon (C-(C=O)-O) and the
aliphatic carbons (C-C) for Cs1, α-oxygen (O-(C=O)) and the ether (C-O-C) for
Os1 peaks. The adjusted peaks were used to calculate (C-C/C-O) /(C-C/C=O)
and (O-(C=O)/(C-O-C) ratios.
81

VIC Attachment, Growth, Cytocompatibility
VICs were seeded at 35,000 cells/cm2 and counted at 24 hours to
determine cellular attachment. Cell attachment was lower than controls but did
not differ significantly between DEGDMA/nOM substrates (Figure 4A). Cell
numbers were measured over nine days to calculate doubling times. Osteoblastic
media (OB) VICs proliferated significantly faster than all other substrates. TCPS,
19% and 33% DEGDMA/nOM VICs showed no difference between groups.
Finally, VICs on 3% DEGDMA/nOM grew significantly slower than all other
substrates (Figure 4B). To confirm DEGDMA/nOM substrates were not inducing
chronic toxicity, VIC apoptosis was measured after seven days of culture. No
significant differences were found in VICs grown on TCPS, live controls, and
DEGDMA/nOM substrates (Figure 4C).

Gene Expression and Immunocytochemical Staining (ICC) of VICs
Results from qPCR show a significant increase in αSMA gene expression
of VICs grown in osteoblastic media at all time points (Figure 5A). However,
there is no significant increase of VIC αSMA expression between different
stiffness formulations of DEGDMA/nOM. ICC visualization of αSMA protein
structure at day 3 shows stress fiber formation is more pronounced on OB VICs
and 33% DEGDMA/nOM VICs compared to softer substrates 3% and 19%
DEGDMA/nOM VICs (Figure 6).
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At day 3 cells on, 3% and 19% DEGDMA/nOM have significantly lower
osteocalcin expression than OB VICs (Figure 5B). By day 5 cells on, 33%
DEGDMA/nOM have significantly higher OCN expression than 3% and 19%, and
are at levels comparable to those expressed in OB VICs at the same time point.
Trends remain at day 7 for 33% and OB VICs, however 19% DEGDMA/nOM
VICs now have similar levels of OCN expression to 33% DEGDMA/nOM and OB
VICs. Only 3% DEGDMA/nOM OCN expression levels remains low throughout
the experiment.
Elastin mRNA is lower in VICs grown on DEGDMA/nOM surfaces
compared to OB VICs on day 3. An increasing trend of elastin expression is seen
in VICs on DEGDMA/nOM correlating to stiffness on day 5. Only VIC elastin
expression on 3% DEGDMA/nOM are significantly lower than OB VICs on day 5
(Figure 5C). Col1α2 (collagen) mRNA expression in VICs on 3%, 19% and 33%
DEGDMA/nOM surfaces are significantly increased compared to OB VICs on
days 3 and 5 (Figure 5D). On all surfaces however, VICs show no difference in
collagen or elastin expression on day 7 (Figure 5C, D).

Late Stage VIC morphology and Nodule Formation
At day 7 only OB VICs and VICs on 33% DEGDMA/nOM exhibit formation
of nodules. TCPS and 3% DEGDMA/nOM VICs maintain an elongated
morphology. 19% DEGDMA/nOM VICs shows both elongated and rhomboidal
morphology indicative of a partial transition to the OB phenotype, however no
nodules were visible (Figure 7).
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Discussion
Controlling valvular interstitial cell (VIC) phenotype using synthetic
materials is a promising technique with great potential for aortic valve tissue
engineering. Before this can be realized a better understanding of cellular
responses to biomaterial microenvironments, such as substrate stiffness, need to
be established. Current attempts to measure the influence of stiffness on cell
behavior using hydrogel, polyacrylamide, and polydimethylsiloxane surfaces
have been inconsistent and confounded by a number of issues including limited
ranges of stiffness, changes in surface chemistry presented to the cells, and/or
material alteration and/or degradation [1-3, 14, 15, 21, 23, 24, 29].
The co-polymer network of diethelyene glycol dimethacrylate and n-octyl
methacrylate (DEGDMA/nOM) was chosen to address the limitations of the
available materials based on its biocompatibility as demonstrated by its use as a
dental restorative material [34]. This copolymer can cover a large range of
stiffness while maintaining a consistent surface chemistry, it does not require
surface modification for cellular attachment, and it does not degrade under
culture conditions. In this study, DEGMDA/nOM copolymers were made in three
monomer ratios of DEGDMA to nOM: 3:97 (3%); 19:81 (19%); and, 33:67 (33%)
by weight. The compressive modulus changes exhibited between these
formulations represent a three order of magnitude range (Figure 2). The lower
limit of 3% DEGDMA/nOM was selected to obtain the softest stable freestanding
substrate. 19% DEGDMA/nOM, bounds a critical point for the copolymer where
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additional DEGDMA content has a significant impact as a crosslinking agent. As
a result the copolymer mechanical properties greatly increase with small
additions of DEGDMA beyond this point [34, 35]. For the 3% and 19%
DEGDMA/nOM formulations, the mechanics are primarily controlled by the
concentration of crosslinked chains which is known as the ‘crosslinking effect.’
The 33% DEGDMA/nOM is below its glass transition temperature at 37C and is
a crystalline solid [34]. For the 33% DEGMA/nOM formulation, mechanical
properties are controlled purely based on the monomer ratios present which is
known as the ‘co-polymerization effect’ [31, 34]. As seen in figure 2, the
compressive modulus of the 3% and 19% DEGDMA/nOM substrates increase
from 25 ± 2 to 920 ± 60 kPa. Further increase of DEGDMA content to 33%
results in an increase of ~3,600 kPa above that of the 19% formulation to achieve
this study’s highest compressive modulus of 4,700 ± 300 kPa. These data
demonstrate the flexibility and wide range of the achievable compressive moduli
available with this co-polymer system. This large range of stiffness is important
for study of cells of the heart valve, because healthy tissue to very severe aortic
stenosis stiffness ranges from .001 to 7.38 MPa [12].
Sessile drop goniometry and x-ray photoelectron spectroscopy (XPS)
were conducted to examine the surface properties of the co-polymer network
films. In order to truly isolate stiffness, it is imperative that all other surface
characteristics are preserved between the different formulations. All formulations
exhibit consistent contact angles of ~88.5° indicating that all surfaces exhibit the
same wettability, a property that greatly influences protein adsorption. While
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goniometry is an indirect method that allows us to infer that the surface chemistry
among the formulations remains consistent, XPS was conducted to directly
measure the elemental and chemical binding environment of the material
surface. The maximum and minimum content DEGDMA formulations were
evaluated to ensure that the formulations with the greatest difference in monomer
ratio still maintained a consistent surface chemistry. XPS survey spectra showed
that the elemental composition was the same in each formulation, while the highresolution spectra showing that the surfaces also displayed consistent
presentation of functional groups between treatment groups (Figure 3). These
data indicate that the DEGDMA/nOM copolymer networks present consistent
chemical surfaces regardless of copolymer ratio and stiffness (Table 1).
Utility as a substrate for in vitro cell culture of primary valvular interstitial
cells was assessed by initial VIC attachment and apoptosis after 7 days in culture
(Figure 4). Compared to TCPS, all DEGDMA/nOM substrates had reduced initial
attachment, most likely due to the slightly increased hydrophobicity. This is
shown by goniometry with a contact angle of ~88.5°of the DEGDMA/nOM
compared to the 64.3° ± 1.5 of TCPS [36]. As the attachment results gave
information on the initial response of the cells to the materials, apoptosis was
assessed after 7 days to determine whether long-term exposure resulted in
increased cell death. No increase in apoptosis was detected, signifying
DEGDMA/nOM substrates were cytocompatibility and viable as a cell culture
platform for VICs (Figure 4).
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In previous studies, VICs grown on very soft stiffness moduli (<10 kPa)
substrates exhibited quiescent fibroblastic qualities. While those grown on ~15–
55 kPa substrates, similar to 3% DEGDMA/nOM (25 kPA), preferentially
differentiate to myofibroblasts exhibiting high levels of αSMA [3, 17, 18, 29, 37].
Among all DEGDMA/nOM formulations, αSMA expression did not significantly
differ throughout the experiments. In addition, VICs grown on the DEGDMA/nOM
substrates had significantly lower αSMA expression on all formulations than VICs
on TCPS and OB VICs at all time points (Figure 5A). Generally, αSMA
expression has been considered a hallmark of myofibroblastic VIC differentiation
[17, 23, 26, 29, 38, 39]. Despite consistent levels of αSMA gene expression on
DEGMDA/nOM substrates, there are noticeable differences in αSMA stress fiber
formation corresponding to increases in substrate compressive modulus (Figure
6). Increased actin fiber formation resulting from growth on stiff substrates has
been linked to osteoblastic differentiation in the pre-osteoblastic cell line
MC3T3’s [40], suggesting that the increasing αSMA stress fiber assembly of
VICs may be an important step in VIC OB differentiation [17]. At day 7, nodules
were detected via brightfield microscopy on 33% (4.7 MPa), but not 3% (25 kPa)
or 19% (920 kPa) DEGDMA/nOM supporting the theory that increased αSMA
stress fiber formation may be related to VIC OB differentiation and nodule
formation (Figure 7) [41, 42]. Investigation into the signaling pathways resulting in
αSMA stress fiber formation in VICs without increasing gene expression has not
yet been identified and warrants further study.
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The hypothesis that substrate compressive modulus alone influences VIC
OB differentiation is further supported by changes in VIC expression of the late
stage osteoblastic marker osteocalcin (Figure 5B) [17]. On the softest substrate,
3% DEGDMA/nOM (25 kPa), osteocalcin expression was significantly lower than
for the VICs cultured on the stiffest substrates, 33% DEGDMA/nOM (4.7 MPa) as
well as OB VICs at days 5 and 7. When grown on 33% DEGDMA/nOM (4.7
MPa), VICs expressed OCN near the same levels of OB VICs, suggesting the
higher moduli substrates induce expression of OCN (Figure 5B). We believe that
seeding cells on DEGMA/nOM substrates with compressive moduli in the
megapascal range upregulates osteoblastic gene expression through mechanical
signaling, transmitted through mechanotransduction and integrin activation [2, 5,
16, 43, 44]. However, with lower αSMA gene expression on 33% DEGDMA/nOM
(4.7 MPa) than TCPS and OB VIC controls, we hypothesize that the negatively
charged surface chemistry of TCPS significantly contributes to the activation of
signaling pathways leading to increased αSMA expression, much like that seen
on charged SAMs surfaces described in Rush et al. [5, 7]. For DEGDMA/nOM
substrates, αSMA expression is not changing with compressive modulus, but
stress fiber formation is. Therefore, VIC differentiation to an OB phenotype may
be tied more closely to αSMA fiber formation rather than expression.
Valvular interstitial cell extracellular matrix proteins (ECM) gene
expression was also assessed. The underlying ECM has been shown to induce
changes in VIC phenotype in vitro [5, 14-16, 21, 25]. A large upregulation of
collagen is seen on all DEGDMA/nOM surfaces at day 3, with a significant down
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regulation of collagen expression by day 5 and 7 (Figure 5D). Since collagen
does not differ between DEGDMA/nOM formulations, we believe early collagen
expression does not correlate with VIC OB differentiation. Rather, the VICs
produce collagen to favorably modify the surface of the slightly hydrophobic
DEGDMA/nOM to allow for better VIC attachment, spreading, and proliferation
[15]. Our results also show that elastin gene expression is elevated at day 3 in
OB VICs and VICs cultured on TCPS compared to those grown on
DEGDMA/nOM surfaces (Figure 5C). By day 5, an increasing trend in elastin
corresponding with increasing substrate compressive modulus can be seen,
suggesting that increases in elastin expression may correlate with VIC
differentiation on substrates that differ in compressive modulus.
It has been well established that physical cues from the extracellular
environment influence the phenotypic behavior of cells [2, 5, 45]. However,
studies focusing on the effects of a substrate’s stiffness have been limited due to
a lack of material platforms capable of isolating substrate compressive modulus
without changing the material’s surface chemistry [1-4]. The design of a tunable
material with consistent surface chemistry is therefore very important to the fields
of tissue engineering and biomedical sciences. With the aim of generating better
tissue models of health and disease, use of mechanically relevant materials will
allow for more precise control of growth environments and cellular behavior. As
such, the material DEGDMA/nOM allows for the isolated testing of stiffness
effects on cell behavior over a wide range of stiffness while maintaining
consistent surface chemistry. Our results show that stiffness on the scale of
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megapascals affects VIC behavior. Our 4,700 kPa substrates induce OB VIC
behaviors that include upregulation of OB gene marker osteocalcin, creation of
nodules, and changes in elastin production, all of which are correlated with VIC
OB differentiation. Although αSMA expression did not vary between different
substrate’s compressive modulus, the increase in fiber formation on stiffer
substrates suggests an alternative pathway is being activated to cause VIC OB
differentiation that has not been previously reported. Further studies should
examine the intracellular pathways involved in fiber rearrangement and
mechanosensing of VICs caused by material stiffness.

Acknowledgements
We would like to thank Dr. Kateryna Artyushkova for assistance in X-ray
photoelectron spectroscopy data acquisition and analysis and Dr. Kirsten N.
Cicotte for mechanical testing and helpful discussions. This research was
partially funded by the American Heart Association (10BGIA4570031), NSF
Career Award (NSF CBET1351947), and NSF-PREM (DMR-0611616), UNM
Research Allocation Committee (11-L-01). Educational support was provided by
NSF IGERT (0504276), NSF LS-AMP (HER1026412 (BDVIII)), NIH IMSD (5R25GM060201), and NIH PREP (R25GM075149) fellowships.

90

References
1.

Brown, X.Q., K. Ookawa, and J.Y. Wong, Evaluation of
polydimethylsiloxane scaffolds with physiologically-relevant elastic moduli:
interplay of substrate mechanics and surface chemistry effects on
vascular smooth muscle cell response. Biomaterials, 2005. 26(16): p.
3123-3129.

2.

Nemir, S. and J.L. West, Synthetic Materials in the Study of Cell
Response to Substrate Rigidity. Annals of Biomedical Engineering, 2010.
38(1): p. 2-20.

3.

Quinlan, A.M.T. and K.L. Billiar, Investigating the role of substrate stiffness
in the persistence of valvular interstitial cell activation. Journal of
Biomedical Materials Research Part A, 2012. 100A(9): p. 2474-2482.

4.

Nikkhah, M., et al., Engineering microscale topographies to control the
cell-substrate interface. Biomaterials, 2012. 33(21): p. 5230-5246.

5.

Rush, M.N., K.E. Coombs, and E.L. Hedberg-Dirk, Surface chemistry
regulates valvular interstitial cell differentiation in vitro. Acta biomaterialia,
2015. 28: p. 76-85.

6.

Balgude, A.P., et al., Agarose gel stiffness determines rate of DRG neurite
extension in 3D cultures. Biomaterials, 2001. 22(10): p. 1077-1084.

7.

Dewez, J.L., et al., Competitive adsorption of proteins: Key of the
relationship between substratum surface properties and adhesion of
epithelial cells. Biomaterials, 1999. 20(6): p. 547-559.

91

8.

Ghanian, M.H., et al., Nanotopographical control of human embryonic
stem cell differentiation into definitive endoderm. Journal of Biomedical
Materials Research Part A, 2015. 103(11): p. 3539-3553.

9.

Janson, I.A. and A.J. Putnam, Extracellular matrix elasticity and
topography: Material-based cues that affect cell function via conserved
mechanisms. Journal of Biomedical Materials Research Part A, 2015.
103(3): p. 1246-1258.

10.

Hannigan, G.E., et al., Regulation of cell adhesion and anchoragedependent growth by a new beta(1)-integrin-linked protein kinase. Nature,
1996. 379(6560): p. 91-96.

11.

Danen, E.H.J., et al., The fibronectin-binding integrins alpha 5 beta 1 and
alpha v beta 3 differentially modulate RhoA-GTP loading, organization of
cell matrix adhesions, and fibronectin fibrillogenesis. Journal of Cell
Biology, 2002. 159(6): p. 1071-1086.

12.

Maleki, H., et al., A metric for the stiffness of calcified aortic valves using a
combined computational and experimental approach. Medical & Biological
Engineering & Computing, 2014. 52(1): p. 1-8.

13.

Desmouliere, A., et al., Apoptosis during wound healing, fibrocontractive
diseases and vascular wall injury. International Journal of Biochemistry &
Cell Biology, 1997. 29(1): p. 19-30.

14.

Gu, X.X. and K.S. Masters, Role of the Rho pathway in regulating valvular
interstitial cell phenotype and nodule formation. American Journal of

92

Physiology-Heart and Circulatory Physiology, 2011. 300(2): p. H448H458.
15.

Gu, X.X. and K.S. Masters, Regulation of valvular interstitial cell
calcification by adhesive peptide sequences. Journal of Biomedical
Materials Research Part A, 2010. 93A(4): p. 1620-1630.

16.

Schroer, A.K. and W.D. Merryman, Mechanobiology of myofibroblast
adhesion in fibrotic cardiac disease. Journal of Cell Science, 2015.
128(10): p. 1865-1875.

17.

Liu, A.C., V.R. Joag, and A.I. Gotlieb, The emerging role of valve
interstitial cell phenotypes in regulating heart valve pathobiology.
American Journal of Pathology, 2007. 171(5): p. 1407-1418.

18.

Kheradvar, A., et al., Emerging trends in heart valve engineering: part I.
solutions for future. Annals of Biomedical Engineering, 2015. 43(4): p.
833-843.

19.

Zacks, S., et al., Characterization of Cobblestone Mitral-Valve InterstitialCells. Archives of Pathology & Laboratory Medicine, 1991. 115(8): p. 774779.

20.

Durbin, A.D. and A.I. Gotlieb, Advances towards understanding heart
valve response to in injury. Cardiovascular Pathology, 2002. 11(2): p. 6977.

21.

Gu, X.X. and K.S. Masters, Role of the MAPK/ERK pathway in valvular
interstitial cell calcification. American Journal of Physiology-Heart and
Circulatory Physiology, 2009. 296(6): p. H1748-H1757.
93

22.

Benton, J.A., H.B. Kern, and K.S. Anseth, Substrate Properties Influence
Calcification in Valvular Interstitial Cell Culture. Journal of Heart Valve
Disease, 2008. 17(6): p. 689-699.

23.

Merryman, W.D., et al., Correlation between heart valve interstitial cell
stiffness and transvalvular pressure: implications for collagen
biosynthesis. American Journal of Physiology-Heart and Circulatory
Physiology, 2006. 290(1): p. H224-H231.

24.

Yip, C.Y.Y., et al., Calcification by valve interstitial cells is regulated by the
stiffness of the extracellular matrix. Arteriosclerosis Thrombosis and
Vascular Biology, 2009. 29(6): p. 936-U417.

25.

Rodriguez, K.J. and K.S. Masters, Regulation of valvular interstitial cell
calcification by components of the extracellular matrix. Journal of
Biomedical Materials Research Part A, 2009. 90A(4): p. 1043-1053.

26.

Davis, J. and J.D. Molkentin, Myofibroblasts: Trust your heart and let fate
decide. Journal of Molecular and Cellular Cardiology, 2014. 70: p. 9-18.

27.

Hutcheson, J.D., et al., Cadherin-11 Regulates Cell-Cell Tension
Necessary for Calcific Nodule Formation by Valvular Myofibroblasts.
Arteriosclerosis Thrombosis and Vascular Biology, 2013. 33(1): p. 114-+.

28.

Rodriguez, K.J., et al., Manipulation of valve composition to elucidate the
role of collagen in aortic valve calcification. Bmc Cardiovascular Disorders,
2014. 14: p. 10.

94

29.

Wang, H., et al., Redirecting Valvular Myofibroblasts into Dormant
Fibroblasts through Light-mediated Reduction in Substrate Modulus. Plos
One, 2012. 7(7): p. 12.

30.

Johnson, C.M., M.N. Hanson, and S.C. Helgeson, Porcine cardiac valvular
subendothelial cells in culture: Cell isolation and growth characteristics.
Journal of Molecular and Cellular Cardiology, 1987. 19(12): p. 1185-1193.

31.

Young, J.S., A.R. Kannurpatti, and C.N. Bowman, Effect of comonomer
concentration and functionality on photopolymerization rates, mechanical
properties and heterogeneity of the polymer. Macromolecular Chemistry
and Physics, 1998. 199(6): p. 1043-1049.

32.

Watts, J.F., High resolution XPS of organic polymers: The Scienta ESCA
300 database. G. Beamson and D. Briggs. 280pp., £65. John Wiley &
Sons, Chichester, ISBN 0471 935921, (1992). Surface and Interface
Analysis, 1993. 20(3): p. 267-267.

33.

Beamson, G. and D. Briggs, High-Resolution Monochromated X-ray
Photoelectron-Spectroscopy of Organic Polymers - A Comparision
Between Solid-State Data for Organic Polymers and Gas-Phase Data for
Small Molecules. Molecular Physics, 1992. 76(4): p. 919-936.

34.

Kannurpatti, A.R. and C.N. Bowman, Structural evolution of
dimethacrylate networks studied by dielectric spectroscopy.
Macromolecules, 1998. 31(10): p. 3311-3316.

35.

Kannurpatti, A.R., J.W. Anseth, and C.N. Bowman, A study of the
evolution of mechanical properties and structural heterogeneity of polymer
95

networks formed by photopolymerizations of multifunctional
(meth)acrylates. Polymer, 1998. 39(12): p. 2507-2513.
36.

Arima, Y. and H. Iwata, Effect of wettability and surface functional groups
on protein adsorption and cell adhesion using well-defined mixed selfassembled monolayers. Biomaterials, 2007. 28(20): p. 3074-3082.

37.

Chen, J.H., et al., Identification and characterization of aortic valve
mesenchymal progenitor cells with robust osteogenic calcification
potential. American Journal of Pathology, 2009. 174(3): p. 1109-1119.

38.

Duan, B., et al., Three-dimensional printed trileaflet valve conduits using
biological hydrogels and human valve interstitial cells. Acta Biomaterialia,
2014. 10(5): p. 1836-1846.

39.

Mol, A., et al., Tissue engineering of heart valves: advances and current
challenges. Expert Review of Medical Devices, 2009. 6(3): p. 259-275.

40.

Khatiwala, C.B., S.R. Peyton, and A.J. Putnam, Intrinsic mechanical
properties of the extracellular matrix affect the behavior of pre-osteoblastic
MC3T3-E1 cells. American Journal of Physiology-Cell Physiology, 2006.
290(6): p. C1640-C1650.

41.

Walker, G.A., et al., Valvular myofibroblast activation by transforming
growth factor-beta - Implications for pathological extracellular matrix
remodeling in heart valve disease. Circulation Research, 2004. 95(3): p.
253-260.

96

42.

Prager-Khoutorsky, M., et al., Fibroblast polarization is a matrix-rigiditydependent process controlled by focal adhesion mechanosensing. Nature
Cell Biology, 2011. 13(12): p. 1457-U178.

43.

Pelham, R.J. and Y.L. Wang, Cell locomotion and focal adhesions are
regulated by substrate flexibility. Proceedings of the National Academy of
Sciences of the United States of America, 1997. 94(25): p. 13661-13665.

44.

Rehfeldt, F., et al., Cell responses to the mechanochemical
microenvironment - Implications for regenerative medicine and drug
delivery. Advanced Drug Delivery Reviews, 2007. 59(13): p. 1329-1339.

45.

Rehmann, M.S., et al., Tuning microenvironment modulus and
biochemical composition promotes human mesenchymal stem cell
tenogenic differentiation. Journal of Biomedical Materials Research Part A,
2016. 104(5): p. 1162-1174.

97

Figures and Tables

Figure 1. Network crosslinking scheme of DEGDMA/nOM.
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Figure 2. Compressive modulus of 3% (25 kPa inset), 19% (925 kPA) and 33%
(4750 kPa) DEGDMA/nOM are significantly different (p< 0.05*).
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Table 1. X-ray Photoelectron Spectroscopy
Percentages
C 1s
O 1s
C / O Ratio
3%DEGDMA
Experimental
3% DEGDMA
Stoichiometric
33% DEGDMA
Experimental
33% DEGDMA
Stoichiometric

79.2

16.4

4.7

85.0

15.0

5.7

80.7

17.4

4.6

81.0

19.0

4.3

Table 1. Elemental composition of the maximum and minimum DEGDMA content
substrates made determined by XPS analysis. Values represent the relative
atomic percentage of each species present on the surface averaged from two
locations. Trace amounts of (<1%) nitrogen and silicon (<4%) was also detected.
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Figure 3. Representative survey and high-resolution scans from 3 and 33 wt%
DEGDMA/nOM. A) Survey scans, show surface elemental composition of
primarily oxygen and carbon with trace amounts of nitrogen and silicon. B) The
O1s hi-resolution spectra for 3% and C) 33 % DEGDMA/nOM demonstrate
similar peak shapes between the two formulations. The surface reproducibility is
confirmed by the C1s high-resolution scans of the D) 3% and E) 33%
DEGDMA/nOM substrates.
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Figure 4. A) Attachment at 24 hrs shows a significant difference in VIC
attachment of DEGDMA/nOM surfaces normalized to TCPS. B) Doubling times
of VICs, with 3% growing significantly slower than 19 and 33% DEGDMA/nOM (*
p ≤ 0.05) and OB growing significantly faster than TCPS (** p ≤ 0.05). C)
Apoptosis at 7 days in culture is significantly increased in the dead control (*p ≤
0.01).
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Figure 5. Gene expression of A) alpha smooth muscle actin (αSMA), B)
osteocalcin (OCN), C) Collagen 1 alpha 2 (Collagen), and D) Elastin. A)
Osteoblastic VICs express significantly higher αSMA at all time points compared
to all DEGDMA/nOM substrates. B) 3% DEGDMA/nOM VICs express
significantly less OCN than OB and 33% DEGDMA/nOM at 5 and 7 days (*p ≤
0.05). 33% DEGDMA/nOM expresses significantly more OCN than 19%
DEGDMA/nOM at day 5 (**p ≤ 0.05). C) OB VICs express significantly higher
elastin than 3 or 33% DEGDMA/nOM at day 3 (*p ≤ 0.05), but remain
significantly higher than 3% DEGDMA/nOM by day 5 (**p ≤ 0.05). D)
DEGDMA/nOM surfaces have increase collagen 1α2 expression at day 3 and
day 5 compared to OB VICs (*p ≤ 0.05).
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Figure 6. αSMA staining (green) on A) 3% B) 19%, C) 33% and D) OB VICs at
day 3 counterstained nuclei with DAPI (blue). Notice the development of αSMA
stress fibers (white arrows) on 33% DEGDMA/nOM and OB VICs compared to
3% and 19% DEGDMA/nOM.
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Figure 7. Optical images of all treatment at day 7. A) 3% B) 19% C) 33% D)
TCPS and E) OB VICs. Arrows indicate nodules.
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Abstract
The primary driver for valvular calcification is the differentiation of valvular
interstitial cells (VICs) into a diseased phenotype. However, the factors leading to
the onset of osteoblastic-like VICs (obVICs) and resulting calcification are not
fully understood. This study isolates the effect of substrate surface chemistry on
in vitro VIC differentiation and calcified tissue formation. Using -functionalized
alkanethiol self-assembled monolayers (SAMs) on gold [CH3 (hydrophobic), OH
(hydrophilic), COOH (COO-, negative at physiological pH), and NH2 (NH3+,
positive at physiological pH)], we demonstrate that surface chemistry modulates
VIC phenotype and calcified tissue deposition independent of osteoblasticinducing media additives. Over seven days VICs exhibited surface-dependent
differences in cell proliferation (COO- = NH3+> OH > CH3), morphology, and
osteoblastic potential. Both NH3+and CH3-terminated SAMs promoted calcified
tissue formation while COO--terminated SAMs showed no calcification. VICs on
NH3+-SAMs exhibited the most osteoblastic phenotypic markers through robust
nodule formation, up-regulated osteocalcin and α-smooth muscle actin
expression, and adoption of a round/rhomboid morphology indicative of
osteoblastic differentiation. With the slowest proliferation, VICs on CH3-SAMs
promoted calcified aggregate formation through cell detachment and increased
cell death indicative of dystrophic calcification. Furthermore, induction of calcified
tissue deposition on NH3+ and CH3-SAMs was distinctly different than that of
media-induced osteoblastic VICs. These results demonstrate that substrate
surface chemistry alters VIC behavior and plays an important role in calcified
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tissue formation. In addition, we identified two novel methods of inducing VIC
calcification in vitro. Further study of these environments may yield new models
for in vitro testing of therapeutics for calcified valve stenosis and although
additional studies need to be conducted to correlate results to in vivo models.
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Introduction
Valvular heart disease (VHD) is estimated to affect 2.5% of the US
population with a disproportionate impact on an increasing elderly community.[1,
2] Derived from infections, valve degeneration, or genetic disorders, VHD can
manifest as regurgitation or stenosis of the valve. As a result of obstructed blood
flow, valve stenosis generates transvalvular gradients that trigger compensatory
ventricular hypertension, leading to increased risk for other cardiovascular
disorders.[1-3] As such, VHD represents a significant health risk worldwide.
Furthermore, rises in the prevalence of VHD will continue to increase as the
elderly population grows due to advances in medical technology.[1-5]
The leading cause of VHD is valve stenosis, characterized by valve
thickening, increased protein deposition, and eventual calcification.[3, 4, 6] The
primary driver for valvular calcification is the differentiation of valvular interstitial
cells (VICs) into a disease inducing phenotype.[6, 7] However, the factors leading
to the onset of VIC differentiation and resulting calcification are not fully
understood and a more complete characterization of VIC differentiation and
phenotypic change is required before treatment of valve disease can be realized.
As the predominant cell type within the valve, VICs are responsible for
valve formation, remodeling, and tissue homeostasis. VICs are a heterogeneous
population that undergo phenotypic changes regulated by environmental factors.
VICs have been shown to alter phenotype in response to soluble factors,[8-11]
substrate stiffness,[6, 8, 12-15] and surrounding extracellular matrix proteins.[8,
10, 11, 16-21] Although phenotypic change is a dynamic event, VIC function is
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frequently compartmentalized in order to clarify and separate the underlying
causes.[22]
VICs are commonly characterized as quiescent (qVIC), activated (aVIC),
and disease phenotypes. In a normal adult valve, qVICs are thought to preserve
physiological structure and function while maintaining a low level of matrix
synthesis and degradation inhibiting angiogenesis.[22] Following injury or
abnormal hemodynamic/mechanical stress, VICs become activated (aVICs,
myofibroblastic) and are associated with increased extracellular matrix secretion
and expression of various biological markers including -smooth muscle actin (SMA), matrix metalloproteinases, and transforming growth factor-β.[22, 23]
Activated VICs exhibit increased contraction, prominent stress fiber formation,
increased proliferation, and migration.[22] In vitro, aVICs display an elongated
morphology and form orthogonal patterns of overgrowth resembling hills and
valleys.[6] Upon completion of remodeling or wound healing, most aVICs are
eliminated by apoptosis or reversion to qVICs.[24]
When VIC dysregulation or abnormal extracellular matrix production
occurs, conversion to diseased phenotypes results in pathological fibrosis and
calcification of the valve.[10, 24] The mechanisms of VICs tissue calcification
have been intensely studied and currently two processes have been proposed.
[5, 25-27] Dystrophic calcification is a passive degenerative process
characterized by early cell injury and deposition of calcium associated with tissue
damage and necrotic cells. [10, 25, 26] Alternatively, osteogenic calcification
(ossification) is an active process involving bone and cartilage development,
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marked by the expression of various osteogenic markers. [7, 25, 26, 28] In vitro,
VICs undergoing osteogenesis and osteoblastic-like VICs (obVICs, are
characterized by a round/rhomboid morphology followed by the formation of
three-dimensional calcified nodules. It is important to note that these two
processes are not mutually exclusive as a common activator of tissue
calcification, TGF-β, has been shown to lead to cellular apoptosis as well as
nodule formation.[10] However, different processes may arise due to variations in
signaling in the cellular microenvironment. Forced obVIC differentiation in vitro is
commonly achieved by adding soluble signaling factors (β-glycerophosphate,
ascorbic acid, and dexamethasone) to media. However, spontaneous in vitro
nodule formation in media lacking osteoblastic inducing additives,[8] as well as
calcification of decellularized biological valves in vivo, suggests calcification may
be mediated by additional physical cues.[29]
To understand how surface chemistry correlates to VIC behavior and
initiation of valvular disease, we used alkanethiol self-assembled monolayers
(SAMs) of -functionalized alkanethiolates on gold as model substrates with
uniform chemistry. The chemisorption of thiols to gold and the hydrophobic
interactions of alkane chains results in stable, ordered, and well-packed
monolayers (Figure 1).[30] As such, SAMs offer well-defined models for
systematically investigating phenotypic change directed by surface chemistry.
Four physiologically relevant functional groups were used to assess the effects of
substrate hydrophobicity and charge on VIC phenotypic behavior. Due to the
negatively charged environment present during valvulogenesis through increased
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hyaluronic acid expression, it was hypothesized that anionic functional groups
would result in VIC activation and tissue production.[31, 32]

Materials and Methods
Reagents and Chemicals
All chemicals were purchased from Sigma-Aldrich chemicals unless
otherwise noted. All cell culture media and reagents were purchased from
Thermo Fisher Scientific, unless otherwise noted.

Fabrication of Self Assembled Monolayers
Gold-coated round 15 mm glass cover slips (26021, Ted Pella Inc.) were
used as substrates for self-assembled monolayer (SAMs) formation. Coverslips
were etched for 30 minutes prior to gold deposition in Piranha solution [70% (v/v)
concentrated H2SO4, 30% industrial grade H2O2 (KMG Chemicals)] rinsed with
diH2O, and blown dry with N2. Gold coating was conducted by sequential electroevaporation of optically transparent films of chromium, adhesion layer (2 nm;
High Vacuum Evaporator Systems), followed by gold (30 nm, 99.99% purity;
Plasmaterials). Metal deposition was accomplished at 2 nm/s using a
Thermionics VE-90 vacuum Evaporation System (TLI Enterprises) with chamber
pressures at or below 1 x 10-5 Torr. Freshly prepared gold substrates were
immersed in 1mM ethanolic alkanethiol solutions [1-dodecanthiol (47-136-4); 11mercapto-1-undecanol (447528-16); 11-mercaptoundecanioc acid (450561-5G);
11-amino-1-undecanethiol, hydrochloride 1N NaOH (A423, Dojindo
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Laboratories)] and SAMs were allowed to assemble for 12 hours.[30, 33] Etched
cover glass and gold-coated controls were incubated alongside SAMs in absolute
ethanol. Before use or characterization, samples were cleaned of unbound thiols
in absolute ethanol and dried with N2. In order to obtain desired charge on COOH
(COO-) and NH2 (NH3+) surfaces, samples were rinsed in 1N basic (NaOH; EMD)
and acidic (HCl; EMD) ethanol solutions, respective of charge group, blown dry
with N2 and then cleaned.[34]

Contact Angle Measurements
Static contact angles and images were evaluated using the sessile drop
technique on a Model 100-00-115 Advanced goniometer (ramé-hart Inc.).
Briefly, 5 μL of ultrapure water was pipetted onto sample surface and the contact
angles were measured immediately after drop formation to minimize the effect of
dynamic surface wetting and evaporation. Contact angle measurements between
the water droplet and the sample surface were determined using DROPimage
Standard software (ramé-hart).

X-Ray Photoelectron Spectroscopy (XPS)
XPS survey and high resolution spectra were obtained using Axis Ultra
spectrometer (Kratos Analytical Ltd.) with a monochromatic Al K(α) (1486.6 eV)
source at 225W. High-resolution spectra of carbon and oxygen were obtained for
three areas for each sample at 30˚ and 90˚ take-off angles. Electron pass energy
of 20 eV was used to analyze the regions of interest and curve fitting was
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performed on each spectral region to calculate atomic percentages. Base
pressure was less than 5 x 10-9 Torr. Charge compensation was accomplished
using low energy electrons. Linear background was used for elemental
quantification of C1s and O1s spectra. Quantification utilized sensitivity factors
provided by the manufacturer. All the spectra were charge referenced to Au at 84
eV. Curve fitting was carried out using individual peaks of constrained width,
position, and 70% Gaussian/ 30% Lorentzian line shape.

Atomic Force Microscopy
Scanning was performed at 2.50 µm/s (0.25 Hz) using a super sharp
silicon probe (SSS-NCH, r > 5nm, Nanoworld) on an MFP3D-BIO (Asylum
Research).

Ellipsometry
Freshly prepared samples were analyzed for film thickness using a
Nanofilms EP3 optical ellipsometer @ 532nm (Accurion). Samples were
collected at an incident angle of 70˚ for three areas on three different samples.
The layer thickness was calculated using an index of refraction n = 1.52.[35, 36]

Primary Cell Extraction & Characterization
VICs were obtained through primary cell extraction from recently excised
pig hearts (Hormel Foods Corp.) shipped overnight on ice. Aortic heart valves
leaflets were removed and washed in 25 mL Dulbecco’s phosphate buffered
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solution (DPBS) containing 2% (v/v) penicillin/streptomycin (P/S, Life
Technologies). Three hearts (9 leaflets) were combined in 25 mL collagenase
solution [12,500 units collagenase (LS004174, Worthington Biochemical Grp.) in
50 mL Media 199 (Hyclone, SH30253.01)] filtered through 22 µm Steriflip unit
(Millipore) and incubated at 37°C for 15 min with gentle agitation. Both sides of
leaflets were scraped and rinsed in DPBS to remove endothelial cells. Leaflets
were then incubated with 25 mL fresh collagenase solution at 37°c for 60 min
with gentle agitation. Leaflets were vortexed for 2 min to loosen attached cells.
Supernatant was collected and filtered through 100 µm cell strainer (BD Falcon).
To remove valvular endothelial cells (VECs), cell solutions were incubated with
50 µL of magnetic beads labeled with CD31 antibody (Dynabead CD31, Life
Technologies) at 4°C for 30 minutes with occasional mixing. Dynabeads were
removed by magnetic separation. VICs were then placed in a new conical tube
and centrifuged. Supernatant was removed and cells were re-suspended in VIC
media [Media 199 (Hyclone), 10% FBS, 1% P/S, & 1% Fungizone]. Cells were
seeded in T75 flasks (collagenase sample), and remaining leaflet material was
diced and plated into 6-well plates (Corning), 1 leaflet/well, to allow remaining
VICs to migrate from leaflet (explant sample).
VICs were incubated (37°C, 5% CO2, ~90% RH) and grown for 7-10 days,
with media changes every other day. Cell supernatant was removed from T75
flasks after 2 days of attachment. Heart valve leaflets were removed from well
plates after 3 days. Cells were grown to 70% confluence and enzymatically
detached from surface with 2 mL of .25% (w/v) trypsin (Life Technologies).
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Collagenase and explant samples were combined in M199 media with 10% FBS
(v/v) and 10% DMSO (EMD), and cryogenically frozen until use. VICs were
seeded on SAMs between passages 3-4.

Cell Growth & Viability
Before seeding on substrates, VICs were thawed and grown to 80%
confluence to ensure cell viability. For all experiments, substrates were
equilibrated with complete growth media [Medium 199, 10% fetal bovine serum,
1% penicillin/streptomycin, 1% fungizone] prior to cell seeding at 21,500
cells/cm2. Media was replaced after 12 hours to remove unbound cells
(attachment) and changed every two days. Osteoblastic controls were grown in
OB media [Media 199, 10% fetal bovine serum, 10mM β-glycerophosphate, 2
mM ascorbic acid, & 10-7M dexamethasone] [6] after initial 12-hour attachment.
Substrates were rinsed prior to testing. Cell attachment and proliferation was
assessed after 12 hours, and at 3, 5, & 7 days using MTT calorimetric assay (301010K, ATCC) according to manufacturer’s instructions.
VIC viability was further investigated using AlexaFluor 488 Annexin
V/Dead cell apoptosis kit (V13241, Life Technologies) according to
manufacturer’s instructions. Briefly, at 12 hrs and 5 and 7 days, culture media
was removed and retained for apoptotic/dead cell concentrations while attached
cells were enzymatically removed from surfaces. Cells were centrifuged,
supernatant removed, and cell pellet re-suspended in 1x annexin binding buffer.
Necrotic controls were achieved by incubating with 70% (v/v) ethanol. Apoptotic
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controls were achieved by leaving cultures at room temperature overnight. All
samples were incubated with 100 µL staining solution [5 µL Annexin V and 1 µL
propidium iodide @ 100µg/mL in 1x annexin binding buffer] for 15 minutes.
Samples were read on Accuri C6 flow cytometer (BD Bio.).

Calcium Content
After 5 and 7 days, calcium deposition was visualized by incubating cells
with the anthriquinone dye alizarin red S (ARS), forming a complex via chelation.
Briefly, culture medium was aspirated and cells were rinsed 3x with DPBS
followed by fixation using 10% formalin for 1 hour. After fixation, 100 µl of 40 mM
ARS staining solution (pH 4.1) was added to each well and incubated for a
minimum of 30 minutes in the dark at room temperature. [6] Upon completion the
ARS solution was aspirated and the wells were rinsed 3x with diH20 then PBS in
order to ensure removal of non-specific ARS stain. Samples were imaged under
brightfield with phase contrast 10x magnification objectives (Eclipse TS1000).
Calcified tissue and nodule diameter was determined using Image J (NIH).

Gene Expression
All reagents for gene expression were purchased from Life Technologies
unless otherwise noted. mRNA was extracted from cell samples using RNAeasy
plus micro kit (Qiagen 74034) with gDNA removal, according to manufacturer’s
instructions. Total mRNA content was analyzed using Nanodrop UV/Vis
Spectrometer (Model 2000c, Thermo Fisher Sci.) and reverse transcription
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carried out using GoScript reverse transcriptase system (Promega). Gene
expression of αSMA/ACTA (Ss04245588_m1), osteocalcin/BGLAP
(Ss03373655_s1), collagen I-α2 (Ss03375690_U1), and elastin (EMLIN: Custom
Primer#AJLJIR9) were analyzed using TaqMan Gene Expression master mix,
according to manufacturers specifications, and measured on a StepOne Real
Time-PCR (Applied Bio). Data was collected and analyzed using StepOne
software v2.2.2. All samples were compared to GAPDH (Ss03374854_g1)
endogenous controls.

Immunocytochemical (ICC) Staining
Cells were fixed with 10% formalin for one hour and washed twice with
DPBS. Cells were then permeabilized with 0.01% (v/v) Tween20 in DPBS
(PBST) for 15 min followed by reactive ion removal using 10% (m/v) sodium
azide and 10µM H2O2 in PBST. Samples were incubated with primary antibodies
(αSMA, ab7817) diluted 1:75 in a 3% (w/v) BSA solution for 90 minutes. Primary
antibodies were removed and samples washed twice with PBST followed by
secondary antibodies goat anti-mouse AlexaFluor 488 (A11001, Invitrogen)
1:400 in DPBS incubation for 90 minutes. Cells were counter stained with DAPI
in DPBS (1:1000, Invitrogen) for 5 minutes. Samples were mounted
(Fluoromount, F4680-25ML) on glass slides and sealed with clear nail polish.
Samples were imaged on a Zeiss LSM 510 META microscope with 40x oil 1.3
NA objective.
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Statistical Analysis
All results were analyzed using one-way analysis of variance followed by
Tukey-Kramer post hoc analysis with Sidak correction for multiple comparisons
and a 95% confidence interval (p < 0.05). All analyses were done using Prism 6
software (GraphPad).

Results
Surface Characterization of Self-Assembled Monolayers
Self-assembled monolayers expressing four different functional groups
(CH3, OH, COO-, NH3+) were used as model surfaces to assess the effect of
substrate chemistry on VIC phenotype. These four chemistries exhibit different
degrees of wettability and charge. CH3-SAMs are non-polar and relatively
hydrophobic, whereas, OH, COO-, and NH3+ are relatively hydrophilic. At
physiological pH (7.4) partially ionized COOH and NH2 SAMs present negative or
positive charges, respectively (COO- and NH3+).[34, 35] Gold-coated and
uncoated glass were run as negative control substrates. Results from all
experiments performed showed no statistical difference between the gold (Au)
and glass controls. Therefore, only Au data are included. As current methods of
osteoblastic differentiation utilize supplemented media, obVIC-media induced
positive control samples on glass were used. All surface treatments and controls
were characterized prior to VIC studies.
Static water contact angles of SAMs measured by goniometry are
summarized in Figure 1. Measured values are in agreement with those reported
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in literature.[33, 37] X-ray photoelectron spectroscopy analysis of surface
chemistry agrees with theoretical percentages (Supplemental Figure I).
Ellipsometric measurements of SAMs indicate monolayer formation, with
confirmation by atomic force microscopy (Supplemental Figure II and Table
1).[34, 35]

Proliferation and Cellular Density of VICs
Initial differences in the number of attached cells were observed within the
first 12 hours (Supplemental Figure III). CH3-SAMs resulted in significantly lower
attachment (53% of attachment average) as compared to all other treatments
when seeded at 21,500 cells/cm2. Results reflect literature showing decreased
cell adhesion to hydrophobic surfaces.[37-39] In order to provide uniform seeding
density all subsequent experiments were seeded at 43,000 cells/cm2 on CH3SAMs and 21,500 cells/cm2 on all other surfaces ensuring no significant
difference in initial cell density between treatments (Figure 2).
Proliferation of VICs was assessed over seven days, demonstrating
variations in growth rate due to substrate chemistry. A lack of initial proliferation
on CH3 and OH-SAMs resulted in a significantly lower cell concentration at day 3.
Over the same time, VICs on glass induced with OB media demonstrated the
greatest proliferation rate and significantly higher cell concentration. All other
treatments (Au, COO-, and NH3+) resulted in a moderate initial proliferation rate.
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Morphological Variation Between Surfaces
By day 3 VICs on all surfaces exhibited an elongated morphology (Figure
3). However, between days 3 and 5, significant morphological differences
amongst treatments emerged. Individual VICs in OB media developed a
round/rhomboid morphology and spread to fill the entire growth area. Similar
round/rhomboid VIC morphology was exhibited by NH3+, CH3, and OH-SAMs to
varying degrees (Figure 3, Supplemental Figure IV-V). VICs on COO--SAMs and
Au maintained elongated morphology through 5 days.
By day 7 VICs on Au, OH, and COO--SAMs developed highly aligned
confluent cultures, similar to aVICs,[6, 22] while VICs in OB media and on NH3+SAMs tended to adopt a round/rhomboid morphology with non-linear/spread
confluent cultures (Figure 3). As the only surface not to reach confluence, VICs
on CH3-SAMs had a round morphology in lower density regions, and formed
clustered aggregates in higher density areas. The tendency for cellular
aggregates on CH3-SAMs to partially detach from the surface led to the formation
of sheeted aggregates semi-suspended in culture media (cell sheets). Cell
sheets were typically bound by a single edge resulting in the cell sheet folding
back upon itself (Supplemental Figure VI).

Development of Calcified Nodules
At confluence (day 7), cells on all treatments except COO--SAMs and
osteoblastic culture exhibited some degree of calcification (Figures 3 and 4). On
CH3-SAMs early cellular clustering resulted in the formation of large cellular
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aggregates (221 ± 123 µm). On Au and OH-SAMs, small spherical nodules were
observed infrequently and the nodules were typically small (30-60 µm), indicative
of recent formation. Distinct from all other treatments, VICs grown on NH3+-SAMs
exhibited nodule formation by day 5, which increased in size (115 ± 40 µm) and
frequency by day 7 (Figure 3 and Table 1). VICs grown in OB media exhibited no
nodule formation through 7 days, consistent with the observation that nodules
typically appear between 14 and 21 days under supplemental media conditions
(without TGF-β).[6, 8, 40] Small nodules were observed in OB cultures when
cultured at 14 days (Supplemental Figure VII).
Nodule formation is typically accompanied by apoptosis and deposition of
Ca2+. In order to determine calcium deposition and apoptosis/necrosis, samples
were stained with alizarin red S and imaged using bright field microscopy, or
evaluated by flow cytometry using annexin V and propidium iodide. After 7 days,
VICs grown on COO--SAMs were the only cells to lack nodule formation or
calcium staining (Figure 4). On Au and OH-SAMs VICs exhibited few small
alizarin red S stained nodules, while VICs on CH3-SAMs exhibited calcium within
cellular aggregates with no distinct boundary. OB media induced VICs exhibit
some cellular alizarin red S staining, but no aggregate nodular structures were
observed. NH3+-SAMs, however, developed tightly bound, spherical calcium
nodules with significant alizarin red S staining (Figure 4, arrows). When
apoptosis was assessed at day 7, VICs exhibited equivalent levels of apoptosis
on all treatments (Figure 5a). Overall cell death, staining positive for annexin V
and propidium iodide, was statistically elevated on CH3-SAMs (Figure 5b).
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Genetic Analysis of Phenotypic Markers
In order to determine phenotype of VICs, samples were tested for
common genetic markers. The development of contractile α-SMA cytoskeletal
filaments is an accepted indicator of activation.[22, 41] At 3 and 5 days VICs
grown on NH3+-SAMs and OB media had a significant up-regulation of α-SMA
mRNA expression compared to other treatments (Figure 6A). Similar upregulation was observed in VICs stained for α-SMA using immunocytochemistry
(Supplemental Figure V). Osteocalcin (OCN), a late-stage marker of OB
differentiation[6, 22] that typically accompanies the onset of nodule formation
was evaluated at 5 and 7 days of culture. By day 7, VICs grown on NH3+-SAMs
had a significant increase in OCN mRNA expression compared to all other
treatments including media-induced obVICs (Figure 6B). To assess ECM
production, collagen I and elastin mRNA expression were quantified at 3 and 5
days (Figure 7). After 3 days, collagen was upregulated on NH3+-SAMs hand
media induced osteoblastic controls. Collagen expression appeared to be
elevated in CH3-SAMs, but results were not statistically different from Au
controls. By day 5, all SAMs treatments are significantly lower than Au controls.
Elastin expression was elevated on NH3+ surfaces at day 5, accompanying
nodule formation.
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Discussion
Many factors influencing VIC phenotype have been studied to better
understand calcified nodule formation and to manipulate in vitro culture for
healthy tissue production.[6, 8-11, 17-21] Previous research investigating the
effect of distinct protein layers on VIC phenotype has attempted to control the
cellular binding environment through adsorption and presentation of specific
proteins onto tissue culture polystyrene. [6, 8-11, 17-21] However, the nonhomogeneous surface of tissue culture substrates causes disorganized
deposition of proteins with uncontrolled orientations,[8, 42] resulting in conflicting
results in the literature.[18, 20]

Alkanetiolate Self-Assembled Monolayers
The uniform SAMs surface chemistry appears to facillitate for controlled
protein deposition and orientation, with distinct and reproducible culture surfaces
to study cell behavior in different microenvironments.[37, 38, 42, 43] In previous
work, it has been observed that proteins in culture adsorb at a faster rate than
cell attachment, and dictate cell-surface interactions.[38, 44] Specifically the
adsorption of serum proteins and specific extracellular matrix proteins varies with
hydrophobic/hydrophilic and charged surfaces. Variability in their tertiary
structure changes with surface chemistry, resulting in variation in available
cellular attachment domains.[37-39, 43, 45]
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Media-Induced Osteoblastic VICs
As a positive control VICs were grown in OB media on glass. Proliferation
rate and cell spreading was similar to results reported in the literature.[6] While
calcification did not occur in cell cultured in OB media within the seven days of
this study, cultures extended for 14 days developed the expected nodule
formation. This is in agreement with previous studies showing nodule formation
occurs between 14-21 days in low-density (<25,000 cells/cm2) cultures, typically
after the development of αSMA stress fibers, cellular detachment, and
contraction.[6, 9, 40] For this reason, αSMA is considered necessary for
osteoblastic differentiation, suggesting that qVICs must go through activation to
transform to in obVICs and develop tissue calcification.[9, 23] However, cells
grown on CH3-SAMs suggest a direct transition through well-defined stress fiber
formation (quiescent  activated  osteoblastic) is not always necessary for the
development of calcification, similar to previous observations of dystrophic
calcification caused by cell death.[10]

Non-activated VIC Calcium Deposition on CH3-SAMs
As hydrophobic CH3-SAMs have been shown to irreversibly adsorb and
denature proteins resulting in loss of cellular binding domains, CH3-SAMs provide
examples of into changes in VIC phenotype that result from low cell
adhesion.[38, 39, 44] The slow proliferation, cellular aggregation, and formation
of loosely adhered cell sheets suggest minimal interaction between the VICs and
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CH3-SAMs. As such, the early aggregate behavior of VICs maybe the result of
cell-cell adhesion to compensate for a lack of cell-surface adhesion.
Previous experiments have shown the release of mechanical tension on
VICs also leads to increased apoptosis and in vitro calcification.[6, 7, 46, 47]
Increased αSMA expression typically accompanies nodule formation, thus,
calcification on hydrophobic surfaces without elevated αSMA expression
suggests that VIC detachment may result in calcification without the need for
αSMA-mediated contraction.[9, 23] Higher Ca2+ deposition under hydrophobic
conditions are therefore likely related to the high cell necrosis levels observed
through classical dystrophic mechanisms of cell death resulting in release of
intracellular calcium and aggregation under this condition. Previous results by
Jain B. et al. have shown that tissue calcification in vitro does not require cellular
contraction and spherical nodule formation to induce apoptosis and calcium
deposition.[6, 10] As such, less cell adhesion and possibly altered integrin and
cell-cell signaling may be the triggering events for increased cell death and Ca2+
deposition under these experimental conditions.[6, 48] Further studies are
needed to determine if this observed behavior is similar to that in vivo disease.

Osteoblastic VIC Differentiation on NH3+-SAMs
With increased proliferation, elongated morphology, and increased αSMA
expression over other functionalized SAMs, VICs grown on NH3+ surfaces exhibit
early myofibroblastic behavior. With the onset of a round/rhomboid morphology,
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robust nodule formation, and OCN expression, NH3+-SAMs undergo a clear
transition from an aVIC to obVIC between days 3 and 5. The expression of OCN,
a late stage osteoblastic marker, and the early appearance of calcified nodules
suggests an accelerated transition between activated and osteoblastic
phenotypes on cationic surfaces. Such behavior correlates with the observed
osteoblastic differentiation of pre-osteoblastic cells on NH3+ surfaces.[39]
Compared to the soluble factors used in OB media induction, the rapid obVICs
differentiation on NH3+-SAMs is controlled by cell-surface interactions, as no
media additives were present. As no calcium deposition and gene expression in
osteoblastic culture were observed during this same timepoint, the accelerated
obVIC behavior is likely the result of signaling induced by cell-material
interactions specific to protein adsorption on NH3+ surfaces.
NH3+-SAMs have been shown to preferentially adsorb greater amounts
collagen and fibronectin than other hydrophilic groups (COO- and OH).[43]
However, the influence of collagen and fibronectin on VIC nodule formation is
unclear.[10, 18-20] Such behavior may result from different extracellular matrix
proteins in these cultures. Interestingly, NH3+-surfaces also resulted in a
significant up-regulation of elastin expression over all other surfaces, which
seems to correspond with development of nodules in culture at day 5. As
fibronectin is required for microfibril formation onto which elastin is deposited, the
early availability of fibronectin on NH3+-SAMs may be at least partially
responsible for the increased rate of nodule formation by VICs.[49, 50]
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Delayed Growth on OH-SAMs
Previous research has demonstrated decreased protein adhesion on OHSAMs, and thus, lower levels of binding domains available for cell attachment
and proliferation.[36, 37, 45, 51] In this study VICs have shown limited
attachment and proliferation over the first 3 days, but do not undergo significant
apoptosis (Figure 5). No significant increase in collagen or elastin mRNA
expression was observed up to 3 days in culture. However, collagen expression
increased by 5 days. The increased cell spreading and proliferation of VICs on
OH-SAMs suggests secretion of ECM proteins by VICs on these surfaces is
sufficient to maintain viability and recover cellular functions. Lack of OCN
expression and adoption of an elongated morphology with highly aligned cultures
suggests OH-SAMs maintain the aVIC phenotype. However, as VICs on OHSAMs eventually develop to nodule formation at high cell densities, OH
substrates may not be ideal for VIC expansion in vitro.

Non-Osteoblastic Activation of VICs on COO--SAMs
The activation of VICs on COO--SAMs characterized by rapid proliferation
and maintenance of an elongated, myofibroblastic morphology at confluence
indicates COO--SAMs are a favorable substrate for cell amplification. While
confluent VIC cultures tend to undergo rapid conversion to obVICs,[8, 10, 40]
COO--SAMs do not exhibit such behavior, suggesting the negative charged
environment inhibits osteoblastic differentiation of VICs.[18, 39, 43] Proliferation
without confluent nodule formation with confluence supports the hypothesis that
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activation of VICs on negatively charged substrates is similar to hyaluronic-acid
rich valvulogenesis.[31] However, the lack of increased αSMA expression and
protein (collagen or elastin), suggests secondary signaling may be required for
healthy tissue production.

Cell-Material Phenotypic Signaling
It has been suggested that VICs in osteoblastic media do not become true
osteoblasts due to a lack of osteoblastic expressed gene markers. This has led
to the theory of dystrophic calcification mechanisms in VICs.[52] In this study,
osteocalcin expression and an osteoblastic morphology suggest VIC phenotype
on NH3+ SAMs may mimic osteogenic differentiation rather than dystrophic
mechanisms. This may be due to changes in integrin expression and focal
adhesion formation resulting in up an osteoblastic phenotype. Previous research
has shown NH3+-SAMs expose more α5β1integrin binding domains, causing
differentiation of pre-osteoblastic cell (MC3T3-E1) to osteoblasts.[39] Similar
responses using VICs and primary osteoblasts also indicate the necessity of
α5β1 integrin binding is necessary for calcified nodule formation and osteoblastic
gene expression.[18, 53]
Conversely, it has been observed that COO- surfaces provide for greater
binding availability of αvβ3, and reduce mineralization by MC3T3s, which was
reversed when β3 binding was inhibited.[39] Furthermore, increased αvβ3
integrin expression in MC3T3s increases proliferation but down-regulates
expression of osteocalcin and other osteoblastic markers, similar to VICs on
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COO--SAMs.[54] Although some correlations between integrins are suggested in
the current data, a more complete examination of integrin expression and
phenotype is needed to better understand the importance and influence of
specific cell-material interactions on VIC phenotype. Once these are better
understood a correlation between in vitro and in vivo conditions can be sought.

Experimental Limitations
It is well understood that self-assembled monolayers allow control of
surface chemistry to investigate the effects of charge on cell behavior. However,
the use of gold-bound alkanethiolate SAMs on glass do present some
experimental difficulties for comparison with in vivo tissue development, primarily
though the use of stiff substrates [55] and two-dimensional environments. It has
previously been observed that VIC growth on stiffer matrixes results in greater
differentiation towards myofibroblastic and calcifying phenotypes.[6] However,
this is also a limitation of standard methods of in vitro expansion of VICs on
TCPS.
It is also well understood that variations in fetal bovine serum (FBS) alters
cell-behavior.[56] As batch-to-batch variations in FBS result in differences in
protein constituents, this work conducted with a single lot of FBS. To
accommodate for such changes, surfaces can be pre-incubated with specific
proteins to create of a more-homogeneous environment. However, even surfaces
treated for single protein interactions can become attenuated upon addition of
FBS proteins layer can dissociate and be replaced by new protein with higher
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affinities to the surface before cell attachment.[38, 43, 57] As such, when
attempting to control cell-surface interactions, it is important to characterize
protein adlayers or utilize well-defined surfaces such as SAMs to guide protein
adsorption.[43, 58]
Furthermore, species-specific differences exist between VICs in culture.
These differences lead to greater susceptibility of porcine VICs to develop
calcified nodules in vitro. However, the limited availability of human VICs and the
similarities between human and porcine heart tissue, make porcine VICs the
predominant cell type used to investigate the development of valve stenosis.[59,
60]

Conclusions
Although VIC activation and proliferation can result in calcified nodule
formation in confluent cultures, tissue mineralization is likely the result of several
distinct mechanisms in vitro. Through variations in surface chemistry we have
identified an osteoblastic-inhibiting environment (COO-), and surfaces which
possess characteristics of dystrophic calcification (CH3) and osteogenic
differentiation/calcification (NH3+). The rapid nodule formation by VICs on NH3+SAMs may provide an accelerated in vitro model of heart valve disease, although
additional studies remain to verify that our results resemble VIC differentiation in
aortic valve disease in vivo. While cell-signaling cascades will be the subject of
future investigations, these results clearly establish surface-dependent effects on
VIC phenotypic behavior. Using SAMs to study VIC behavior should also provide
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a clinically relevant guide the selection of biomaterials for heart valve implants
and tissue engineering scaffolds. Overall, these results establish the importance
of surface chemistry on VIC phenotypic behavior and establish SAMs as
excellent model surfaces for studying in vitro VIC differentiation.
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Figures

Figure 1. A) Schematic of alkanethiol self-assembled monolayer (SAM) on gold
(Au, 30nm) coated glass with chromium (Cr, 2nm) adhesion layer. B) Air-watersurface contact angles determined using the sessile drop goniometry (ultrapure
H2O in air).
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Figure 2. Valvular interstitial cell (VIC) proliferation on monolayer surfaces as
compared to bare glass/osteoblastic (OB) and gold controls (dashed lines). Initial
inhibition of VIC growth (1-3 days) is exhibited by OH and CH3-SAMs with
significant lower cell concentration, while osteoblastic (OB) controls are
significantly greater than other treatments. Between 3 and 5 days, VICs on OHSAMs begin proliferating while CH3-SAMs yields significantly lower cell
concentration throughout the experiment. By day 5, COO--SAMs have
significantly higher cell concentrations than any other treatment. Between five
and seven days in culture all samples, except CH3-SAMs, reach confluence. *p <
0.05, n = 6.
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Figure 3. Bright field (phase contrast) representative images of cell morphology
on varying surfaces chemistry compared to gold (Au) and osteoblastic controls
over seven days of growth. Day 5 and 7, insets show morphology and relative
size of nodules formed in culture, COO- surfaces did not show any nodule
formation over the course of this study. Further images can be found in online
data supplement. Scale = 50 µm, inset images same scale.
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Figure 4. Representative images of alizarin red S calcium staining after seven
days of growth. Arrows indicate distinct calcium-stained nodules. Scale = 50µm
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Figure 5. Measurement of valvular interstitial cell A) apoptosis and B) overall cell
death after seven days. CH3-SAMs result in significant increase of dead cells
over all other treatments. Cell death assessed through measurement of annexin
V activity (apoptosis) and propidium iodide infiltration (dead). *p < 0.05, n = 6.
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Figure 6. A) α-smooth muscle actin (αSMA) and B) osteocalcin (OCN) gene
expression (mRNA) by valvular interstitial cells (VICs) at later stages of growth
on functionalized surfaces. Initial expression of αSMA visualized through
immunocytochemical staining (data not shown) is reduced by day 5 on most
surfaces except NH3+-SAMs and osteoblastic controls, which have a significantly
higher in αSMA expression. NH3+-SAMs also express significant increases in
OCN expression (a late stage osteoblastic marker observed in between days 14
& 21 in osteoblast-like VICs) as early as day 7. *p < 0.05, n = 6.
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Figure 7. A) Collagen-I and B) Elastin genetic expression (mRNA) by valvular
interstitial cells (VICs) at three and five days of growth on functionalized surfaces.
After 3 days, collagen is up regulated on NH3+-SAMs and media induced
osteoblastic controls. Elevated collagen expression was also observed on CH3SAMs, but results were not statistically different from Au controls. Collagen
expression is significantly greater in all treatments between days 3 and 5. By day
5, all SAMs treatments are significantly lower than Au controls. * Indicates a
statistically significant difference (p < 0.05) between treatments and Au controls
and † indicates significant differences among SAMs treatments, n = 4.
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Table 1. Calcified tissue/nodule diameter after 7 days
Average Nodule Diameter (μm)
Treatment
Au
60.5 ± 27.0
CH3 †
221 ± 123*
OH
29.8 ± 10.9
COO
+ ‡
NH3
115 ± 39.8*
OB
(-) No nodules observed during culture
†
Highly irregular cellular aggregates, no distinct boundary
‡
Tightly bound, spherical calcium nodules
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Abstract
The macromolecule oligo(poly(ethylene glycol) fumarate) (OPF) exhibits
promising attributes for creating 3D hydrogel environments to study cell behavior,
deliver therapeutics, and serve as a degradable, non-fouling scaffold. However,
previous synthesis techniques were time consuming, contained salt
contaminants, and generated a large amount of solvent waste. These issues
have been overcome with an alternative, one-pot approach utilizing inert gas
sparging methods. Departing from previous synthetic schemes requiring acid
scavengers, sparging removes HCl byproducts in situ; eliminating significant
filtration and post processing steps while allowing for increased molecular weight,
and producing a more uniform product. Furthermore, nitrogen-sparged OPF (N2OPF) readily cross-links using either UV initiator or thermal initiator methods with
or without the addition of short chain diacrylate units which allows for greater
tunability in the material properties of the resulting hydrogels. Overall, sparge
synthesis provides a better polymer product for hydrogel material studies, while
maintaining degradable hydrogel characteristics.
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Introduction
Oligo(poly(ethylene glycol) fumarate) (OPF) has been extensively investigated as
a biodegradable hydrogel for use in tissue engineered scaffolds and drug
delivery [1-13]. The step-growth polymerization of polyethylene glycol (PEG) and
fumaryl chloride produces a linear polyester and hydrochloric acid byproducts.
The resulting oligomer consists of a repeating scheme of PEG and fumarate
which chemically crosslink through unsaturated double bonds into a non-fouling
hydrogel (Figure 1). The ability of OPF to undergo hydrolytic degradation through
ester hydrolysis gives OPF greater utility over previous PEG diacrylate hydrogels
[14-17]. Additionally, the physical properties of OPF can be easily tailored by
changing the PEG molecular length [1, 18]. Due to the presence of unsaturated
double bonds, modification of the oligomer backbone can also be achieved prior
to or during cross-linking with the incorporation of short chain polymers [4, 10].
Overall, these factors make OPF a desirable synthetic polymer for multiple
applications.
Originally developed by Jo, et al., the OPF synthesis procedure has not been
significantly modified since its inception [1, 2, 19]. However, several groups have
reported issues with removal of secondary reaction byproducts affecting
crosslinking efficiency and cell viability [20-22]. In order to trap hydrochloric acid,
groups have used acid scavengers such as triethylamine, potassium carbonate,
and sodium hydroxide [16, 23-28]. However, batch-to-batch inconsistencies in
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polymer product are common due to inefficient removal of insoluble hydrochloric
acid-acid scavenger salts [22].
Common in waste treatment and manufacturing procedures, sparging is a fast
and efficient method which can be easily introduced into the process
environment [29-33]. By bubbling a chemically inert gas such as nitrogen, argon,
or helium through a liquid, sparging allows for the removal of low boiling-point
solutes in real time, without post-processing steps [32, 33]. Furthermore, the
introduction of compressed gas into the system serves as a heat sync, through
adiabatic expansion, maintaining the low temperatures required for efficient stepgrowth polycondensation [34]. Through the introduction of gas sparging, we have
developed a one-pot, straight-forward, and improved method for the production
of OPF while simultaneously eliminating the complications of acid removal,
cooling, filtration and post-processing, and working with peroxide forming
chemicals.

Experimental Section/Materials and Methods
Reagents and Chemicals
Polyethylene glycol (PEG, Mn 4600, 1000, and 10000), fumaryl chloride (FuCl),
ascorbic acid (AA), IRGACURE 2959, trimethylamine (TEA), polyethylene glycol
diacrylate (PEGDA, Mn 575), deuterated chloroform (CDCl3), and tetrahydrofuran
(THF) were purchased from Sigma-Aldrich. Ammonium persulfate (APS, ACS
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grade) and ethanol were purchased from Fisher Scientific. Dichloromethane
(DCM), ethyl ether, ethyl acetate, anhydrous toluene (99.8%), and sodium
hydroxide were purchased from EMD. Whatman qualitative 413 filter paper was
purchased from VWR. The fine-fritted sparge/gas dispersion tube (CG-203-01)
was purchased from Chemglass.

Synthesis of Oligo(Poly(Ethylene Glycol) Fumarate) (OPF)
Polyethylene Glycol (PEG) Drying
PEG was dried by azeotropic distillation prior to use as previously described [2].
Briefly, 100g of PEG was added to 200 mL of toluene. At least 150 mL of toluene
and residual water were distilled off at 200˚C. Toluene was removed on a rotary
evaporator followed by drying in a vacuum oven overnight. Dried PEG was
stored in a desiccator until use.

OPF Oligomer Synthesis – Triethylamine (TEA-OPF)
TEA-OPF was prepared according to previously described methods [1, 2].
Briefly, dried PEG (100g) was dissolved in 700 mL of dichloromethane (DCM) in
a 1 L 3-neck round bottom flask set in an ice bath. Air was removed and replaced
with a nitrogen (N2) environment. Using molar ratios of 1: 0.9 PEG to fumaryl
chloride (FuCl) and 1:2 FuCl to triethylamine (TEA), FuCl and TEA were
dissolved in 60 mL DCM in separate addition funnels and simultaneously added,
157

dropwise, to PEG over 4 hrs. The reaction was stirred vigorously using a stir bar.
Upon complete addition of FuCl and TEA to the PEG solution, the reaction was
allowed to progress in an ice bath overnight, followed by solvent removal in
vaccuo. The product was subsequently dissolved in warm ethyl acetate, chilled
to recrystallize OPF, and filtered to remove trimethylamine hydrochloride salts.
This process was repeated three times. After the final collection, the OPF was
washed with ethyl ether, and fully dried under reduced pressure overnight.

OPF Oligomer Synthesis - Nitrogen Sparging (N2-OPF)
Similar to the TEA-OPF, dried PEG (100 g) was dissolved in 700 mL DCM in a
three-neck round bottom flask with stir bar and nitrogen environment. Sparging,
using nitrogen (N2), was introduced through central arm with a 24/40 adaptor
fitted with a fine-fritted gas dispersion tip and forced out through 90˚ flow control
adapter into a secondary vessel containing of 10 wt% sodium hydroxide in
ethanol (Figure 1B). Fumaryl chloride was dissolved in 60 mL DCM at a molar
ratio of 1:0.9 PEG to FuCl and added dropwise to PEG over 4 hours while stirred
vigorously. Upon complete addition of FuCl to PEG solution, DCM was added to
the reaction mixture to bring the volume back up to 700 mL. The reaction was
allowed to progress overnight with sparging, followed by solvent removal in
vaccuo.
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Characterization of OPF
Degree of Oligomerization
OPF products were characterized by 300M Hz 1H NMR (Bruker Avance III 300)
in CDCl3. Peaks were assigned to confirm the hydrogen binding environment.
The degree of polymerization was assessed through comparison of using peak
integration of olefin (6.87 ppm) and PEG (3.38-3.85 ppm) functional groups.

Molecular Weight
Molecular weight of OPF was determined through gel permeation
chromatography (GPC). Styragel HR 4 + 4E, 7.8x300mm (WAT044225,
WAT044240) columns were used to elute the samples at a 1mL/min flow rate on
an Agilent 1100 Series HPLC (Hewlett Packard, RID G1362A). Samples (3 mg)
were run in tetrahydrofuran (1 mL). Sample weight-average (Mw) and numberaverage molecular weights (Mn) were calculated as compared to polyethylene
glycol (PEG) standards (PL2070- 194, 440, 600, 1080, 1470, 4100, 7100, 12600,
23600, Polymer Laboratories/Agilent Technologies). The degree of
oligomerization (Xn) was determined using Equation 1:
̅̅̅𝑛̅ = 𝑀𝑛,𝑂𝑃𝐹
𝑋
𝑀

(1)

̅̅̅𝑛̅ = 1+𝑟
𝑋
1+𝑟−2𝑟𝑝

(2)

𝑛,𝑃𝐸𝐺

Here, Mn,OPF and Mn,PEG represent the number average molecular weight (Mn) of
OPF and monomeric PEG, as determined by GPC. Carother’s equation
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(Equation 2) was used to determine monomer conversion percentage, where r
represents the ratio of [fumaryl chloride]/[PEG] and p the monomer conversion
percentage [35].
Changes in molecular weight over time were measured by removing a small
volume (1 mL) of OPF product from both TEA-OPF and N2-OPF synthesis
reaction vessels over the initial 14 hours of synthesis in parallel reactions.
Solvent was removed in vacuuo and 3 mg of product were suspended in 1 mL
tetrahydrofuran. Refractive index intensity was normalized to the highest peak of
the eluted product.

Fluorescent Byproduct
Fluorescence of the polymer product was detected during GPC through the use
of a fluorescence detector (Hewlett Packard, FLD G1321A, Ex 250 nm, Em 410
nm) upstream of the refractive index detector; retention time difference approx. 1
min.

Melting Temperature and Crystallinity
Differential scanning calorimetry (DSC, TA instruments model 2920) was carried
out to determine the properties of OPF. The samples were analyzed at a heating
rate of 10 °C/min from 0 to 70 °C. Melting temperature (Tm) and the heat of
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fusion, ¢Hm (cal/g), were obtained from the thermograms. The percent
crystallinity (X) of OPF was determined from the following equation:
Δ𝐻

𝑋 = Δ𝐻𝑚
∗ 𝑥 100

(3)

𝑚

Here, H*m, is the theoretical heat of fusion of 100% crystalline PEG (49 cal/g) [36].

Yield
Percent yield was calculated by weighing the product recovered from the reaction
and dividing it by the weight of reagents originally added.
𝑤𝑒𝑖𝑔ℎ𝑡 𝑂𝑃𝐹 𝑓𝑖𝑛𝑎𝑙 𝑝𝑟𝑜𝑑𝑢𝑐𝑡

1.1.2. % 𝑌𝑖𝑒𝑙𝑑 = 𝑤𝑒𝑖𝑔ℎ𝑡 𝑃𝐸𝐺+𝑤𝑒𝑖𝑔ℎ𝑡 𝐹𝑢𝑚𝑎𝑟𝑦𝑙 𝑐ℎ𝑙𝑜𝑟𝑖𝑑𝑒
(4)
1.1.3.
Characterization of Crosslinked OPF Hydrogels
Crosslinking of OPF
OPF hydrogel products were crosslinked with and without polyethylene glycol
dimethacrylate (PEGDA) (Sigma Aldrich). The UV crosslinked formulations were
as follows; 25% (wt%) OPF, 0.5% Irgacure 2959 initiator, 74.5% DI water or
16.5% OPF, 8.5% PEGDA, 0.5% Irgacure 2959 initiator, 74.9% DI water. UV
formulations were exposed to 365 nm UV light in a UVP light box (CL-1000) for
15 min. The thermally crosslinked hydrogels had the same formulations stated
above, except 17.6x10-6 wt% (0.1 mM) ascorbic acid (AA) with 22.8x10-6 wt%
(0.1 mM) ammonium persulfate (APS) was added as a free-radical initiator
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instead of Irgacure 2959. Polymer solutions (1 mL) were transferred to syringe
molds before being crosslinked [21]. Thermally initiated formulations were placed
in the incubator (37° C) for 15 min to form hydrogels. Final products were then
dried overnight at room temp before being placed in the vacuum oven for 24
hours. TEA-OPF product only formed solid hydrogels when using thermal crosslinkers, 0.1 mM (AA/APS).

Water Ingress and Removal of Uncrosslinked Material
Hydrogels were weighed after drying in vacuum oven to measure the initial mass
of polymer (W i). Hydrogels were then soaked in 5 mL of deionized water and
allowed to swell. Hydrogel weights were recorded each day, for 4 days, until
mass loss was negligible. The maximum swollen weight (W s) was recorded.
Swollen gels were then removed from water and re-dried in the vacuum oven for
48 hrs before being weighed to measure the dry weight (W d). The water ingress
fraction was calculated by dividing the weight dry by the swollen weight (Equation
5). Sol fractions were calculated taking the weight initial minus the weight dry
divided by the weight initial (W i) (Equation 6).
𝑆𝑤𝑒𝑙𝑙𝑖𝑛𝑔 𝑟𝑎𝑡𝑖𝑜 =
𝑆𝑜𝑙 𝑓𝑟𝑎𝑐𝑡𝑖𝑜𝑛 =

𝑊𝑖 −𝑊𝑑
𝑊𝑖
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𝑊𝑠 −𝑊𝑑
𝑊𝑑

(5)
(6)

Hydrogel Elasticity
Twenty microliters (20 µL) of TEA-OPF and N2-OPF samples, using thermal
cross-linking formulations described above, were deposited onto AFM metal
specimen discs (TedPella, 16218) and placed in the incubator (37° C) for 15 min
to form hydrogels. Samples were swollen for four days by immersion in deionized
water. Force maps, comprised of force distance curves, were gathered over 10
x10 µm area of each hydrogel sample using a TL-FM tip-less cantilever
(Nanoworld) affixed with 5 µm silica microsphere (Bangs Laboratory, SS05N)
using thermal-set epoxy (Epon 1004F), see supplement for more information.
Elastic modulus and virtual deflection of each cantilever was calibrated prior to
hydrogel indentation using thermal methods, followed by deflection on a rigid
substrate (glass) [37][38]. The hydrogel elastic modulus was calculated using
Oliver-Pharr model fitting [39].

Results and Discussion
Synthesis and Characterization of OPF
The polymerization of oligo(poly(ethylene glycol) fumarate) produces a linear
polyester through the reaction of PEG and fumaryl chloride to form dimers,
trimers, and eventually oligomers, in a step-growth process. The primary
limitation of this reaction is the production of hydrochloric acid byproducts which
must be isolated to prevent secondary reactions. Previously, removal of
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hydrochloric acid was accomplished by acid scavengers such as trimethylamine,
potassium carbonate, or sodium hydroxide [16, 23-28]. In the current work,
previously published OPF synthesis using triethylamine was compared to a OPF
synthesis using nitrogen sparging. The use of sparging for the in situ removal of
hydrochloric acid eliminates the need for an acid scavenger, thereby avoiding the
production of hard to remove TEA salts.
For both reaction methods, formation of PEG/fumarate oligomers were confirmed
by 1H-NMR with the appearance of an ester bond peak at 4.33 ppm. The shift in
the olefin peak from 7.87 (fumaryl chloride) to 6.87 ppm indicates attachment of
fumaryl chloride to PEG (Figure 2).[40] Nitrogen-sparged OPF (N2-OPF) shows a
greater olefin (6.87 ppm) to PEG (3.38-3.85 ppm) ratio as well as a reduction in
signal from PEG hydroxyl end-groups (3.01 ppm) resulting in a greater degree of
oligomerization and larger molecular weight than triethylamine OPF synthesis
methods (TEA-OPF).[1] Size exclusion chromatography confirms a significant
increase in N2-OPF molecular weight over TEA-OPF (Figures 3A-4A&B).
Furthermore, the polydispersity index was lower for N2-OPF, indicating a more
homogeneous product (Figure 3A and Table 1). In side-by-side TEA-OPF and
N2-OPF reactions, temporal analysis of the product demonstrates a limited
maximum achievable molecular weight using TEA-OPF methods. After 4 hours,
the maximum molecular weight was obtained by TEA-OPF with no additional
oligomerization at subsequent time points. In contrast, the oligomerization of the
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N2-OPF method continues through 12 hours (Figure 4). In step-growth
processes, the final conversion, and hence the average molecular weight, is
affected by the concentration of condensation byproducts [41]. In situ removal of
acid byproducts during nitrogen sparging eliminates TEA salt formation allowing
for the synthesis of a higher molecular weight OPF (Figure 4A) [1, 22].
In contrast to the nitrogen sparge method, TEA-OPF synthesis requires the
additional steps of filtration, re-crystallization, and solvent washing in order to
remove acidic by-products [1, 2]. The incomplete removal of TEA salts during
work-up is apparent in 1H-NMR (1.4 ppm). The TEA-OPF also retains a brown
coloration even after repeated filtrations steps. Alternatively, the pure N 2-OPF
appears white immediately after synthesis and does not require additional
purification steps (supplemental Figures 7 & 8). Fluorescent analysis of eluted
product through size-exclusion chromatography reveals the presence of a
fluorescent molecule within TEA-OPF that is absent from N2-OPF (Figure 3B).
The fluorescent signal corresponds with the elution time of TEA-OPF oligomers,
indicating that the TEA salts are complexed to the OPF backbone. Cai and
Wang, 2010 have previously reported the formation of a cell-cytotoxic TEA
complexes during polymerization of fumaryl chloride in the presence of TEA that
cannot be completely removed during purification [22]. The inability to completely
remove the TEA salts limits the utility of the TEA-OPF.
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Thermal characterization of OPF by DSC shows that there is little difference
in crystallinity and melting temperature (Tm) among synthesis methods, see
Error! Reference source not found.. This data implies the OPF products to be
similar in composition. However, the slight decrease in crystallinity of N2-OPF
corresponds with the increased incorporation of rigid fumarate units which
prevent close-packing of the flexible PEG chains [1].

Characterization of Crosslinked Hydrogel Properties
To examine the cross-linking capabilities of N2-OPF and TEA-OPF, two
different commonly used, free-radical initiators systems were applied; ascorbic
acid/ammonium persulfate, a thermally activated initiator and IRGACURE 2959,
a UV activated initiator [1, 2, 20, 21, 42]. In addition, hydrogels were fabricated
with and without polyethylene glycol diacrylate (PEGDA), a copolymer commonly
used in the cross-linking of PEG-based hydrogels. Hydrogels successfully
crosslinked with ascorbic acid/ammonium persulfate and PEGDA for both TEAOPF and N2-OPF. However, UV initiated TEA-OPF/PEGDA and TEA-OPF
hydrogels did not cross-link adequately to maintain their 3D structure when
placed in water, and subsequently fell apart. In comparison, N2-OPF readily
crosslinked using both initiator systems with and without PEGDA, highlighting the
versatility of N2-OPF product (Figure 5-6). The inefficient removal of triethylamine
salts in the TEA-OPF synthesis method are likely a significant factor in the cross166

linking behavior of TEA-OPF. The brown color most likely limits UV intensity and
penetration into the gels and the TEA salts may interfere with the initiator as well
as the cross-linking reaction. In order to overcome the limitations of TEA-OPF,
previous groups have increased reaction time to an hour to fully crosslink TEAOPF [1, 18, 21]. As OPF is commonly used as a biomaterial for cell
encapsulation, minimizing UV exposure time reduces cellular cytotoxicity [20,
21]. Cross-linking of hydrogels was therefore limited to a 15 minute exposure
period, a time which has been shown to optimally balance the cross-linking
reaction with cell viability [21].
Fully crosslinked OPF hydrogels exhibited swelling characteristics dependent on
the synthesis method and the use of the cross-linking molecule. Using ascorbic
acid/ammonium persulfate as the thermal initiator and PEGDA as the crosslinker, there was no difference in swelling between TEA-OPF and N2-OPF
hydrogels. However, TEA-OPF/PEGDA did not cross-link using the UV initiator,
while N2-OPF/PEGDA did using either initiator. The choice of initiator did not
influence the swelling of the N2-OPF/PEGDA hydrogels. Only N2-OPF was able
to form crosslinked hydrogels without the addition PEGDA. As expected, the
absence of a cross-linking molecule resulted in a looser N2-OPF hydrogel with
greater swelling (Figure 5A) [17, 42]. Within the sol fraction data the only
observable trend is an increase in sol fraction with the exclusion of PEGDA,
indicating greater oligomer incorporation (Figure 5B&D).
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Mechanical testing of OPF hydrogels with and without PEGDA was conducted
utilizing colloidal nano-indentation methods (supplement). This method allows for
the measurement of elastic modulus at the submicron level of molecular
interactions, a factor important in characterizing OPF applicability for biomedical
and microscale material applications [14, 39, 43]. Similar to swelling and sol
fraction results, the mechanical properties of crosslinked OPF hydrogels were
solely dependent on PEGDA, not OPF synthesis method (Figure 6). Since N 2OPF is the only product that can be crosslinked with and without PEGDA, N2OPF can be fabricated into hydrogels of with a wider range of mechanical
properties, increasing its utility beyond that of TEA-OPF [44].

Conclusions
Through the use of nitrogen sparging, we have shown that OPF can be
produced with decreased post-processing, increased product purity, and greater
oligomerization. These properties lead to greater tunability in mechanical
properties and a more versatile hydrogel. Instead of using triethylamine as a
proton scavenger, in situ nitrogen gas sparging eliminates the need for postprocessing washes using ethyl acetate and ethyl ether, which have proven to be
inefficient while also being acutely toxic and potentially explosive through
peroxide formation. With greater oligomerization, N2-OPF has more unsaturated
double bonds per molecule that can be used for crosslinking and addition of
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covalently bound side chains. This straightforward method of fabrication should
allow for facile production that eliminates post-processing. The simplification of
synthesis and elimination of impurities will expand the utility of N2-OPF as a
degradable hydrogel for cell culture, tissue engineering, regenerative medicine,
and therapeutic delivery, among other applications.
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Supporting Information is available from the Wiley Online Library or from the
author.
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Figures and Tables

Figure 1. Glassware set-up for the polycondensation of fumaryl chloride (FuCl)
with polyethylene glycol (PEG) in dicholoromethane (DCM) using A) the acid
scavenger triethylamine (TEA) or B) nitrogen sparging (N2) to remove
hydrochloric acid (HCl) byproducts. C) Reaction schemes for TEA-OPF and D)
N2-OPF. E) Crosslinking structure of OPF oligomers through consumption of
unsaturated double bonds.
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Figure 2. 1H NMR spectra of 4.6K OPF from A) nitrogen sparging or B)
triethylamine acid scavenging methods. The presence of ester groups (b, 4.33
ppm) and olefin groups (c, 6.87 ppm) indicate bond formation and
oligomerization of OPF. NMR (300 MHz) measurements were carried out in
CDCl3 (7.24 ppm). Some residual dichloromethane can be observed at 5.26 ppm
with triethylamine contaminates at 1.43 ppm.
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Table 1. Properties of TEA-OPF and N2-OPF†

%
Synthesis
Method

%

Tm

Yield

[˚C]

Mn

Mw

[g/mol]

[g/mol]

Crystal.

PDI

Xn

(x)
TEA OPF

86.8 ±
9.2

60.7 ±
0.4

64.1 ± 2.1

7,779 ±
847

10,891 ±
1,368

1.4 ±
0.04

1.8 ±
0.2

N2 OPF

95.1 ±
3.0

60.3 ±
1.3

58.3 ± 3.4

13,097 ±
3,494

17,271 ±
3,632*

1.3 ±
0.1*

3.93 ±
0.8*

†All

OPF synthesized with 4.6k PEG; * (p <0.05) n = 3-4
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Figure 3. A) Representative elution profiles of OPF polymer products and
pure 4.6K PEG as determined by gel permeation chromatography. Decreased
retention time indicates higher molecular weight N2-OPF oligomers. B)
Fluorescence profiles of OPF products and 4.6K PEG were collected in series
with GPC. A large fluorescence peak was detected only in TEA-OPF indicating
unremoved triethylamine hydrochloride, Ex 250 nm/Em 410 nm.
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Figure 4. During synthesis small samples of A) N2-OPF and B) TEA-OPF
product were removed periodically over fourteen hours to and analyzed by GPC.
Each labelled peak (i-iv) corresponds to an increasing oligomer length. TEA
method limits molecular weight after addition of fumarate to reaction vessel (4
hours).
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Figure 5. Swelling ratio of crosslinked OPF hydrogels using A) thermal and C)
UV initiator methods. Sol Fraction of crosslinked OPF hydrogels using B) thermal
and D) UV initiator methods. Swelling of N2-OPF without PEGDA was
significantly greater than all other gels, †p < 0.05, n = 6. UV-initiated N2-OPF
with PEGDA had significantly lower sol fraction than N2-OPF without PEGDA,
††p < 0.05, n = 6. ∆ indicates gels did not cross-link sufficiently to be
characterized. N2-OPF is a more versatile polymer because it can be crosslinked
with and without PEGDA.
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Figure 6. Compressive modulus of thermally crosslinked TEA-OPF and N2-OPF
with and without PEGDA as compared to crosslinked PEGDA alone.
Compressive modulus was determined using atomic force cantilever nanoindentation with Oliver-Pharr fitting. N2-OPF without PEGDA was significantly
softer than hydrogels with PEGDA, * p < 0.05, n = 3. ∆ indicates gels did not
crosslink sufficiently to be characterized.
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Table 2. Qualitative comparison between synthesis methods
TEA-OPF

N2-OPF

Synthesis Time

2 Days

12-16 Hours

Molecular Weight

Variable-Low

High

Contaminates

Triethylamine Salts

N/A

Crosslinking

Requires Crosslinker

With and Without
Crosslinker

Post Processing

Ethyl Acetate / Ethyl Ether

N/A

Waste Production

Rxn Solvents + Solvent
Wash (x3)

Rxn Solvents

Synthesis Method
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Abstract
Studies have shown that surface chemistry can effect valvular interstitial
cell behavior in two-dimensional cell culture systems, however the threedimensionality of tissues is poorly emulated in monolayer environments. To
create more relevant models for the study of valvular interstitial cell behavior we
generated a hydrogel cell culture platform using polyethylene glycol and fumaryl
chloride. The resulting polymer oligo(polyethylene glycol) fumarate was
functionalized with specific alkanethiols along its backbone to control the charge
of the resulting molecules and crosslinked in three dimensional (3D) hydrogels.
This allowed for testing of valvular interstitial cell behavior in specific charged 3D
environments to determine how they affect VIC growth and differentiation in vitro.
In conclusion, charge alone was insufficient to induce VIC viability within the
hydrogels. Therefore, further modification of OPF with adhesion molecules will be
required for future research.
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Introduction
With an increasing elderly population, health care expenditures for aortic
valve disease (AVD) continue to rise. To address this increased burden better
treatments for AVD need to be developed [1]. Left untreated the likelihood of
death due to AVD is 50% within 2 years [2]. The current gold standard of
treatment for AVD is surgical replacement of the diseased valve. Typically
mechanical or decellularized biological valve replacements are used, but major
limitations in their requirement for anticoagulation therapy or their 5-10 year
limited lifespan before requiring replacement makes these valves undesirable for
long term use [3]. Creating a replacement valve that could last a lifetime without
deleterious effects, and could also be used as an accurate in vitro model for the
study of AVD is essential to advance AVD care.
In order to address these issues research is being conducted to develop
tissue engineered heart valve (TEHVs). TEHVs would overcome the current
limitations of mechanical and decellularized biological valves replacing them as
the gold standard of AVD treatment [3]. With the ability to integrate into the
surrounding host tissue and utilize the body’s natural repair functions, TEHV’s
would act just like native tissue [4]. Well-designed TEHVs could also be used as
relevant in vitro testing platforms to study the cellular mechanisms involved in
AVD progression and as models to develop and test therapeutic drugs. However,
the technology to grow functional TEHV tissue is still in nascent stages. Different
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strategies to create TEHVs utilizing natural polymers, deceullarized tissue, or
synthetic polymers are popular in literature, but a gap in knowledge exists in how
a cell’s growth, behavior, and differentiation are effected by the scaffold
environment they are grown on [5-10].
The main cells of the aortic valve, valvular interstitial cell (VICs), are
commonly used to grow and study aortic valve tissue. However, biological and
mechanical cues of the scaffold have been shown to alter valvular interstitial cell
(VIC) phenotype and behavior, but the cellular signaling mechanisms behind
these changes are not yet well defined [11-16]. Synthetic hydrogel platforms are
used to study cell signaling mechanisms because they offer the benefit of
isolating the effects of specific tailorable scaffold on cell behavior. This is due to
their innate ability to be modified with specific chemical moieties that alter
specific environmental conditions using simple chemistry. In addition, these
synthetic scaffold can be further modified and shaped into 3 dimensional (3D)
systems that better mimic the native tissue. Many synthetic materials also do not
interact directly with cell, so cells placed on/in a synthetic scaffold are forced to
interact with the engineered biologically active portions of these materials. As a
result cell culture systems can be designed with individual bioactive molecules or
with variations in a single mechanical property that can be reliably reproduced to
control and study the effect of specific environmental cues on cell behavior.
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A common synthetic polymer used to create hydrogels scaffolds for VICs
is polyethylene glycol (PEG) [8, 12, 17, 18]. PEG hydrogels are desireable for
their biocompatible hydrophilic properties, controllable pore size, mechanical
properties, and their ability to be chemically modified. In addition, PEG can be
polymerized and crosslinked through a number of chemistries to create 3D cell
culture environments. Recent examples of VICs grown on top of PEG base
hydrogels with an attached RGD, YGSIR, DEGA, or VAPG peptides have shown
that VICs attach and grow differently dependent on the adhesion sequence [17].
When a similar PEG hydrogel system functionalized with RGD, VGVAPG, or P15
peptides were used to encapsulate and culture VICs over a 42 day period,
differences in activation and extracellular matrix protein production were
observed [5].
While peptide functionalization of 3D hydrogel has been utilized in the
development of TEHVs, less research has been done to look at how the charge
of the hydrogel environment effects VIC behavior. Charge is of interest because
during embryogenesis the valves develop from the pericardial cushion, which is a
soft gel-like substance that has high concentration of the negatively charged
molecule hyaluronic acid and hyaluronan also makes up 60% of the
glycosaminoglycans in valve tissue [19]. These data suggest VICs naturally exist
within a negatively charge environment and recapitulating this environment in a
3D scaffold may help VICs to grow into healthy aortic valve tissue.
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In a recent study VICs were grown on 2 dimensional (2D) surfaces where
the chemistry of the underlying substrate was controlled [11]. It was found that
VICs grown on negatively charged 2D surfaces grew rapidly, did not express VIC
osteoblastic markers, and avoided confluence based nodule formation. However,
positively charged 2D substrates caused VICs to rapidly undergo osteoblastic
differentiation [11]. These results show that the surface chemistry of the
underlying substrate can effect cellular behavior in monolayer culture.
In order to transition into a 3D systems we used a PEG based polymer,
oligo(poly(ethylene glycol) fumarate) (OPF), to form functionalized hydrogels.
Unlike the previously described PEG hydrogels, OPF has a repeating
unsaturated double bond along the polymer’s backbone which can be
functionalized. OPF also has a repeating ester groups which can undergo
hydrolytic degradation allowing the hydrogel to slowly degrade and be replaced
by developing tissue over time. The repeating unsaturated double bond of OPF
allows the alkanethiol chemicals used in chapter 5, 11-mercaptoundecanoic acid
or 11-aminoundecanoic acid, to be attached to OPF to make a negatively charge
OPF (OPF-COO-) and positively charged OPF (OPF NH3+) functionalized
molecules. The slow degradation of OPF via hydrolysis means that the scaffold
can slowly degrade and allow new tissue growth to eventually take over the
scaffold. These functionalized OPF molecules can also be used to generate 3
dimensional (3D) hydrogel environments with encapsulated VICs to test how a
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negative or positively charged 3D environments effect VIC behavior. Based on
the observation of VICs in 2D culture we hypothesized that OPF-COO- 3D
hydrogels will promote VIC proliferation and prevent osteoblastic differentiation in
vitro.

Material and Methods
Synthesis of Oligo(Poly(Ethylene Glycol) Fumarate) (OPF)
OPF was synthesized as described in chapter 5. Briefly, 1K PEG (Sigma
Aldrich) was dried and fumaryl chloride (Sigma Aldrich) purified using distillation.
100g of dried PEG was dissolved in 700 mL of methylene chloride and placed in
a nitrogen environment. Nitrogen gas was continuously bubbled through the
liquid using a sparge and forced out through tubing into a base bath. Distilled
fumaryl chloride (1:0.9, PEG:FuCl) was dissolved in 60 mL methylene chloride
and injected at 10 mL/hour into the reaction vessel using a syringe pump. As
FuCl was added, DCM was added periodically added to maintain the reaction
volume at 700 mL. After 10 hours of stirring and addition of DCM the vessel was
left stirring overnight with nitrogen sparging. Upon completion, remaining solvent
was removed by rotary evaporation at 30°C followed by drying at a reduced
pressure in a vacuum oven overnight before being stored at -20 °C.
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GPC of OPF
The molecular weight of OPF was determined using a Waters Breeze
GPC system equipped with a 2707 autosampler, a 1515 isocratic HPLC pump,
and a 2414 refractive index detector. For each sample 10-20 mg of OPF was
dissolved in 2 mL of chloroform, run at 1 mL/min, and compared to a PEG A
16100, 3870, 1020, 410, 106; PEG B 21160, 8160, 1450, 615, 194 (Polymer
Laboratories/Agilent Technologies) standard to calculate the molecular weight.

Dialysis and Functionalization of OPF
Dried OPF was dissolved in 190 proof EtOH (ACS) at a 1:1 g/ml ratio and
sealed inside Spectra/Pore 7 Dialysis Membrane Pre-Treated RC tubing MWCO
1000 (Spectrum Labs). The membrane was transferred into a large covered
beaker with 100 times the sample volume in 190 proof EtOH and left stirring
overnight to remove any unreacted PEG. The next day dialyzed solution was
collected and dried using a rotovap at 30°C to remove the majority of solvent
before being transferred to a Pyrex dish and dried in a reduced pressure
environment overnight . To attach alkanethiols to dialyzed OPF, it was dissolved
in 0.1 M sodium bicarbonate (6:1 Buffer:OPF) with various amounts of 11mercaptoundecanoic acid (COO-) or 11-aminoundecanoic acid (NH3+) overnight
(Table 1).
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The reacted solution was dried on the rotovap at 50° C for 30 min to
remove most of the water. The left over solution was poured into a Pyrex dish
and finished drying at a reduced pressure in the vacuum oven overnight. The
final product was collected and stored at -20 °C in a sealed container.

Nuclear Magnetic Resonance (NMR) of OPF
6-10 mg of sample was dissolved in 2 mL of deuterated chloroform
(Sigma-Aldrich) and filtered using a 0.45 um nylon Aerodisc syringe filter to
remove salts (Fisher Scientific). 700 μL of filtered solution was transferred to 5
mm, 500 MHz NMR sample tubes (Wilmad LabGlass) and were read on a Bruker
Avance III 300 at 300 Hz for 1H NMR. The degree of functionalization was
calculated by using ratio of olefin (6.78 ppm) to PEG (3.4-4.0 ppm) peak
integration values between un-functionalized and functionalized OPF.

Crosslinking of Functionalized OPF Hydrogels
OPF, and OPF-COO- molecules were crosslinked using a UV initiator and
polyethylene glycol dimethacrylate (PEGDA). The formulations were mixed as
follows; 25 wt% OPF, 5% PEGDA, 0.05-1% Irgacure 2959 initiator, with
remaining wt% as Dulbecco’s Phosphate Buffered Saline without calcium or
magnesium (DPBS). Hydrogel were poured into 3 mL syringes to create a 2:1
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height to width sample before being exposed to 15 min of 365 nm UV light in a
UVP light box (CL-1000).

Primary Cell Extraction and Culture
VICs were isolated as previously described [20]. Porcine hearts were
shipped overnight from Hormel and aortic valve leaflets were excised. Leaflets
were incubated in collagenase type 2 (Worthington) in 199 medium (Hyclone)
before scraping to remove valvular endothelial cells (VECs). Residual VECs were
removed using CD31+ magnetic dynabeads (ThermoFisher Scientific). VICs
were cultured under normal conditions, 37 ⁰C with 5% CO2 in 199 EBSS Hyclone
growth media [10% Fetal Bovine Serum (FBS) (Hyclone), 1%
Penicillin/Streptavidin (Hyclone), and 1% Fungizone (Hyclone)] and allowed to
reach ~80% confluence before being frozen down and stored in liquid nitrogen.

Encapsulation of Cells
OPF, and OPF-COOFunctionalized OPF 1:0.27, 1: 1.1, 1: 1.7 (Alkanethiol:PEG molar ratio)
and unfunctionalized OPF hydrogels were crosslinked using the following
formulation; 25 wt% OPF/OPF-COO-, 2-5% PEGDA, 0.05-1% Irgacure 2959
initiator, and remaining wt% DPBS, with 1 x 106-5 x 106 cells/mL. 500 μL of
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solution was moved to 10 mL syringe molds before being exposed to 15 min of
365 nm UV light in a UVP light box (CL-1000). The resulting gels had a diameter
of 17.3 mm and were ~3 mm thick. After crosslinking gels were placed in 6 well
plates with 3 mL of growth media 199 medium a (Hyclone) with 10% FBS
(Gibco), 1% Penicillin Streptavidin (Gibco), 1% Fungizone (Gibco) and cultured
under normal conditions.

Live/Dead assay
Immediately after crosslinking and after 24 hours of incubation VIC
viability was analyzed using a Live/Dead Mammalian Cell Assay Kit (Life
Technologies). Briefly, media was removed from the wells and replaced with
live/dead solution (2 µM calcein AM and 4 µM EthD-1 in 199 medium). After 30
min of incubation hydrogels were washed with DPBS 2 time with a 5 min
incubation, and imaged on a Nikon Eclipse TS100 fluorescent microscope.

Results
Characterization and Functionalization of OPF
Using nitrogen sparging method from chapter 5, 1K PEG and fumaryl
chloride were used to synthesize OPF. The final product OPF had the chemical
structure expected seen via NMR with an olefin peak at 6.8 ppm, and PEG at
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3.2-4 ppm (Figure 1) [21]. GPC showed the average molecular weight (Mw) of
OPF was 6063 ± 706 and a polydispersity index (PDI) of 1.5 (n=4).
Successful functionalization of OPF with 11-mercaptoundecanoic acid
(COO-) or 11-aminoundecanoic acid (NH3+) was demonstrated via H1 NMR with
the appearance of a peak at 4.2 ppm and reductions of the olefin signal at 6.8
ppm, indicating a successful reaction of the thiol group on COO- or NH3+ to the
unsaturated double bond of the OPF backbone (Figure 1). In addition the amount
of functionalization of OPF with COO- was varied by adjusting the stoichiometry
of COO- to OPF in the reaction. Comparing the ratio of olefin (6.8 ppm) to PEG
peak (3.2-4 ppm) integration values before and after functionalization indicated
the percent of OPF double bonds consumed during functionalized could be
varied from 11-42% (Table 1). Although a higher levels of functionalization were
tested the resulting products did not crosslink under conditions acceptable for cell
encapsulation (data not shown).

Viability of Encapsulated VICs
Initial Live/Dead assays were conducted on VICs encapsulated in 25 wt%
OPF using 0.05-1% Irgacure 2959, 2.5% PEGDA, with the remaining wt% as
DPBS. Immediately after encapsulation Live/Dead was conducted and showed
greater viability (~80%) was observed when Irgacure 2959 concentrations were
limited to 0.1 wt% and below (Figure 2). Therefore, all experiments of VICs
197

encapsulated in OPF-COO- were run at 0.1 wt% Irgacure 2959 concentrations,
25 wt% OPF, and 5 wt% PEGDA, 70% DPBS. VICs were again encapsulated in
OPF by itself with 1X106 VICs and in OPF-COO- (1:0.27) at a higher
concentration of 5X106 cells/ml. Optical images show cells were successfully
encapsulated at both cell concentrations however live/dead indicates that the
majority of VICs died after 24 hours of incubation in all conditions (Figure 3).

Discussion
Previously, it is was shown that VICs grown on 2D surfaces with either a
positive and negative surface chemistry induced an osteoblastic or proliferative
healthy phenotype, respectively. This work focused on developing a 3D hydrogel
system with charged functional groups. OPF was synthesized using a 1K PEG
and had a final molecular weight of 6046. Therefore, each OPF molecule had an
average of ~5.2 olefin bonds per molecule. Traditional PEG hydrogels are
modified with acrylates to so they can only functionalized on one end and
crosslinked into a 3D structure on the other [22]. With OPF, however, the ~5
double bonds on available on the backbone of each OPF can functionalization
with more than one molecule and still are able to be crosslinked. Therefore OPF
has increased the utility and versatility as a molecule to create controlled
hydrogel environments.
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Crosslinking OPF into a hydrogel using Irgacure 2959 is initiated by the
generation of free radicals using UV light. Free radicals are known to be
cytotoxic, therefore optimization of Irgacure 2959 concentration for OPF hydrogel
crosslinking while maintaining VIC viability was assessed. The greatest viability
was observed at 0.05% Irgacure 2959 however the efficient hydrogel formation
occurred with 1% Irgacure. With ~80% viability in 0.1% Irgacure hydrogels this
concentration was chosen as the ideal condition to encapsulated VICs while
forming solid hydrogels (Figure 2).
Next OPF was functionalized with the alkanethiols 11mercaptoundecanoic acid or 11-aminoundecanoic acid using a thiol-ene click
chemistry to create OPF molecules with negative (OPF-COO-) and positive
(OPF-NH3+) charges (Figure 1). These OPF molecules were tailored to have
increase or decrease concentration alkanethiol moiety attachment by changing
the stoichiometry of alkanethiol to OPF used in the functionalization reaction
(Table 1). This simple method allows for the amount of charge within the final
hydrogel to be tailored while allowing for the possibility of attaching other
molecules, like peptides, to the same OPF molecule.
For VIC encapsulation studies OPF-COO- (1:1.7) 42% functionalization
was used to maximize the negative charge in the final hydrogel. We
hypothesized that this negative charge would be sufficient to help encapsulated
VICs proliferate and remain in an activated phenotype over time. However, 12
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hours after encapsulation under normal culture conditions all the VICs died. The
inability of VICs to adhere to the modified OPF-COO and OPF hydrogels is likely
the largest contributing factor to cell death. Due to the result seen with OPFCOO- hydrogels, OPF-NH3+ hydrogels systems will not be tested until VIC
viability is increased.
In the two dimensional system cell adhesion wasn’t an issue because
proteins from the serum added to media was able to quickly absorb to the
modified surfaces when cells were seeded. The VICs could then attach to these
absorbed serum proteins and survive [11, 23, 24]. In the hydrogel system the
serum proteins would have a hard time moving into the hydrogel so cell are
forced to attempt to interact with the OPF backbone or the functionalized
alkanethiols. The OPF backbone is made of PEG, which has previously been
shown to resist protein absorption and cellular interactions creating a blank slate
material [25]. In many studies to help VIC attachment to PEG, bioactive
molecules such as attachments peptides were covalently attach to the PEG
molecules [5, 8, 17, 26]. The fact that VICs did not survive in OPF-COO- suggest
that proteins from the media did not penetrate the hydrogel fast enough and were
unable to absorb to the alkanethiol molecules in the hydrogel to support cell
attachment. Therefore, the negative environment provided by the OPF-COOhydrogels by itself was not sufficient to support VIC attachment.
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Previous studies have added adhesion peptide RGD, P15, and YGSIR to
special PEG hydrogels, showing VIC viability out to 48 days of culture [15]. In
future studies with OPF it would be prudent to add some attachment peptides to
OPF in addition to the alkanethiols. With the peptide being immediately available
for VIC attachment they could survive the initial encapsulation and cell culture,
but still allow for the long term study of VIC growing in a charged 3D scaffolds.
A second theory for why the VICs didn’t survive is that there were not
enough alkanethiols present within the gel for VICs to bind. Unfortunately,
increasing the functionalization of OPF with alkanethiols above 42% inhibited
crosslinking. A strategy to overcome this issue would be to make OPF with a
smaller molecular weight PEG. The current length of OPF is limited by the steric
hindrance caused by the large PEG molecules. By decreasing the PEG
molecular weight more repeat units of PEG to FuCl could be oligimerized than
our current system and therefore would have more unsaturated double bonds per
OPF molecule that could be functionalized and crosslinking. The concentration of
the alkanethiols could then be increased and still have enough remaining
functional groups for crosslinking.

Conclusion
The understanding of how VICs react to scaffold cues is essential to the
production of healthy heart valve tissue. In this study the negative environment of
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the pericardial cushion created by the high concentrations of hyaluronic acid was
mimicked in a unique PEG based hydrogel system [27]. The molecule OPF was
functionalized with 11-mercaptoundecanoic acid to create a negatively charged
hydrogel environment with a carboxyl group being presented to encapsulated
cells. In contrast OPF was also functionalized with 11-aminoundecanoic acid to
create positively charge environment, which has been shown previously to
induce osteoblastic differentiation in 2D cultures [11].
Successful functionalization of OPF with COO- and NH3+ was
demonstrated as well as the ability to tailor the amount attached using
stoichiometric controls. This control creates a versatile hydrogel system were the
concentration of functionalized molecules can be easily altered for biological
studies. As the concentration of peptides has been shown to effect VIC behavior
in PEG hydrogels we hypothesized that changing the concentration of COO - in
OPF will similarly affect VICs in 3D hydrogels [17]. However, results showed that
a negative charge by itself was not enough to allow for VIC survival after being
encapsulated in this system.
In the previous 2D studies proteins could easily be absorb from the media
onto the surface that was completely covered in COO- or NH3+ surface
chemistries. The absorbed proteins in turn allowed for VIC to attach and grow on
the surface. In a 3D hydrogel system, however, the dominating the PEG
environment, a molecule known for its non-fouling properties prevents cell or
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protein attachments. Adding the alkanethiol 11-mercaptoundecanol to the
backbone should have helped to increase protein absorption to the gel, however
it was either not at a high enough concentration to effect the overall PEG
dominate environment or the proteins were not able diffuse into the hydrogel
quickly enough to help VICs adhere in the early stages of hydrogel swelling.
Therefore, future work with OPF functionalized with attachment peptides and
COO- need to be synthesized to create a 3D hydrogel systems in which VICs can
survive initial encapsulation.
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Figures and Tables
Table 1. Formulation for alkanethiol Functionalization of OPF
11-mercaptoundecanoic acid : OPF

0.27:1

1.1:1

1.7:1

11.1 ± 5.7*

28.2 ± 8.0*

42.2 ± 2.5*

5.4

21.0

35.0

(mol)
Double Bonds Functionalized (%)
NMR Calculation
Theoretical Functionalization (%)
* p=0.05, n=3
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NaHCO3

Figure 1. A) Scheme of OPF functionalization with 11-mercaptoundecanol or
11-aminoundecanol alkanethiol in sodium bicarbonate buffer reaction. H1 NMR
spectra of OPF (blue) and OPF functionalized with either B) 11-mercapto-1undecanol or C) 11-aminoundecanol alkanethiols. Appearance of the c peak
on functionalized OPF (red lines) indicates a covalent bond between the thiol
group of 11-mercaptoundecanol and 11-aminoundecanol to the backbone of
OPF.
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50 um

Figure 2. Live/Dead taken immediately after VICs (1x106 VICs/mL)
encapsulation in OPF using 0.05% to 1% wt Irgacure 2959 with 15 min of UV
exposure. At 0.1% Irgacure 2959 and below VICs show ≤ 80% viability.
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Figure 3. A) Optical image of VIC encapsulate in OPF-COO- hydrogel after
24 hours of incubation. Live/dead images of VIC in B) OPF-COO- and c)
OPF-COO- after 24 hours of incubation.
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Chapter 8
Conclusion

Summary
In the realm of tissue engineered heart valves (TEHV) there are many
concepts that need to be expounded to successfully grow tissue in the
laboratory. In this work, we have examined some specific questions about in vitro
aortic valve (AV) tissue growth including; which subpopulation of heart valve cells
should be used to grow aortic valve tissue models and how specific mechanical
and chemical properties of the scaffold influence cellular behavior and
differentiation. To answer these questions specific tunable properties of tissue
growth environments were identified. These properties were then systematically
engineered into an in vitro model to create experimental systems used to study
the effect of each property on valvular interstitial cells (VICs) growth and
behavior.

Specific Aim 1: Identify relevant VIC subpopulations for tissue engineering.
The first question investigated in this work was whether unique cell
subpopulations could be readily separated out from a heterogeneous VICs
population. Use of a heterogeneous population of VIC is problematic due to
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observed changes in propensity for disease arising from different locations within
the valve [1, 2]. Each aortic valve leaflet is comprised of spatially and structurally
defined layers; the fibrosa, spongiosa, and ventricularis [3]. These three layers
are integral to the proper opening and closing of the AV, have distinct
extracellular matrix (ECM) structures and composition, and also exhibit specific
mechanical properties [4]. On the arterial side of the valve the fibrosa contains
large collagen 1 fibrils, which provide mechanical stability and withstand the high
pressures experienced on the valve when it is closed. Directly underneath the
fibrosa is the spongiosa. This layer is primarily composed of sulfated
glycosaminoglycans, which absorb mechanical stress by dampening the force
exerted on the valve during valve cycling [4]. On the bottom side of the AV is the
ventricularis. Comprised primarily of elastin, the ventricularis is highly elastic and
returns the valve to a closed position after ejection of the blood from the heart. In
vitro both ECM and mechanical properties have been shown to alter the behavior
of many different cell types [5-7]. In the case of the AV it has also be observed
that calcific nodule formation generally starts in the fibrosa layer of the AV [1, 2].
It has been observed that VICs induced to an osteoblastic phenotype (OB VICs)
using osteoblastic induction media as well as a small population of VICs in
normal culture take much longer to detach during passaging [8]. Taking
advantage of this natural phenomenon, we separated the heterogeneous VIC
population taken from the valve into less adherent or more adherent VIC
subpopulations. We hypothesized that attachment and focal adhesion formation
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cause different subpopulations to express different phenotypes in culture.
However, without a rapid method to isolate each VIC subpopulation the study
and identification of these specific subpopulations remains difficult.
In chapter three, differences in adhesion were utilized to separate VIC
subpopulations in vitro, characterize each subpopulation, and identify unique
protein surface markers. The more adherent subpopulation exhibited increased
expression of osteoblastic gene markers, proliferated significantly slower, and
had a rhomboidal morphology similar to osteoblastic media induced OB VICs.
This more adherent subpopulation may be useful for developing diseased
models to study the mechanisms behind AVD or as an in vitro platform for the
development of therapeutic drugs. In contrast, the less adherent VIC
subpopulation which proliferated rapidly and did not express OB gene markers
are better suited for tissue engineering aimed at growing healthy valve tissue.
To further distinguish these subpopulations integrin proteins were
investigated due to their involvement in cell substrate adhesion, ability to alter
cell phenotype, and the natural difference in attachment strength seen between
our subpopulations. We found that the integrin αvβ3 was upregulated in the more
adherent VICs but was not present in the less adherent VIC subpopulation. In
combination with data showing the osteoblastic nature of more adherent VIC
subpopulation we can concluded that increased αvβ3 expression on the surface
of the VICs correlates with the OB VIC phenotype.
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Future work could take advantage of the differences in αvβ3 expression
and use as a unique surface maker to sort OB VIC subpopulations. If VICs could
be separate directly from freshly excised valves using methods such as
fluorescence activated cell sorting, the environmental stresses caused by
passaging in this study could be bypassed. Another positive aspect of sorting
would be that extraction of purified VIC subpopulations with specific phenotypes,
which could be used to develop more accurate models of AV health or disease.
To our knowledge no other surface marker has been identified that could be used
to distinguish between activated and OB VIC phenotypes, making this work
impactful to the field of AV cell biology.

Specific Aim 2: Define environmental factors that will create the ideal substrate to
grow valvular interstitial cell models of health or disease.
The next question addressed was whether the mechanical or chemical
properties of the scaffold affect the growth and differentiation of VICs. During
valve aging and disease valve thickening and tissue deposition result in
increased stiffness of the valve [9]. Conversely, during embryogenesis as the AV
develops from the endocardial cushion, large amounts of the negatively charged
polysaccharide hyaluronic acid (HA) are expressed and serve as scaffold from
which the healthy valve develops [10, 11]. With a terminal carboxylic acid group
repeating along its backbone, HA is the dominant molecule in the endocardial
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cushion and results in a negatively charged environment. From these two
observations, we hypothesized that physical cues like mechanical stiffness and
substrate charge affect VIC growth and phenotype in vitro. To investigate these
behaviors, in chapters 3 and 4 we engineered two environmental properties into
unique cell culture systems designed to isolated and mimic the cues of
mechanical stiffness and environmental charge observed in vivo.
In chapter 3 the co-polymer system dietheylenegycol dimethacrylate and
n-Octyl methacrylate (DEGDMA/nOM) was utilized to test the affect of increasing
substrate mechanical stiffness on VICs behavior. Using this FDA approved
dental material we generated cell culture platforms that could be mechanically
tailored without altering surface chemistry [12, 13]. Three different stiffness
ranges were created with the softest having a compressive modulus close to that
of the native heart valve at 25 kPA [4]. This soft substrate allowed VICs to
proliferate, but did not induced osteoblastic differentiation. In comparison, when
VICs were grown on the surfaces with the greatest stiffness level (4700 kPa),
they underwent osteoblastic differentiation upregulating osteoblastic gene
markers and forming calcific nodules in culture. This study indicates that stiffness
of the underlying substrate alone is able to cause VICs to undergo osteoblastic
differentiation. Since the VIC OB phenotype is responsible for calcific nodule
development in AVD, stiff biomaterials should be avoided for future TEHV
studies.
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A main limitation of this work was the reduced adhesion of VICs to
DEGDMA/nOM in comparison to TCPS cell culture flasks. Future work could
alleviate this issue by plasma treating the surface of DEGDMA/nOM. This
method oxidizes the surface of the DEGDMA/nOM decreasing its hydrophobicity
and thereby promoting cellular attachment [14]. This technique is commonly used
on tissue culture polystyrene (TCPS) which is universally used in the growth of
adherent cell lines.
In summary, using DEGDMA/nOM highlights the importance of material
stiffness in VIC behavior. The softest material (25 kPa) showed sufficient VIC
proliferation and avoided the expression of osteoblastic markers and calcified
nodules. Previous research has shown that materials with compressive modulus
lower than 2-8 kPa promote a quiescent VIC state that fail to proliferate [15, 16].
Therefore, we hypothesize that an ideal biomaterial for the growth of healthy
aortic valve tissue from VICs should possess a compressive modulus between 225 kPa. This stiffness range should better allow VICs to be grown into healthy
tissue and influence the next generation of biomaterials.
Using a well characterized cell culture system, alkanethiol self-assembled
monolayers (SAM), in chapter five we investigated the growth and behavior of
VICs on 2D surfaces with different charge and hydrophobicity [17]. While each
surface resulted in distinct VIC behaviors, the surface most interesting for tissue
engineering applications was alkanethiol 11-mercaptoundecanoic acid (COO-).
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When VICs were cultured on COO- SAM’s they proliferated quickly, resisted
nodule formation after reaching confluence, and did not express osteoblastic
gene markers. In comparison positively charged 11-aminoundecanthiol (NH3+)
functionalized SAMs resulted in rapid and robust osteoblastic differentiation with
nodule formation, upregulation of osteoblastic diseased gene markers, and
exhibited pronounced αSMA stress fiber formation and expression after 3-5 days
in culture. This indicates that negatively charged surfaces can help prevent VIC
differentiation to an OB phenotype. Therefore, future iterations of biomaterials
should be engineered with negatively charged surfaces to help maintain a
proliferative and healthy VIC phenotype for future TEHV studies.
To our knowledge this is the first time that the differentiation of VICs has
been shown to be dictated solely through surface chemistry. In comparison to
classic OB media induction, which activates cellular signaling cascades with
soluble factors like transforming growth factor beta 1, dexamethasone, βglycerolphosphate, or ascorbic acid, we hypothesize that VICs on COO- SAMs
and NH3+ SAMs are interacting with the culture surfaces through adhesion based
mechanical receptors that induce changes in VIC differentiation [18]. Therefore,
we hypothesize that an ideal biomaterial for the growth of healthy aortic valve
tissue from VICs should possess a negatively charged environment. Conversely,
a positive charged biomaterial could be a very effective method to create a
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diseased cell model to study AVD development, progression, and could be used
as a platform to develop novel AVD therapeutics.
Future work also needs to be done to look more closely at how these cellmaterial interactions occur in both the DEGDMA/nOM and SAMs VIC systems. It
is generally accepted that cells don’t attach directly to synthetic materials.
Instead the material absorbs proteins to the surface or is modified with
biologically active molecules that allow cell attachment [19-21]. In the case of the
2D models discussed, the concentration and bioactivity of serum proteins
absorbed onto the surface of our materials is being investigated for their
responsibility in controlling cell attachment and behavior. It has been shown that
surfaces do not only preferentially absorb certain proteins but that protein
confirmation and availability of cellular adhesion domains can be affected by
surface chemistry [21-25]. Therefore, investigating absorbed proteins as well as
protein confirmation on the different SAMs surfaces and DEGDMA/nOM will be
important in further studies defining the driving factors in VIC phenotype.
Another interesting concept that arises from the work of chapters 3 and 4
relates back to the current method to grow VICs in vitro. In almost every lab,
TCPS flasks are routinely used to grow and expand every type of adherent cell in
vitro . With a modulus of 20 GPa, 4 times greater than the osteoblastic-inducing
DEGDMA/nOM substrates in chapter four, TCPS is unsuited for TEHV studies
[26]. However, as TCPS undergoes plasma treatment to create a negatively
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charged environment for cell attachment, confounding factors in cellular signaling
are likely at work [14]. The combination of negative charge and high stiffness of
TCPS may help to explain why VICs grow so well on this material, but form
nodules at confluence. From these data, it is likely that the first cell culture
environment VICs encounter in the laboratory induces them toward a diseased
OB phenotype and we should reconsider using TCPS to expand VICs in the
future [27, 28].
Through the use of these model surfaces, it has also become apparent
that the use of alpha smooth muscle (α-SMA) as a marker of activated or
myofibroblastic VICs (aVICs) can lead to misinterpretations in VIC phenotpye.
Classically aVICs proliferate rapidly, produce ECM proteins, expresses α-SMA,
and are thought to be the most useful phenotype for producing tissues in the lab
[15, 29, 30]. However, in our studies α-SMA was expressed highest in more
adherent, disease prone VICs. If this gene is highly upregulated in the
osteoblastic phenotype as well as an activated phenotype it needs to be used in
conjunction with additional markers of osteoblastic differentiation like runx-2,
osteocalcin, and osteopontin to help identify which treatments are creating aVIC
versus OB VICs [7, 31-33].

Specific Aim 3: Develop a modifiable 3D hydrogel system to elucidate the effects
of microenvironmental cues on VIC behavior in 3D.
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The final goal of this dissertation, chapters 5 and 6, was to synthesize a
synthetic polymer to create tailorable three-dimensional hydrogels to test the
effect of chemical and mechanical cues on VIC behavior. With previous studies
conducted on 2D monolayer surfaces, we recognized the need to investigate cell
behavior in a more biologically relevant 3D platform that mimics the structure and
properties of the aortic valve. Creating a modifiable cell culture platform would
help to bridge this understanding in cell behavior in more complex environments.
To this end, the polymer oligo(polyethylene glycol) fumarate (OPF) was chosen
to create a mechanically tunable, 3D culture system with unsaturated double
bonds along its backbone which could be chemically modified to control the local
environment. These modified OPFs can then be crosslinked together to create a
3D hydrogel cell culture scaffolds with well-defined environments.
The original synthesis method for producing OPF (TEA-OPF), published
in 2001 by Jo S. et al., had major limitations due to a long synthesis time and
inability to completely remove triethylamine HCl salt byproducts [34].
Triethylamine HCl salts have been shown to be cytotoxic to cells as well as
interfere with crosslinking, therefore we sought a new synthesis method that
would eliminate this problem [35]. Chapter 5 discusses our strategy to address
this issue with a new synthesis method utilizing nitrogen gas sparging to
generate OPF (N2-OPF). This technique removes hydrochloric acids in situ,
precluding the need for triethylamine during synthesis and therefore the
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generation of cytotoxic triethylamine HCl salt byproducts . As a result of fewer
post-processing steps in the nitrogen sparging method, synthesis time is also
decreased while yield was increased. These optimizations resulted in a cleaner,
higher molecular weight N2-OPF polymer product which is advantageous for
downstream applications, such as modifying the OPF backbone. Overall, the
advantages of using nitrogen sparging make OPF a far better product that
standard TEA-OPF methods.
In chapter 6 we utilized our superior synthesis method to generate N2OPF to develop tunable 3D hydrogel environments for VIC growth. As discussed
previously, the surface chemistry of a scaffold effects VIC behavior and our focus
was to show that OPF can be modified with the same alkanethiol molecules used
in chapter five. Addition of alkanethiols to the backbone of OPF creates modified
OPF molecules that have a negative or positive charge dependent on the
alkanethiol attached. These charged OPF molecules were then crosslinked to
form 3D cell culture environments. We have shown that both 11mercaptoundecanoic acid and 11-aminoundecanol can be attached to OPF using
a simple thiol-ene click chemistry. OPF functionalized with 11mercaptoundecanoic acid (OPF-COO-) was then tested for its crosslinking ability.
As the OPF molecule is functionalized with more COO- alkanethiol molecules it
becomes more charged but has less double bonds available to be utilized for
crosslinking. Therefore, a balance between functionalization and remaining
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double bonds for crosslinking had to be found. To allow for a highest percentage
of thiols functionalization to OPF the molecule PEDGA was added the help
facilitate crosslinking of the modified molecule into solid hydrogels. This strategy
allowed for OPF ranging from 11-42% of double bonds functionalized with
alkanethiols to still for a solid hydrogel charged environments.
After showing OPF-COO- could be crosslinked successfully, VICs were
added to OPF-COO- and crosslinked into a three-dimensional hydrogel. Livedead studies show that while VICs survive the initial encapsulation and
crosslinking of the hydrogel they do not survive past 24 hours. We hypothesize
this is due to their inability to bind to the OPF hydrogel. One explanation for the
die off of VICs after 24 hours is that the small alkanethiol molecule is too close to
the OPF PEG backbone. This steric hindrance by the large PEG molecules make
the thiol unavailable to absorb serum proteins which are need for VIC
attachment. Future work could alleviate this issue by attaching the alkanethiol
molecules to the end of a pendent group before attaching it to the OPF
backbone. This will cause the alkanethiol to stick out more from the backbone
and thereby increase its availability for interactions.
A second possibility is that VICs were unable to bind to the hydrogel
because proteins were unable to penetrate and be absorbed to the inside of the
hydrogel. In 2D systems serum proteins are easy absorbed to the flat surface
and cells can attach to these absorbed proteins. In a hydrogel system however
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proteins have a much harder time diffusing into the hydrogel and coating the
surfaces to allow for cellular attachment. In addition, the main component of our
hydrogel, PEG, has previously been shown to prevent protein absorption. We
hypothesized that adding a charge to the hydrogel would increase the absorption
of proteins but is seems this was not the case. As a result, the encapsulated
VICs have nothing to attach to after encapsulation and as an adhesion
dependent cell, they eventually die.
In future work, functionalizing the OPF backbone with the attachment
peptide RGD will help to alleviate this issue of cellular attachment. VICs will be
able to attach immediately onto the RGD peptides after encapsulation thereby
allowing for the survival of the attachment dependent VICs. Further culture of
VICs within these negatively charged OPF-COO- hydrogels can then be
assessed to understand how 3D charged environments affect VICs growth and
behavior. Additionally, OPF functionalization is not limited to RGD peptides and
alkanethiols, any molecule that can dissolve in water and has a free thiol group
can be attached to OPF using a thiol-ene click chemistry. This makes OPF a
highly versatile material that could be functionalized with a large array of
bioactive molecules.

Broader Impacts
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Overall this dissertation impacts the future design of biomaterials and
laboratory practices of aortic valve tissue engineering. It is important that any
biomaterial used to grow aortic valves in the laboratory be near the same
modulus as the aortic valve tissue since substrate stiffness alters the cellular
behavior of valvular interstitial cells. The ideal material should lie between the
somewhere between 2-25 kPa [15, 16]. Although the perfect stiffness is not yet
defined this work helps to define the upper limit of this range significantly
decreasing the range that should be used to engineered and developed future
biomaterials.
Additionally, the use of TCPS as the standard material being used to
expand valvular interstitial cells needs to be reconsidered. The high modulus
near 20 GPa is four times higher than the stiffest DEGDMA/Nom substrate [26].
Current research practices isolate VICs from the valve and then expand them in
TCPS flask and wells plates. This means VICs are immediately being exposed
to stiff mechanical cues that were shown in this work to cause VIC osteoblastic
differentiation.
This work also reflects the first experiments to examine how the surface
chemistry of materials can alter VIC behavior. Our work using 2D model selfassembled monolayers shows that a substrate with positive charge induces OB
VIC differentiation while a substrate with a negative charge allows for VIC
proliferation and maintenance of the aVIC phenotype. This not only suggests
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mechanically activated cell signaling pathways can control VIC behavior, but also
indicates that designed future scaffolds with negatively charged surfaces will help
VICs to form healthy valve tissue.
Finally we started translating this work into a 3D cell culture system using
the polymer oligo(poly(ethylene glycol) fumarate) (OPF). With our new synthesis
method this unique molecule can now be synthesized rapidly in a pure form that
enables us attach alkanethiols and create OPF molecules with a charge. In
addition these molecules can be tailored to have increased or decrease amounts
of charge and can be generated with varying Mw PEG molecules to alter the final
hydrogels stiffness.
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